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Abstract 
 
The innate immune system protects against infection but also drives inflammatory 
disorders. Key molecular drivers of both processes are ‘inflammasomes’, multi-protein 
complexes that assemble in the cytosol to activate the protease, caspase-1. Active 
caspase-1 cleaves specific proinflammatory cytokines [e.g. interleukin (IL)-1β] into their 
mature, secreted forms, and initiates a form of inflammatory cell lysis called pyroptosis. 
Inflammasomes are assembled by select pattern recognition receptors such as NLRC4, 
NLRP3, AIM2, or via a non-canonical pathway involving caspase-11.  
 
Whilst inflammasomes functions have been intensely researched, the cell types mediating 
inflammasome signalling in distinct in vivo settings were unclear. Neutrophils are one of 
the first cells to arrive to a site of infection or injury, and thus have the opportunity to detect 
inflammasome-activating molecules in vivo, but their ability to signal by inflammasome 
pathways had not been closely examined. This thesis offers a detailed investigation of 
NLRC4, NLRP3 and caspase-11 inflammasome signalling in neutrophils during in vitro or 
in vivo challenge with whole microbe, purified microbial components, or adjuvant. 
 
This thesis demonstrates that acute Salmonella infection triggered NLRC4-dependent 
caspase-1 activation and IL-1β processing in neutrophils, and neutrophils were a major 
cellular compartment for IL-1β production during acute Salmonella challenge in vivo. 
Importantly, neutrophils did not undergo pyroptotic cell death upon NLRC4 activation, 
allowing these cells to sustain IL-1β production at a site of infection without compromising 
their crucial inflammasome-independent antimicrobial effector functions. Since IL-1β drives 
neutrophil recruitment and activation, the finding that neutrophils themselves produce IL-
1β suggests neutrophils perform novel and important auto-regulatory functions during 
infection. 
 
Neutrophil NLRP3 pathways were next examined. In macrophages, diverse molecules can 
trigger NLRP3 activation. Some of these agonists are insoluble molecules (particles or 
crystals), which activate NLRP3 through lysosomal rupture. Interestingly, the neutrophil 
NLRP3 inflammasome selectively responded to soluble, but not insoluble, NLRP3 
agonists, and lysosomal rupture was a weak stimulus for neutrophil NLRP3 activation. This 
finding was replicated in vivo, where neutrophils did not significantly contribute to IL-1β 
production during alum-induced peritonitis. 
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Prior studies in macrophages demonstrated that NLRP3 activation triggers the 
oligomerisation of the inflammasome adaptor ASC, which then recruits two caspases, pro-
caspase-1 and -8. Inflammasome-activated caspase-8 initiates macrophage apoptosis in 
parallel to caspase-1-dependent pyroptosis. This thesis shows that like macrophages, 
neutrophil NLRP3 activation triggered ASC oligomerisation, caspase-1 cleavage and IL-1β 
secretion, but unlike macrophages, caspase-1 activation did not induce cell lysis, 
suggesting that resistance to pyroptosis is a universal feature of neutrophil inflammasome 
pathways. Neutrophils also appeared unable to undergo NLRP3/ASC/caspase-8-
dependent apoptosis, likely due to inefficient caspase-8 self-processing. This finding 
prompted examination of other caspase-8/NLRP3 pathways in neutrophils. Chemical 
inhibition of the inhibitor of apoptosis proteins (IAPs) in LPS-primed macrophages leads to 
RIPK3 activation and formation of a caspase-8 activating platform, the ripoptosome, which 
promotes apoptosis and can cleave pro-IL-1β into its mature form. If caspase-8 activity is 
suppressed, RIPK3 forms a different molecular complex, the necrosome, to induce 
necroptosis. In macrophages, ripoptosome and necrosome signalling induces NLRP3 
inflammasome activation and downstream caspase-1 activity. Surprisingly, blockade of 
IAP function was a weak stimulus for cell death in LPS-stimulated neutrophils, and did not 
trigger caspase-8-dependent IL-1β maturation or NLRP3/caspase-1 activation, suggesting 
that NLRP3 regulation by RIPK3/IAPs is differentially regulated in macrophages versus 
neutrophils.  
 
Caspase-11 functions are important for host defence against cytoplasmic Gram-negative 
bacteria, but also contribute to pathological immune responses in murine models of septic 
shock. Like caspase-1, caspase-11 induces pyroptosis. But caspase-11 appears unable to 
directly cleave cytokines, and instead triggers pro-IL-1β/18 processing through activation 
of the NLRP3 inflammasome. Because neutrophilia is a hallmark of sepsis, and 
neutrophils produce NLRP3-dependent IL-1β without concomitant cell death, the possibility 
that neutrophils contribute to septic shock was next investigated. Neutrophil exposure to 
intracellular LPS in vitro indeed triggered caspase-11-dependent IL-1β production but not 
cell death. Nlrp3-/- mice, like Casp11-/- mice, were protected from lethal endotoxin shock, 
suggesting that caspase-11/NLRP3-dependent cytokine production may contribute to LPS 
lethality. Importantly, prior neutrophil depletion protected wild type but not Casp11-/- mice 
from endotoxic shock. Although further investigations are required, these data suggest that 
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neutrophils may be a sustained cellular source of caspase-11/NLRP3-dependent, 
pathogenic IL-1β during murine endotoxic shock. 
 
In summary, this thesis demonstrates that neutrophils signal via specialised inflammasome 
pathways to maximise host responses during pathogen challenge in vivo. The finding that 
neutrophils themselves secrete IL-1β to drive their own recruitment, activation and survival 
is in line with an emerging theme that neutrophils perform important immunoregulatory 
functions during infection. Although neutrophils are often regarded as pro-apoptotic cells, 
this thesis reports that, surprisingly, neutrophils resist all known forms of inflammasome-
induced cell death. Presumably this allows neutrophils time to exert their important 
functions in host defence, but may also contribute to sustained cytokine production and 
thus pathology in inflammatory diseases such as endotoxic shock. The interplay between 
inflammation and neutrophil cell death warrants further examination to understand the 
underlying mechanisms of neutrophil-driven inflammatory disorders. 
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1. Introduction 
The innate immune system provides the first line of defence against infection and co-
ordinates tissue repair during injury.  Cells of the innate immune system use germ-line-
encoded receptors called pattern recognition receptors (PRRs) to recognise conserved 
microbial structures or host-derived molecules released during cellular or tissue damage, 
known as pathogen-associated molecular patterns (PAMPs) or danger-associated 
molecular patterns (DAMPs) respectively (1) . PRRs are primarily expressed in cells at the 
front line of defence against infection, including macrophages, dendritic cells (DCs), 
neutrophils and epithelial cells. Engagement of PRRs initiates signal transduction 
pathways that culminate in the elimination of pathogens and/or tissue repair. A major 
proinflammatory pathway conferring host defence against infection is triggered by 
molecular complexes called ‘inflammasomes’ that are assembled by select members of 
the NOD-like receptor (NLR), pyrin and HIN domain-containing (PYHIN) protein families of 
‘danger’ sensor proteins (2). The pyrin domain (PYD)-containing protein, PYRIN was also 
demonstrated to facilitate inflammasome assembly (3). Upon direct or indirect ligand 
sensing, inflammasome-forming NLR, PYHIN protein family members and PYRIN 
oligomerise and recruit partner proteins. Inflammasome complex assembly facilitates the 
activation of the protease, caspase-1, and downstream immune activation (2, 4). 
 
Caspases are a family of cysteine proteases involved in cell death and inflammation. 
There are currently 13 caspases identified in humans and mice and their functions can be 
broadly divided into apoptotic or inflammatory caspases (5). The apoptotic caspases 
include caspase-2, -3, -6, -7, -8, -9, -10 and -14 while caspase-1, -4, -5, -11 and -12 
comprise the subgroup of inflammatory caspases (5). Caspase-8, -9 and -10 are caspases 
that are involved in the initiation of apoptosis. These initiator caspases contain a large pro-
domain that facilitate its clustering on activating complexes, driving proximity-induced auto-
activation, substrate cleavage, and apoptosis. Inflammatory caspases also contain a large 
pro-domain for its recruitment and activation by inflammasomes (6) discussed in detail 
below. 
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1.1 Nod-like receptors and the inflammasomes 
NLRs are cytosolic PRRs that detect cellular damage and cytoplasmic microbial infection. 
The NLR gene family is comprised of 22 human genes and 34 mouse genes, several of 
which assemble into inflammasome complexes (2, 6), and is defined by a common 
nucleotide-binding and oligomerisation (NACHT) domain. Inflammasome-forming NLRs 
also contain a leucine-rich repeat (LRR) domain and a caspase recruitment (CARD) or 
pyrin (PYD) effector domain (Figure 1.1) (2). The LRR domain is thought to be involved in 
ligand sensing, whereas the CARD or PYD domains mediate downstream signalling via 
homotypic interactions between protein domains. 
 
Upon activation, NLRs oligomerise through their NACHT domain in an ATP-dependent 
manner (7). In the case of many inflammasome-forming NLR proteins, oligomerisation of 
NLRs facilitates the recruitment of apoptosis-associated speck-like protein containing a 
caspase recruitment domain (ASC; Figure 1.2) through homotypic PYD interactions. ASC 
serves as an adaptor to recruit pro-caspase-1 via CARD-CARD interactions. For CARD-
containing inflammasome scaffolds (i.e. NLRP1 and NLRC4), pro-caspase-1 can be 
directly coupled to the inflammasome complex through CARD-CARD interactions, 
bypassing the requirement for ASC. Clustering of pro-caspase-1 on the inflammasome 
complex enables its activation through homodimerisation, an essential and likely sufficient 
step for the acquisition of enzymatic activity that may be further influenced by self-
cleavage (8-10). 
 
Pro-IL-1β and pro-IL-18 are inactive cytokine precursors, and are key cellular substrates 
for active caspase-1 (2). These cytokines are critical for protective inflammatory responses 
during host defence; however, they can also trigger tissue pathology. IL-1β and IL-18 
maturation is therefore tightly regulated, requiring at least two signals (Figure 1.2). Most 
cells do not constitutively express pro-IL-1β, and express low levels of the inflammasome 
sensor molecule NLRP3, thus ‘Signal 1’ (often referred to as a ‘priming signal’) induces the 
intracellular expression of these proteins. Priming can be achieved in vitro by cell 
stimulation with TLR agonists or proinflammatory cytokines (e.g. tumor necrosis factor, 
TNF) that trigger the function of the nuclear factor-κB (NF-κB) transcription factor and 
downstream promoter activation of the IL1B and NLRP3 genes. Cytokine conversion from 
the inactive to the active form is regulated independently of NF-κB activity, and depends 
upon the inflammasome-dependent activation of caspase-1 (‘Signal 2’). This second signal 
also regulates release of IL-1β and IL-18 via an unconventional protein secretion pathway 
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that is poorly understood (11). A recent study identified IL-37, a human-specific cytokine, 
as a substrate for caspase-1. Interestingly, cleavage of IL-37 triggers the translocation of 
IL-37 to the nucleus and suppresses inflammatory cytokine production (12). IL-37 also 
appears to possess an extracellular immunosuppressive function by engaging the IL-1 
family decoy receptor IL-1R8 (13). 
 
In addition to regulating the maturation of IL-1β and IL-18, caspase-1 activation is also 
associated with the initiation of pyroptosis, a form of inflammatory cell death that is distinct 
from apoptosis and necrosis (14). Pyroptosis occurs independently of the apoptotic 
caspases, and is initiated by inflammatory caspases such as caspase-1. Pyroptosis is 
characterised by the rapid formation of 1–2.5 nm pores, Ca2+ influx, DNA degradation, 
vacuole formation and cell swelling, leading to cell rupture and the release of cellular 
contents (15). This unusual form of cell death enables the release of alarmins, such as IL-
1α, which is closely related to IL-1β but is not directly cleaved by caspase-1 (16). 
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Figure 1.1 Protein domains of inflammasome scaffolds from the NLR and PYHIN families and the 
PYD-containing protein PYRIN. 
Domains are classified according to the NCBI domain annotation tool (3). The domain structure of NLRP3, 
NLRC4 and AIM2 is identical between humans and mice, whereas human NLRP1, but not its murine 
counterparts, contains a PYD.  Murine PYRIN lacks the B30.2 domain of the human PYRIN protein. 
Abbreviations for domain names: PYD, pyrin domain; CARD, caspase-activation and recruitment domain; 
NACHT, nucleotide-binding and oligomerisation domain; LRR, leucine-rich repeat; FIIND, domain with 
function to find; CC, coiled-coiled. Abbreviations for protein names: NLRP, Nod-like receptor protein; NLRC, 
NOD-like receptor containing a CARD; AIM2, absent in melanoma 2. 
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Figure 1.2 Activation pathways of AIM2, murine NLRP1, NLRP3 and NLRC4 inflammasomes.  
The AIM2 inflammasome is activated by double-stranded DNA. The murine NLRP1b inflammasome is 
activated by anthrax lethal toxin. The NLRP3 inflammasome is triggered by various cell stress pathways 
triggered by infection or injury (see Table 1.1). The NLRC4 inflammasome is activated by NLRC4 interaction 
with other NLR family members of the neuronal apoptosis inhibitor proteins (NAIP) sub-family, upon NAIP 
binding to specific ligands (see Table 1.2). An ASC-containing NLRC4 inflammasome promotes cytokine 
processing and secretion, but ASC is dispensable for NLRC4/caspase-1-dependent cell death (pyroptosis). 
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1.1.1 The NLRP3 Inflammasome 
The NLRP3 inflammasome is particularly interesting because it has the capacity to 
respond to a wide variety of unrelated activators ranging from whole pathogens, bacterial 
toxins, metabolic products, large insoluble particulates, environmental irritants and 
endogenous-derived danger signals (Table 1.1).  
 
The precise molecular events governing the assembly and activation of the NLRP3 
inflammasome are still unclear. The chemical diversity of NLRP3 agonists suggests these 
molecules elicit a common stress pathway sensed by NLRP3 that triggers NLRP3 
oligomerisation and inflammasome formation. Five major models of NLRP3 inflammasome 
activation are proposed in the literature, and may not be mutually exclusive. The first 
model suggests that NLRP3 is a sensor for pathways triggering the production of reactive 
oxygen species (ROS) (17, 18). The second model pertains to particulate or crystalline 
NLRP3 agonists that are endocytosed by phagocytes and lead to lysosomal rupture. 
Lysosomal rupture is suggested to cause leakage of lysosomal proteases (e.g. cathepsin 
B) into the cytoplasm to enable NLRP3 activation by an unknown mechanism (19). The 
third model suggests NLRP3 is a sensor of potassium efflux, as a number of NLRP3 
agonists trigger intracellular ionic flux (e.g. bacterial pore-forming toxins and extracellular 
ATP, which engages the P2X7 potassium efflux pump). Indeed, suppression of potassium 
flux (e.g. by culturing cells in high extracellular potassium) can inhibit NLRP3-dependent 
caspase-1 activation (20). The fourth model proposes that NLRP3 is a sensor of 
mitochondria perturbation (21-24). Finally, calcium mobilisation has also been implicated in 
triggering NLPR3 activation (21, 25). All of these models are highly controversial, and the 
field is yet to reach a consensus opinion. 
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Table 1.1 Stimuli known to activate the NLRP3 inflammasome. 
Pathogens/pathogen products References 
Candida albicans (26) 
Saccharomyces cerevisiae (26) 
Staphylococcus aureus (27) 
Listeria monocytogenes (27) 
Neisseria gonorrhoeae (28) 
Salmonella Typhimurium (29) 
Group B Streptococcus (30) 
Burkholderia cenocepacia (31) 
Orientia tsutsugamushi (32) 
Citrobacter rodentium (33) 
Sendai virus (34) 
Influenza virus (34) 
Encephalomyocarditis virus (35) 
Measles virus (36) 
Hepatitis C virus (37) 
Pore forming toxins (27) 
Host derived molecules 
ATP (27) 
Glucose (38) 
β-amyloid (39) 
Monosodium urate (40) 
Oxidised low-density lipoprotein (41) 
Hydroxyapatite (HA) crystals (42) 
Environmental irritants 
Alum (19) 
Abestos (17) 
Silica (19) 
Others 
R837 (43) 
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1.1.2 The NLRC4 Inflammasome 
The NLRC4 inflammasome appears to respond to a narrower spectrum of agonists 
compared to NLRP3. NLRC4 is primarily activated by Gram-negative bacteria such as 
Salmonella enterica serovar Typhimurium (S. Typhimurium), Legionella pnuemophila (L. 
pneumophila), Shigella flexneri (S. flexneri) and Pseudomonas aeruginosa (P. aeruginosa) 
(Table 1.2). NLRC4 does not directly interact with its microbial agonists, instead the ligand 
is sensed by an NLR co-receptor called neuronal apoptosis inhibitor protein (NAIP in 
humans, of which there are multiple orthologs in mice) (44-49) (2). Pathogenic bacteria 
use a sophisticated injection apparatus, the Type 3 or 4 secretion system (T3SS or T4SS), 
that injects effector proteins into the host cytoplasm to mediate survival and virulence (50). 
Due to evolutionary conservation between the bacterial secretion system and the flagellar 
machinery, flagellin and components of the secretory apparatus (PrgJ and PrgI-like 
proteins) are ‘unintentionally’ translocated into the host cell cytoplasm and are detected by 
murine NAIP1, 5 and 6 or human NAIP (Table 2). Surprisingly, the LRR domain of NAIP is 
dispensable for ligand recognition. Instead, ligand specificity is mediated by the nucleotide 
binding domain of NAIP proteins (46).  
 
NLRC4 contains a CARD domain and so can directly interact with pro-caspase-1 without 
an absolute requirement for the adapter ASC (Figure 1.2). Indeed, ASC-deficient 
macrophages are able to trigger IL-1β maturation and pyroptosis following NLRC4 
activation (8, 29). However, ASC-replete macrophages show increased secretion of 
mature IL-1β and faster kinetics pyroptotic cell death compared to ASC-deficient 
macrophages following NLRC4 activation (8, 29).  
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Table 1.2 NLRC4 agonists. 
Pathogen Bacterial 
ligands 
Recognition by NAIP proteins References 
Salmonella Typhimurium Flagellin NAIP, NAIP5 and 6 (44, 48, 49) 
PrgJ NAIP2 (44, 48) 
PrgI NAIP, NAIP1 (45, 47) 
Pseudomonas 
aeruginosa 
Flagellin NAIP5 (48) 
Pscl unknown (51) 
Legionella pnuemophila Flagellin NAIP5 (48) 
Shigella flexneri Mxil unknown (52) 
MxiH NAIP, NAIP1 (47) 
Burkholderia 
pseudomallei 
Flagellin unknonwn (53) 
BsaK NAIP2 (48) 
BsaL NAIP, NAIP1 (47) 
Chromobacterium 
violaceum 
Cprl NAIP, NAIP1 (47, 48) 
Enteropathogenic 
Escherichia coli (EPEC) 
Flagellin unknown (48, 54) 
EscL unknown  
Enterohemorrhagic 
Escherichia coli (EHEC) 
Eprl NAIP, NAIP1 (47) 
Listeria monocytogenes Unknown Unknown (55) 
Candida albicans Unknown Unknown (56) 
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1.1.3 The NLRP1 inflammasome 
The NLRP1 inflammasome was the first to be identified (57) and is activated by NLRP1 N-
terminal cleavage by anthrax lethal toxin (Figure 1.2) (58, 59). Humans encode a single 
NLRP1 gene, whereas 3 orthologous genes are present in mice (Nlrp1a-c) (60). The 
Nlrp1b gene is highly polymorphic between inbred mice and appears to confer 
susceptibility to anthrax lethal toxin (60). Similar to NLRC4, human NLRP1 contains a 
CARD domain that can directly interact with pro-caspase-1, bypassing an absolute 
requirement for ASC. However, ASC can still bind to the N-terminal PYD domain of human 
NLRP1 (Figure 1.2). Unlike human NLRP1, murine NLRP1 proteins lack functional PYD 
domains, and so were initially believed not to interact with ASC. Surprisingly, NLRP1b 
activation triggered ASC polymerisation in murine macrophages, suggestive of NLRP1b-
ASC CARD-CARD interactions (61). However, ASC was not required for NLRP1-
dependent IL-1β maturation and pyroptosis in mouse macrophages (61, 62).  
1.1.4 The AIM2 inflammasome 
The cytosolic receptor AIM2 was the first non-NLR family member identified to form an 
inflammasome (63-66).  The AIM2 inflammasome is activated by cytosolic double-
stranded DNA (dsDNA), which indicates the presence of intracellular pathogens such as 
Listeria monocytogenes, Francisella tularensis (F. tularensis), cytomegalovirus and 
vaccinia virus (67).  The AIM2 inflammasome is comprised of AIM2, ASC and caspase-1 
(Figure 1.2). Instead of clustering via an oligomerisation domain, the oligomerisation of 
AIM2 is likely achieved by aggregation upon the dsDNA ligand, which contains multiple 
AIM2 binding sites (68). AIM2 activation triggers the recruitment of ASC and pro-caspase-
1 through PYD-PYD (AIM2-ASC) and CARD-CARD (ASC-procaspase-1) interactions, 
resulting in cytokine maturation and secretion, and lytic cell death in macrophages.  
1.1.5 Non-canonical caspase-8 inflammasome 
In addition to pro-caspase-1, inflammasome assembly also recruits and activates pro-
caspase-8 through ASC (69-71). Caspase-8 activation downstream of AIM2, NLRP3, and 
NLRC4 triggers apoptosis and serves as a back up mechanism when cells fail to 
pyroptose or when caspase-1 expression or activity is inhibited (69, 70, 72). However, the 
finding that caspase-8 activation triggered apoptosis downstream of NLRC4 and ASC was 
recently contested by a single study. The authors of this study proposed that caspase-8 
processing on the NLRC4 inflammasome did not regulate cellular viability, but the non-
enzymatic function of caspase-8 was required for pro-IL-1β synthesis (71). Interestingly, a  
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recent study reported that Aspergillus fumigatus infection in mouse DCs triggers the 
formation of a single NLRP3-AIM2 inflammasome complex, and that caspase-8 
recruitment to this complex is required for optimal caspase-1 activation (73).  
 
Intriguingly, caspase-8 that is activated on a different intracellular platform such as the 
ripoptosome can process IL-1β, similar to inflammasome-activated caspase-1 (74). 
However, inflammasome-activated caspase-8 only triggers a small amount of IL-1β 
cleavage in the cell extracts and supernatant of caspase-1-deficient macrophages (69).  
 1.1.6 Non-canonical caspase-11 inflammasome  
Caspase-11 is a murine inflammatory caspase that is required for host protection against 
Gram-negative cytoplasmic bacteria (75, 76) but also drives pathological inflammation in 
endotoxic shock (77, 78). Caspase-11 is not constitutively expressed by macrophages, but 
is upregulated by type I interferon signalling (79). Activation of caspase-11 during bacterial 
infection also requires interferon signalling, as this triggers the expression of guanylate-
binding proteins (GBPs) that mediate lysis of pathogen-containing vacuoles, and ensuing 
release of bacteria into the cytosol (80). Cytosolic LPS is then directly sensed through the 
CARD domain of pro-caspase-11, triggering caspase-11 dimerisation and activation within 
a so-called ‘non-canonical’ inflammasome complex (81). Caspase-11 activity triggers the 
maturation of IL-1β and IL-18, but caspase-11 does not directly cleave these cytokines, 
rather, it triggers the assembly of the NLRP3 inflammasome, and downstream caspase-1-
dependent cytokine processing (76).  The mechanisms underlying caspase-11-dependent 
NLRP3 activation are not fully resolved, but occur via a cell-autonomous mechanism 
involving caspase-11-dependent K+ efflux (82). In contrast, caspase-11 initiates pyroptosis 
independently of NLRP3 and caspase-1. Caspase-11 thus performs dual functions as both 
a ligand sensor and effector within the non-canonical inflammasome complex. 
 
Murine caspase-11 has two human orthologs, caspase-4 and caspase-5 (83). Similar to 
caspase-11, caspase-4 and caspase-5 also sense LPS through their CARD domains and 
trigger caspase dimerisation and activation (81). Interestingly, transgenic mice that 
express human caspase-4 are hypersensitive to LPS challenge, suggesting that caspase-
4 performs a similar biological function to caspase-11 (84). Consistent with this 
observation, two recent studies demonstrated that caspase-4 activation in human myeloid 
cells drives caspase-1-independent pyroptosis but triggers cytokine production through 
NLRP3/caspase-1, akin to the murine caspase-11 pathway paradigm (85, 86). 
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Interestingly, caspase-5 was dispensable for cell death and cytokine processing upon LPS 
transfection but was required during live Salmonella infection, suggesting that caspase-5 
activation may require other bacterial products (85). 
1.1.7 Cross-talk between inflammasomes and other cell death pathways 
Recent studies revealed an unexpected role for inhibitor of apoptosis proteins (IAPs) as 
central modulators of both death receptor signalling and inflammasome activation in 
macrophages and DCs. IAPs were first described as negative regulators of apoptosis (87) 
and contain up to three copies of the baculovirus inhibitor of apoptosis protein repeat (BIR) 
domain. The most well studied IAPs are cellular IAP (cIAP)-1, cIAP-2 and X-linked IAP 
(XIAP). IAPs inhibit apoptosis by interacting with pro-apoptotic proteins, or by enhancing 
their degradation through the ubiquitin-proteasome pathway. IAPs also block apoptosis by 
inducing the transcription of pro-survival genes through the canonical and non-canonical 
NF-κB pathway (87). Blocking IAP function thus substantially increases the propensity of a 
cell to undergo apoptosis. Two recent reports revealed that genetic IAP deficiency or 
chemical inhibition of IAPs using second mitochondria derived activator of caspase 
(SMAC)-mimetic compounds drives NLRP3/caspase-1 activation in LPS-primed 
macrophages (74, 88). This particular NLRP3/caspase-1 activation mechanism requires 
signalling by the TLR3/4 adaptor, TIR domain-containing adaptor protein inducing IFN-β 
(TRIF), and the assembly of an intracellular multi-protein complex containing RIPK1, 
FADD and casapase-8 termed the ‘ripoptosome’. TRIF contains a receptor-interacting 
protein (RIP) homotypic interactive motif  (RHIM) domain and is able to recruit receptor-
interacting serine-threonine kinase 3 (RIPK3) through homotypic RHIM-RHIM interactions. 
In the absence of IAPs, RIPK3 is not ubiquitinated and fails to deliver a pro-survival signal 
following LPS ligation (Figure 1.3A). Instead, RIPK3 promotes caspase-8 activity on the 
ripoptosome and triggers apoptosis and NLRP3/caspase-1 activation (88). Interestingly, 
caspase-8 activation by the ripoptosome also promotes IL-1β processing independently of 
NLRP3/caspase-1 (74, 88) (Figure 1.3B). When both IAPs and caspase-8 are inhibited 
RIPK3 phosphorylates mixed-lineage kinase domain-like (MLKL) and triggers a form of 
programmed cell death called ‘necroptosis’; interestingly, this process also drives NLRP3 
activation (Figure 1.3B) (88). These observations highlight the complex system of cross 
talk between inflammasome signalling and programmed cell death pathways (89). 
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Figure 1.3 IAPs suppress apoptosis and necroptosis during TLR-TRIF-RIPK3 activation. 
(A) When IAPs are present, TLR4 signalling results in IAP-mediated ubiquitination of RIPK3 to propagate 
pro-survival signals. (B) When IAPs are absent, LPS induces RIPK3-dependent caspase-8 activation 
through the ripoptosome complex and triggers apoptosis and NLRP3/caspase-1 activation. Caspase-8 
activation by the ripoptosome can also directly process IL-1β. When IAPs and caspase-8 is absent, LPS 
induces the formation of the necrosome, which triggers necroptosis and NLRP3/caspase-1 activation. 
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1.2 Antimicrobial functions of the inflammasomes 
Inflammasomes are critical components of the immune system, and mice that are deficient 
in inflammasome components are extremely susceptible to infection (Table 1.3). 
Inflammasomes critically mediate antimicrobial functions via a suite of cytokine-dependent 
and -independent mechanisms and will be discussed in detail below.  
1.2.1 Interleukin-1β 
IL-1β  is one of the major cytokines secreted following inflammasome activation. IL-1β 
signals through the IL-1 receptor-1 (IL-1R1), which is expressed ubiquitously and therefore 
elicits both local and systemic responses in the host. IL-1β targets leukocytes, epithelial 
cells, endothelial cells, fibroblasts, as well as cells of the spleen, liver and brain. IL-1β 
signalling potently accentuates the antimicrobial functions of leukocytes by enhancing their 
phagocytic capability (90), by priming the oxidative burst (91), by regulating nutritional 
starvation (92) and by triggering degranulation to release antimicrobial proteins, and by 
forming neutrophil extracellular traps (92, 93). IL-1β also contributes to neutrophilia by 
enhancing neutrophil bone marrow export and granulopoiesis, by inducing the 
accumulation of neutrophils at inflammatory sites (94, 95) and through prolonging 
neutrophil lifespan (96).  
 
In the liver IL-1β induces acute-phase responses, including hepatocyte production of 
complement proteins, C-reactive protein and serum amyloid A, and the co-ordinate 
redistribution of circulating metal ions (97). IL-1β also enhances hepatic production of C3 
and Factor B, major players in the anti-microbial complement cascade. C-reactive protein 
recognises microbial polysaccharides and activates the complement system, promoting 
phagocyte opsonophagocytosis and ROS production (98). Serum amyloid A exerts various 
functions, including the regulation of immune cell recruitment. Iron deprivation is an 
established antimicrobial strategy (99) and IL-1β also triggers a reduction in the availability 
of free iron in the serum by enhancing hepatocyte production of the iron-sequestration 
protein ferritin (100, 101) and the hormone hepcidin (101), which negatively regulates iron 
absorption in the small intestine and iron efflux from macrophages. IL-1β also promotes 
lymphocyte proliferation and activation in the spleen (97). In concert with the liver-
mediated acute phase response, IL-1β in the brain triggers hypothalamic prostaglandin E2 
production, which raises the hypothalamic set point to induce fever (97). Although fever 
causes discomfort to the host, elevated body temperature augments several protective 
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host immune responses such as granulopoiesis, phagocytosis, T cell proliferation, 
antibody production and the activity of IFNs, and suppresses microbial growth (102, 103). 
1.2.2 Interleukin-18 
IL-18 is best known for its ability to induce the production of IFN-γ by T cells and NK cells 
in collaboration with IL-12 (104). IFN-γ potently affects the function of macrophages 
through enhancing antimicrobial pathways such as the oxidative burst, increasing the 
quantity and diversity of antigen presentation and by boosting cellular sensitivity to 
pathogen recognition receptors such as TLRs (104, 105). In addition, IFN-γ potentiates 
leukocyte migration and instructs the adaptive immune response. IL-18 also augments the 
antimicrobial functions of leukocytes more directly. For example, IL-18 signalling in 
neutrophils promotes the expression of formyl peptide receptors and the complement C3b 
receptor, allowing robust sensing and phagocytosis of pathogens (106). IL-18 also 
enhances microbial killing by augmenting ROS production (106) and amplifies 
inflammatory responses by promoting the release of proinflammatory mediators such as 
IL-6 (106).  
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Table 1.3 Examples of inflammasomes critical for in vivo host defence, and their microbial triggers.  
Pathogen Inflammasome References 
Aspergillus fumigatus NLRP3, AIM2 (73) 
Burkholderia pseudomallei NLRP3, NLRC4 (53, 75) 
Burkholderia thailandensis Caspase-11 (75) 
Candida albicans NLRP3, NLRC4 (56) 
Citrobacter rodentium NLRP3, NLRC4 (33) 
Francisella tularensis AIM2 (107) 
Klebsiella pneumoniae NLRC4 (108-110) 
Salmonella Typhimumrium NLRC4, NLRP3, 
Caspase-11 
(75, 80, 109, 111) 
Pseudomonas aeruginosa NLRC4 (110) 
Staphylococcus aureus NLRP3 (112) 
Streptococcus pneumoniae NLRP3, AIM2 (113) 
Yersinia pestis NLRP12, NLRP3 (114) 
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1.2.3 Pyroptotic cell death 
In addition to its ability to process cytokine pro-forms as discussed above, inflammasome-
activated caspase-1 also initiates a novel form of inflammatory cell death called pyroptosis. 
While the induction of caspase-1-dependent pyroptosis by inflammasomes has been 
extensively observed using in vitro infection models, the mechanics of caspase-1-
dependent cell death remain poorly characterised. Surprisingly, pro-caspase-1 
autoproteolysis appears to be dispensable for NLRP1 and NLRC4-triggered pyroptosis, 
while protease clustering and active site residues are required (8, 61, 62). This suggests 
that uncleaved, clustered pro-caspase-1 may represent an alternative activation state of 
the protease that elicits the pyroptotic program (8, 61, 62). Other inflammatory caspases 
such as caspase-4, -5 and -11 also trigger pyroptosis, however, this occurs in a caspase-
1-independent manner, and the molecular mechanisms are poorly understood (76, 85, 86). 
The role of pyroptosis in vivo was only confirmed recently. Miao and co-workers elegantly 
demonstrated a physiological role for pyroptosis using a Salmonella mutant that 
constitutively activates the NLRC4 inflammasome (115). The authors showed that 
pyroptosis protects the host by releasing intracellular bacteria from their replicative niche, 
rendering bacteria more susceptible to destruction by neutrophils (115) and presumably 
other extracellular defence mechanisms which are concurrently upregulated by IL-1β and 
IL-18 signalling. As some pathogens exploit myeloid cells as a niche to establish systemic 
infection, pyroptotic cell death allows pathogen restriction to the site of infection and 
prevents dissemination. Various cytokines and host-derived alarmins such as IL-1α, 
HMGB-1 and ATP, are also released during pyroptotic cell death (76) and are likely to 
signal to neighbouring cells to promote their immune surveillance and antimicrobial 
pathways.  
1.3 Pathogenic outcomes of inflammasome activation 
Inflammasomes are critical for host defence, but uncontrolled or inappropriate 
inflammasome signalling causes significant collateral damage and can initiate or 
exacerbate disease. NLRP3 has been identified as a key driver of metabolic syndrome 
(40, 116, 117) and neurodegenerative diseases (39, 118-120). Mechanistically, aberrant 
production of peptides and/or metabolic by-products during these diseases is sensed by 
NLRP3, culminating in excessive inflammation in the affected tissue. Examples of aberrant 
peptides and metabolic by-products that trigger NLRP3 activation include islet amyloid 
polypeptide (IAPP) during T2D (116), monosodium urate (MSU) in gout (40), and β-
amyloid fibrils in Alzheimer’s disease (39). Genetic deficiency or pharmacological inhibition 
Chapter 1 
 18 
of NLRP3, or the usage of the recombinant IL-1R antagonist, Anakinra, ameliorates 
several of these pathologies in humans and animal models, indicating a key role for 
NLRP3 in mediating these pathologies (28, 40, 119, 121-123).  
 
Excessive inflammasome signalling during infection also mediates the inflammatory 
disease, endotoxic shock in murine models. While caspase-11 is important for protection 
against cytosolic Gram-negative bacteria, excessive caspase-11 activation triggers clinical 
signs of sepsis such as hypothermia, weight loss, seizure and death (77, 78).  
 
In human immunodeficiency virus (HIV) infection, depletion of CD4 T cells is a hallmark of 
HIV pathophysiology and is a primary driver of acquired immunodeficiency syndrome 
(AIDS) (124). Two recent studies unravelled mechanisms of CD4 T cell depletion during 
HIV infection (125, 126). The authors demonstrated that abortive HIV infection in quiescent 
CD4 T cells triggered caspase-1-mediated pyroptosis. In this scenario, pyroptosis of 
quiescent CD4 T cells does not necessarily deprive HIV of its replicative niche, as this cell 
population is not permissive for viral replication. HIV instead replicates in activated CD4 T 
cells, which represent only a minority of the CD4 T cell population, and die by apoptosis. 
Pyroptosis in quiescent CD4 T cells promoted chronic CD4 T cell depletion, driving the 
progression of AIDS (124-126).  
 
Another example in which caspase-1-dependent pyroptosis may be detrimental is that of 
NLRP1a-mediated pyroptosis in haematopoietic progenitor cells, which occurs during 
haematopoietic stress induced by chemotherapy or bone marrow infection (127). Although 
seemingly intended as a mechanism to prevent infection of daughter cells from 
compromised haematopoietic progenitor cells, chronic pyroptosis resulted in cytopenia and 
immunosuppression. 
 
A number of mutations leading to excessive inflammasome activation have been mapped 
over the past decade. The most studied examples are the cryopyrin-associated periodic 
fever syndromes (CAPS) caused by gain-of-function mutations in Nlrp3 (128). CAPS 
patients typically present with recurring episodes of fever and multiple skin rashes. 
Patients with mutations in NLRP12, which is the closest phylogenetic relative to NLRP3 
(2), have a similar phenotypic presentation to CAPS patients (129). Whether NLRP12 
forms an inflammasome is however still a subject of debate. Some studies suggested a 
direct role for NLRP12 in mediating IL-18 production following Yersinia infection (114), 
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while other studies claimed that NLRP12 regulates inflammasome-independent activities 
such as cell migration and transcription factor activity (130-133). Three independent 
studies recently identified single point mutations in the nucleotide-binding domain of 
NLRC4 in humans (134-136). These mutations drove spontaneous NLRC4 activation in 
the absence of a microbial trigger; resulting in excessive inflammation, cell death and 
neutrophil accumulation. As a result, these patients suffer from varying symptoms ranging 
from rashes, recurrent fever, pancytopenia, enterocolitis and intestinal tissue damage and 
these can lead to death.  
1.4 Salmonella pathogenesis and host defence 
Salmonella enterica species are Gram-negative bacteria that can infect a wide range of 
hosts including humans. Infection usually occurs after the ingestion of contaminated food 
or water and can lead to various disease manifestations. Salmonella enterica serovar 
Typhi (S. Typhi) is the causative agent of typhoid fever in humans. S. Typhimurium is a 
major cause of self-limiting human gastroenteritis, but can also lead to systemic disease 
and mortality in immunocompromised and elderly individuals. In mice, intravascular or 
intraperitoneal infection with S. Typhimurium is often used to model the pathogenesis of 
human systemic salmonellosis.  
 
When ingested, S. Typhimurium is able to withstand the hostile environment of the 
gastrointestinal tract, evading digestive enzymes, acidic pH and secretory IgA to colonise 
the small intestine (137). A specialised secretion system termed the T3SS is essential for 
S. Typhimurium to inject virulence proteins into the host cytoplasm to successfully 
establish an infection. The T3SS is evolutionarily related to the flagellar export system and 
is present in multiple Gram-negative bacteria. At least 20 different proteins are required to 
assemble the secretion apparatus, which consists of a multi-ring base that spans the inner 
and outer membranes of the bacterial envelope, and an inner rod that joins the rings. 
Together, these form a supramolecular structure that is known as the needle complex (50).  
 
S. Typhimurium expresses two virulence-associated T3SS encoded on two distinct 
Salmonella pathogenicity islands (SPI1 and SPI2). The SPI1-T3SS and SPI2-T3SS are 
preferentially expressed during different stages of infection (138). The SPI1-T3SS is 
expressed upon contact with epithelial cells and translocates effectors into the host 
cytoplasm and ensures the efficient uptake of the bacterium and its transcytosis to the 
basolateral surface of the intestinal epithelia. Once the epithelial layer is breached, S. 
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Typhimurium infects the underlying macrophages, which transport the bacteria through the 
reticuloendothelial system (137). Upon internalisation by phagocytes such as 
macrophages, S. Typhimurium senses the change in microenvironment and upregulates 
expression of the SPI2-T3SS. The SPI2-T3SS modulates cellular anti-microbial trafficking 
pathways including those that control the formation of an active NADPH oxidase complex 
(respiratory burst) and the maturation of the phagolysosome. S. Typhimurium subverts 
these trafficking pathways to form a replicative niche within a membrane-bound structure 
known as the Salmonella containing vacuole (SCV) (139, 140). The Salmonella SPI1-
T3SS appears also to be expressed in bacteria residing in phagocytes, and may cooperate 
with the SPI2-T3SS to inhibit phagosome maturation and enhance intracellular replication 
(139, 141). This suggests that the two SPIs likely cooperate to facilitate the intracellular 
lifestyle of the bacterium. 
1.4.1 Innate immune defence against S. Typhimurium 
The successful clearance of Salmonella depends upon the production of cytokines and 
soluble factors at the early stages of infection, as well as the rapid recruitment of 
neutrophils and macrophages. Soluble factors such as complement bind to the bacterial 
membrane, and for example form a membrane attack complex that results in cell rupture. 
Salmonella-derived components such as LPS, flagellin and unmethylated CG 
dinucleotides (CpG DNA) can also activate Toll-like receptors (TLRs), which in turn induce 
potent inflammatory responses and communication between host immune cells. TLR 
activation results in the production of proinflammatory cytokines such as TNF, IL-6 and IL-
12, which trigger the production of chemokine such KC/MIP-2 from the activated 
endothelium and elicit of Th1 cytokines such as IFN-γ from NK/T cells (142). These 
mediators in turn recruit phagocytes and induce the upregulation of multiple antimicrobial 
mechanisms.  
1.4.2 Inflammasome-dependent defence against S. Typhimurium 
In addition to TLRs, inflammasomes are important mediators of host defence host defence 
against S. Typhimurium. In particular, the NLRC4 and NLRP3 inflammasomes, and the 
non-canonical caspase-11 inflammasome, exhibit important functions (Figure 1.4). 
NLRC4-mediated cytokine secretion by murine macrophages and DCs occurs as early as 
1 h after infection with S. Typhimurium (29, 143). Early detection of Salmonella by NLRC4 
requires a functional SPI1-T3SS in mouse cells (29, 143, 144). The only exception to this 
requirement is Salmonella sensing by CD8+ DCs; these cells can recognise Salmonella-
derived molecules in a SPI1-independent manner (for example, in recognising heat-killed 
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bacteria) by employing antigen cross-presentation pathways to transfer Salmonella 
proteins into the host cell cytoplasm for recognition by the NLRC4/NAIP system (145). At 
later time points, Salmonella switches on the SPI2-T3SS in order to stabilise its replicative 
niche, the SCV. Using the PhoP-PhoQ two-component system, S. Typhimurium 
downregulates flagellin expression within the SCV to evade detection by NLRC4 (143). 
However, low levels of bacterial flagellin are yet transferred into the cytoplasm via the 
SPI2-T3SS, and this can be detected by NLRC4. Interestingly, Ssal, the homolog of PrgJ 
encoded on the SPI2-T3SS, is not detected by NLRC4 (54). Both the NLRP3 and 
caspase-11 inflammasomes exert important functions in anti-Salmonella defence at later 
stages of infection (e.g. 17h). Early reports indicated a role for NLRP3 in sensing 
Salmonella infection in a SPI1/2-T3SS-independent manner, however the pathogen 
determinant(s), responsible for NLRP3 activation could not be identified (111). Recently, 
the non-canonical caspase-11 inflammasome was demonstrated to mediate antimicrobial 
responses to defend against Salmonella (75, 80). In light of this, it is possible that NLRP3 
activation by Salmonella occurs as an indirect consequence of caspase-11 activation, 
rather than the previously suggested model, whereby pathogen determinant(s) from 
Salmonella are directly sensed by NLRP3. Interestingly, NLRC4 and NLRP3 can be 
recruited to the same molecular complex upon S. Typhimurium infection, which nucleated 
ASC into a large focus for caspase-1 processing and IL-1β/18 maturation (146).  
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Figure 1.4 Activation of the NLRC4, NLRP3 and non-canonical caspase-11 inflammasome by S. 
Typhimurium.  
Bacterial flagellin is translocated into the host cell cytosol by the SPI1-T3SS and SPI2-T3SS; PrgI/J is 
translocated by SPI1-T3SS only. These ligands are sensed by NAIP5/6 (flagellin), NAIP1 (PrgI) and NAIP2 
(PrgJ), and NAIP proteins act as co-receptors to activate the NLRC4 inflammasome. Clustering of 
(uncleaved) pro-caspase-1 is sufficient to induce pyroptosis via unknown mechanisms, whereas cleaved 
caspase-1 promotes cytokine maturation and secretion. At later time points of infection, S. Typhimurium is 
sensed by NLRP3 through an undefined pathway, and also activates non-canonical caspase-11 
inflammasome, triggering parallel caspase-11-dependent pyroptosis and NLRP3-caspase-1 activation. 
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1.5 Neutrophil biology 
Neutrophils are the most abundant leukocytes in human blood. On average 1-2 x 1011 new 
neutrophils are formed in the bone marrow per day (147, 148). In the circulation, 
neutrophils constitute around 70% of the total leukocyte population (149). However, in 
mice, the standard model organism for in vivo infection studies, circulating neutrophils are 
significantly lower, only accounting for around 20% of blood leukocytes (150). This 
suggests that studies relying on mouse as a model for human immunity may 
underestimate the contribution of neutrophils to host defence in humans. 
1.5.1 Granulopoiesis 
Neutrophils are generated in the bone marrow via a process known as granulopoiesis. 
Myeloblasts are differentiated from pluripotent hematopoietic stem cells and are committed 
to develop into granulocytes (151). As neutrophils mature in the bone marrow, they 
undergo intensive transcription, generating a broad array of proteins including 
antimicrobial peptides (152), proteases (153), metal chelators (154) and cellular receptors 
(155, 156). These proteins are sequentially expressed during neutrophil development for 
storage in a series of granules (149, 157). The ability of neutrophils to deploy preformed 
peptides allows for rapid responses to neutralise invading pathogens. Although the arsenal 
of antimicrobials that neutrophils possess is usually effective in eliminating pathogens, it 
can also inflict cellular damage (158, 159). Thus, the deployment and activation of 
neutrophils requires tight regulation.  
1.5.2 Release of neutrophils from bone marrow 
The release of neutrophils from the bone marrow into the circulation is controlled by two 
chemokine receptors, CXCR2 and CXCR4 that exert opposing effects (160). Both 
chemokine receptors are constitutively expressed on neutrophils and bind to specific 
factors in the bone marrow. Stromal derived factor-1 (SDF-1; CXCL12), which is mainly 
produced by bone marrow osteoclasts, binds to CXCR4 and retains mature neutrophils in 
the bone marrow. In contrast, murine KC (CXCL1 in humans) and murine macrophage 
inflammatory protein -2 (MIP-2; also called CXCL2, or IL-8 in humans) are mainly 
synthesised by bone marrow endothelial cells, bind to CXCR2, and promote neutrophil 
egress from the bone marrow to the circulation. The constant tug-of-war between CXCR2 
and CXCR4 ligands determines whether or not neutrophils are deployed into the 
circulation. Under homeostatic conditions, SDF-1 usually dominates, retaining the majority 
of neutrophils in the bone marrow (161). Granulocyte-colony stimulating factor (G-CSF) is 
Chapter 1 
 24 
the master regulator of neutrophils and controls the generation of mature neutrophils and 
their release into the circulation in both the steady state and during inflammation. 
1.5.3 Neutrophil recruitment 
During infection, professional sentinel cells such as macrophages sense PAMPs and 
DAMPs, leading to the production of cytokines, chemoattractants and hematopoietic 
growth factors that work together to choreograph the rapid recruitment of neutrophils to a 
site of infection (162, 163). The production of G-CSF is greatly enhanced during infection, 
and increases circulating neutrophil numbers by facilitating neutrophil egress from the 
bone marrow. G-CSF inhibits the synthesis of SDF-1 by osteoclasts and increases the 
production of KC and MIP-2, causing a shift in the balance of SDF-1 versus CXCR2 
ligands thereby promoting neutrophil egress into the circulation (160). 
 
Concurrently, endothelial cells surrounding the site of infection upregulate adhesion 
molecules on their luminal surface to halt circulating neutrophils. The presence of bacterial 
products and the release of proinflammatory cytokines by resident sentinel cells induces 
the expression of neutrophil adhesion molecules such as P-selectin, E-selectin and 
several members of the intercellular adhesion molecule (ICAM) superfamily to promote 
neutrophil adhesion and transmigration to a site of inflammation (149, 151).  
1.5.4 Neutrophil transmigration 
Neutrophils constitutively express cell-surface P-selectin glycoprotein ligand-1 (PSGL-1) 
and L-selectin to recognise the activated endothelium (164). As neutrophils transverse the 
endothelium, these molecules engage P- and E-selectin, resulting in selectin-mediated 
tethering to the endothelium (‘rolling adhesion’). The engagement of selectin ligands 
activates a range of kinases, committing neutrophils to an antimicrobial state and 
preparing them for firm adhesion (165, 166). As loosely tethered neutrophils roll along the 
endothelium, they encounter further chemoattractants, cytokines and bacterial products, 
which cause activation and clustering of cell surface β2 integrin family members (Mac-1 
and leukocyte function-associated antigen 1 [LFA-1]) (167). This triggers a second stage 
of neutrophil activation in which they extensively remodel their actin cytoskeleton and 
enhance their capacity for phagocytosis and ROS production. Neutrophils are fully 
activated and ready to transit into ‘firm adhesion’ at this stage. Once firmly engaged by 
members of the ICAM-1 superfamily on the endothelium, neutrophils exit the vasculature 
(‘diapedesis’).  
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Once they have crossed the endothelium, neutrophils travel along a chemokine gradient of 
either host-derived KC/MIP-2 or pathogen-derived N-Formylmethionine-leucyl-
phenylalanine (fMLP). The engagement of chemoattractants onto surface receptors 
maintains neutrophils in an antimicrobial state (168, 169). Simultaneously, the recognition 
of PAMPs by TLRs enhances the phagocyte oxidative burst (169). Upon reaching the 
highest point of the chemokine gradient, neutrophils halt and unleash their antimicrobial 
arsenal. 
1.5.5 Neutrophil antimicrobial mechanisms 
1.5.5.1 Oxidative burst 
Neutrophils employ a number of strategies to kill invading pathogens. Amongst the most 
potent of these is the ability of neutrophils to generate ROS via the oxidative burst. 
Individuals suffering from chronic granulomatous disease harbour genetic mutations in this 
pathway, and are unable to generate ROS; as a consequence, these individuals are more 
susceptible to life-threatening bacterial and fungal infections (170-172). The ROS 
generation via the oxidative burst requires the assembly of the multi-subunit NADPH 
oxidase complex, which is induced by proinflammatory cytokines such as TNF and IFN-γ 
in conjunction with microbial constituents such as LPS and fMLP (172). The NADPH 
oxidase complex is composed of several cytosolic and membrane-bound proteins. 
Depending on the localisation of the complex, the oxidative burst can be directed into the 
extracellular space or channelled towards pathogen-containing phagosomes (172). The 
initiation of the oxidative burst upon NADPH oxidase complex assembly results in the 
reduction of molecular oxygen to superoxide anion. Spontaneous reaction of the 
superoxide anion results in the formation of several ROS species: hydrogen peroxide, 
hydroxyl radical and singlet oxygen. Hydrogen peroxide also reacts with myeloperoxidase 
(MPO), an enzyme present in high quantities in primary granules (see 1.5.5.3), to generate 
hypochlorous acid (155). Because of their reactivity, ROS are able to target a wide variety 
of components of the invading pathogen such as nucleic acids, lipid membranes, metal 
centers and thiols. Taken together, these modifications impair bacterial metabolism and 
ultimately inhibit bacterial replication. 
1.5.5.2 Phagocytosis 
A hallmark of neutrophils is their ability to engulf extracellular pathogens within seconds of 
contact via phagocytosis (173). Once engulfted, the pathogen is contained within the 
membrane-bound phagosome. In contrast to macrophages, neutrophils lack a classical 
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endocytic pathway, and the nascent phagosome does not acidify (174, 175). Instead, the 
phagosomal cargo fuses with pre-formed granules, releasing potent antimicrobials that 
destroy the pathogen.   
1.5.5.3 Granules 
Neutrophils include variably sized granules in their cytoplasm that contain a variety of 
antimicrobial proteins, which can be either directed into the extracellular space or can fuse 
with pathogen-containing phagosomes. Neutrophil granules are formed sequentially during 
neutrophil development and can be broadly classified into three categories: azurophilic 
(primary), specific (secondary) and gelatinase (tertiary) granules (149, 151). Azurophilic 
granules are the first to be synthesised during development, are characterised by the 
presence of MPO, and are considered the most potent amongst the granule types. 
Azurophilic granules contain a variety of lytic enzymes such as serine proteases and 
lysozyme, as well as peptides that disrupt the bacterial cell wall such as defensins and 
bacterial/permeability-increasing protein (BPI) (149). Specific granules are MPO-negative 
and contain a number of anti-microbial compounds, including the iron chelator lactoferrin. 
Iron deprivation is an important antimicrobial strategy as many pathogens require iron to 
sustain their metabolic functions (99). Excessive iron can also dampen antimicrobial 
mechanisms in other myeloid cell types, such as the production of reactive nitrogen 
species (RNS) in macrophages (176). Gelatinase granules are the last granule type to be 
synthesised. Gelatinase granules contain neither MPO nor lactoferrin, but are enriched 
with metalloproteases. Granules are released in reverse order to their formation (177), and 
gelatinase granules are thought to break down the extracellular matrix and collagen to aid 
in neutrophil extravasation. Neutrophils also posses secretory vesicles, although their 
origin may differ from the three granule types mentioned above (155). These secretory 
vesicles are the most easily mobilised and house membrane proteins such as Mac-1 and 
fMLP-receptor that exert important functions during early phase of inflammation.  
1.5.5.4 Neutrophil extracellular traps 
In 2004, a new neutrophil antimicrobial mechanism was discovered, called neutrophil 
extracellular traps (NETs) (178). NET formation is associated with a form of cell death 
distinct from necrosis and apoptosis. ‘NETosis’ arises from the release of material such as 
DNA, chromatin and granular proteins into the extracellular space, to form a web that traps 
microbes. Antimicrobial proteins such as myeloperoxidase, lacteroferrin, defensins, 
elastase, proteinase-3 and calprotectin decorate NETs (179).  
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Although the molecular mechanisms triggering NET formation still remain elusive, it is well 
established that NETosis contributes to host protection against a variety of bacteria, 
fungus and parasites (180, 181). ROS, autophagy and IL-1 signalling have all been 
suggested to contribute to the induction of NETs (182), and neutrophils from chronic 
granulomatous disease patients less efficiently trigger NET formation (183). A single report 
proposed that autophagy inhibition using the chemicals 3-methyladenine (3-MA) or 
bafilomycin A reduced the frequency of NETosis (93). The same authors also 
demonstrated that gout synovial fluid triggered peripheral neutrophils from healthy donors 
to undergo NETosis, but this could be suppressed by co-administration of the recombinant 
IL-1R antagonist (Anakinra), suggesting IL-1 is required to launch NETs (93). It is 
generally believed that NET formation in vivo serves two functions; initially NETs 
immobilise, destroy and trap invading pathogens to prevent their dissemination, but they 
may additionally provide signals to orchestrate downstream inflammatory processes.  
1.5.6 Neutrophil cell death pathways 
Although important for antimicrobial defence, aberrant activation of neutrophils and their 
impaired clearance can cause collateral damage and contribute to numerous pathologies. 
This is exemplified in several inflammatory conditions such as gout (93), rheumatoid 
arthritis (184), inflammatory bowel disease (185) and sepsis (186), where neutrophilia is 
often observed. The clearance of neutrophils at an inflammatory focus is also critical for 
the resolution of inflammation (187, 188). Therefore, it is important for neutrophil lifespan 
to be tightly controlled. Multiple forms of programmed cell death such as apoptosis and 
necroptosis have been described, and will be discussed herein. 
1.5.6.1 Neutrophil cell death by apoptosis 
Neutrophils are relatively short-lived cells and were widely accepted to have a lifespan of 
less than 1 day in circulation. An increasing number of studies are now challenging this 
concept, and a single study demonstrated that neutrophils survive in circulation for 5 days 
under homeostatic conditions (189). The turn over of aged neutrophils occurs mainly 
through apoptosis, an immunologically silent form of cell death, and senescent neutrophils 
are cleared by the reticuloendothelial system and in the bone marrow (190, 191). 
 
Apoptosis can be induced by two major mechanisms, the extrinsic and intrinsic pathways 
(192). The activation of the extrinsic pathway requires engagement of death receptors 
located on the cell surface (Figure 1.5). The major death receptors include the TNF 
receptor 1 (TNFR1), TNF-related apoptosis-inducing ligand receptor (TRAILR) receptor 
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and Fas (also known as CD95), and the ligands for these receptors are TNF, TRAIL and 
FasL, respectively. Death receptor ligation by TRAIL or FasL induces the formation of the 
death-inducing signalling complex (DISC), which is composed to the adaptor molecule 
Fas-associated death domain protein (FADD), the initiator caspase, caspase-8 and 
caspase-10 (in humans) (193, 194). The DISC provides a platform for pro-caspase-8 
dimerisation, which is critical for its activation (195). C-FLIP, a protease-dead homolog of 
caspase-8, prevents apoptosis by competing with pro-caspase-8 for recruitment to the 
DISC and restricts its pro-apoptotic functions by forming a caspase-8/c-FLIP heterodimer 
(196, 197). Active caspase-8 drives apoptosis through the proteolytic activation of the 
executioner caspases, caspase-3 and caspase-7, which in turn execute apoptosis though 
the proteolytic cleavage of numerous substrates (192). TNF induces a similar DISC 
complex but also requires the function of TNF receptor-associated death domain (TRADD) 
and the kinase RIPK1 (198). Depending on the cell type involved, the sole activation of the 
apical caspase in this cascade (caspase-8) may or may not suffice for apoptosis induction 
(199). Cells that do not require an additional caspase signalling cascade are termed ‘type 
I’ cells. In contrast, ‘type II’ cells require caspase cascade amplification via caspase-8-
mediated cleavage of pro-apoptotic B cell CLL/lymphoma-2 (BCL-2) family member BH3-
interacting death domain agonist (Bid) (200). Caspase-8 cleaves Bid into its truncated form 
(t-Bid), which induces the depolarisation of the mitochondria, leading to the subsequent 
release of SMAC and cytochrome C from the mitochondria into the cytosol (201). In turn, 
SMAC relives XIAP-mediated inhibition of caspase-3 -7 and -9, while cytoplasmic 
cytochrome C is sensed by apoptotic protease activating factor 1 (APAF-1) and drives the 
oligomerisation of APAF-1 into a large heptameric complex that enables the recruitment of 
caspase-9 (202, 203). This multi-protein complex, consisting of cytochrome C, APAF-1 
and caspase-9, is termed the apoptosome. Assembly of the apoptosome allows proximity-
induced activation of the apical initiator caspase, caspase-9. Similar to caspase-8, 
activated caspase-9 triggers proteolytic activation of caspase-3 and -7 for apoptosis 
induction. XIAP critically discriminates whether a cell undergoes Type I or Type II 
apoptosis (199). Interestingly, the requirement for Bid cleavage in triggering death ligand-
induced apoptosis in neutrophils is ligand-specific. While FasL-induced apoptosis was 
accelerated upon Bid cleavage; Bid cleavage was dispensable for TNF-induced apoptosis 
(204, 205).  
 
There is no requirement for death receptor engagement for the intrinsic apoptosis 
pathway. The intrinsic pathway is activated following cellular stress such as DNA damage, 
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and growth factor withdrawal, which induces a change in ratio of BCL-2 family proteins and 
triggers the release of SMAC and cytochrome C (206), which promote the formation of the 
apoptosome to initiate the apoptotic signalling cascade (202, 203).  
 
In neutrophils, granular proteases trigger an unusual pathway of non-canonical apoptosis. 
For example, the release of granular cathepsin D into the cytoplasm triggers caspase-8 
activation independently of death receptor engagement and DISC complex formation (207, 
208). Cathepsin D was also reported to mediate Bid cleavage independently of caspase-8 
to initiate apoptosome assembly (209). Lastly, translocation of granular proteinase-3 into 
the cytosol allows proteolytic activation of caspase-3 independently of the canonical 
caspase-8 or caspase-9 pathways (210). 
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Figure 1.5 Apoptotic and non-apoptotic cell death pathways triggered by cell surface receptors.   
(A) Engagement of death ligands (e.g. Fas or TNF) to death receptors triggers the formation of the death-
inducing signalling complex (DISC) that activates caspase-8 to trigger apoptosis. In Type II cells, apoptosis 
induction requires the caspase amplification cascade through the apoptosome. (B) Death receptors trigger 
the assembly of a multi-protein complex containing combinations of molecules including FADD, TRADD, 
RIPK1, and RIPK3, and can trigger apoptosis or necroptosis. Caspase-8 cleaves and inactivates RIPK1 and 
RIPK3 (not shown) to inhibit necroptosis. If caspase-8 and IAPs are absent/inhibited, RIPK3 accumulates 
and phosphorylates MLKL to trigger necroptosis. (C) Ligation of TLR4 or TLR3 (not shown) triggers the 
recruitment of the signalling adaptor TRIF, which in turn recruits RIPK3 and leads to RIPK1-independent 
necroptosis. 
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1.5.6.2 Neutrophil cell death by necroptosis? 
Some cell types such as macrophages trigger a form of programmed necrosis termed 
‘necroptosis’ when the IAP and caspase-8 functions are blocked. Necroptosis is widely 
regarded as a proinflammatory form of cell death, as alarmins such as IL-33 and HMGB-1 
are released during cell rupture (211). However, whether necroptosis is beneficial or 
detrimental during health and diseases is the subject of much debate, and is likely to 
depend on the context of necroptotic cell death.  
 
Members of the TNF superfamily such as TNF, TRAIL and Fas can trigger necroptosis 
though the activity of RIPK1, RIPK3 and MLKL (212). Those TLRs that signal via the TRIF 
adaptor protein (i.e. TLR4, TLR3) also drive necroptosis, however, this occurs in a RIPK1-
independent, RIPK3 and MLKL-dependent manner (213) (Figure 1.5). Ligation of other 
TLRs can also trigger necroptosis, however, this occurs indirectly, via autocrine TNF 
signalling. In many cases necroptosis occurs when cells fail to undergo apoptosis, and in 
keeping with this, pro-apoptotic pathways negatively regulate necroptosis. For example, 
caspase-8 cleaves RIPK1 to limit necroptosis (214). In contrast, a lack of caspase-8 
activity (or expression) allows the accumulation of RIPK1 and RIPK3 and enables the 
recruitment and phosphorylation of its substrate MLKL (215). Phosphorylation induces a 
conformational change in MLKL (216) that allows the induction of necroptosis by either 
acting as a pore-forming complex or by regulating ion efflux and driving osmotic lysis (217, 
218).  
 
The physiological relevance of necroptosis is not well understood, as different studies 
report conflicting results when assessing necroptosis in animal disease models. Infected 
cells undergo apoptosis in order to limit viral replication, as viruses are obligate 
intracellular pathogens. In line with this, several groups have demonstrated that 
necroptosis serves as an alternate cell death pathway to lyse infected host cells and 
prevent viral replication. Indeed, Ripk3-deficient mice are hypersensitive to infection with 
cytomegalovirus (219) and herpes simplex virus-1 (220). In contrast, another study 
suggested that necroptotic death is not a host-driven event, and instead represents a 
pathogen subversion mechanism to facilitate bacterial dissemination. In that study, Ripk3-
deficient mice harboured significantly lower bacterial burden in spleen following S. 
Typhimurium infection (220). Consistent with the notion that necroptosis is detrimental to 
the host, ischemic and neurodegenerative injuries are often accompanied by severe 
necrosis. Pharmacological inhibition of necroptosis using the RIPK1 inhibitor necrostatin-1 
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ameliorates ischemic brain injury (221), Huntington’s disease (222) and hepatic injury 
(223) in animal models. However, these studies need to be carefully reassessed as 
necrostatin-1 was subsequently found to also target indoleamine-2,3-dioxygenase, an 
enzyme intimately involved in regulating both innate and adaptive immunity (224). Lastly, 
another study proposed that necroptosis is a mechanism to halt excessive production of 
proinflammatory cytokines that would otherwise be detrimental to the host if immune cells 
remained viable (225). The authors demonstrated that intraperitoneal administration of 
supernatants collected from cultured necroptotic cells (L929 cells treated with TNF and 
caspase inhibitor) only weakly elicited the recruitment of immune cells to the peritoneum. 
In contrast to cells that rapidly lysed, L929 cells there were only exposed to TNF produced 
sustained levels of proinflammatory cytokines, and supernatants from these cells triggered 
efficient recruitment of neutrophils to the peritoneum. Collectively, these data suggest that 
necroptosis can either be beneficial or detrimental to the host, depending on the 
circumstances of necroptosis induction.  
1.6 Aims of this thesis 
The inflammasome pathway is critical for host defence but also contributes to inflammatory 
diseases, so the molecular and cellular mechanisms regulating inflammasome function are 
of paramount medical importance. Prior to this thesis, inflammasome research was almost 
exclusively performed with macrophages and dendritic cells, without knowing whether 
these are the sole cell types that drive inflammasome-dependent responses during health 
and disease. Preliminary data from our laboratory demonstrated that neutrophils express a 
wide variety of NOD-like receptors, including NLRC4 and NLRP3, suggesting that 
neutrophils may signal via inflammasomes. Therefore, this thesis broadly aimed to 
examine the ability of neutrophils to trigger inflammasome functions upon in vitro and in 
vivo challenge, and investigate any possible cell type-specific adaptations to the 
inflammasome signalling pathway that may allow the coordination of host defence 
responses. 
 
Specific project aims: 
1.  To determine whether neutrophils signal via NLRC4 inflammasome pathway 
during in vitro or in vivo challenge with S. Typhimurium, and examine the 
contribution of neutrophil inflammasome signalling to cytokine production, immune 
cell recruitment and activation, and pathogen control in vivo. 
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2. To determine whether the NLRP3 inflammasome pathway characterised in 
macrophages is conserved in neutrophils, including upstream activation 
mechanisms, downstream cell death pathways, and signal cross-talk from related 
cell death pathways (ripoptosome and necrosome). 
3. To determine whether neutrophil inflammasomes contribute to pathological 
inflammatory responses in diseases such as endotoxin shock. 
 
The first aim of the thesis was addressed in Chapter 3. In investigating the neutrophil 
NLRC4 inflammasome pathway during in vitro and in vivo infection, I made the surprising 
finding that neutrophils trigger cell type-specific responses upon inflammasome activation, 
and that modification of this signalling pathway in neutrophils is critical for host defence. 
The second aim was addressed in Chapters 4 and 5 of this thesis, and extended upon the 
data generated in Aim 1. Chapters 4 and 5 collectively demonstrate that, similar to NLRC4, 
the signalling pathways up and downstream of the NLRP3 inflammasome in neutrophils 
also appear to be distinct as compared to macrophage NLRP3 pathways. Lastly, the third 
aim was addressed in Chapter 6, which described the potential functions for the neutrophil 
caspase-11 inflammasome in driving endotoxic shock. In summary, this thesis provides 
detailed investigations into neutrophil NLRC4, NLRP3 and caspase-11 inflammasome 
signalling pathways during host defence and inflammatory disease. 
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2. Materials and Methods 
 
Materials and methods used in the thesis that were not otherwise part of a publication or 
submitted manuscript are listed here. 
2.1 Materials 
2.1.1 Animals 
3 week-old C57BL/6 animals were ordered from the Animal Resource Centre, WA, 
Australia, and aged in specific pathogen-free animal facilities within the University of 
Queensland Biological Resource Centre (UQBR). Nlrc4-/- (29), Nlrp3-/- (40), Asc-/- (29), Ice-/- 
(226), and Casp11-/- (227) mice were backcrossed at least 10 times to C57BL/6 and bred 
in UQBR specific pathogen-free animal facilities. Age- and sex-matched animals were 
used for all experiments. The University of Queensland Animal Ethics Committee 
approved all experimental procedures.  
2.1.2 Bacterial strains 
Wild type Salmonella enterica serovar Typhimurium SL1344 and its congenic ΔSPI1 
mutant were described in Chapter 3. 
2.1.3 TLR agonists 
TLR ligands were prepared as follows: ultrapure LPS (TLR4 agonist; Invivogen) purified 
from Escherichia coli K12 was solubilised in sterile water at 1 mg/ml and was used at a 
final concentration of 100 ng/ml; LPS (TLR4 agonist; Sigma Aldrich) purified from 
Escherichia coli 0111:B4 was solubilised in sterile DPBS (Life technologies) at 1 mg/ml 
and used at a final dose of 10 mg/kg in a final volume of 200 µl for in vivo challenge; 
poly(IC) (TLR3 agonist; low molecular weight; Invivogen), a synthetic dsRNA analogue 
was solubilised in sterile water at 20 mg/ml and used at a final concentration of 50 µg/ml 
for cell culture and 10 mg/kg in a final volume of 200 µl for in vivo challenge. 
2.1.4 Inflammasome agonists 
Inflammasome agonists were prepared as follows: Nigericin (Sigma Aldrich) was 
solubilised in 100 % ethanol at 5 mM and was used at a final concentration of 5 µM; 
Adenosine triphosphate (ATP) (Sigma Aldrich) was solubilised in sterile water at 1 M and 
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used at a final concentration of 1, 1.25, 2.5 and 5 mM; alum was purchased from Pierce at 
40 mg/ml and was used at a final concentration of 150, 300 or 600 µg/ml; silica (Alfa 
Aesar) was resuspended in PBS at a 40 mg/ml and was used at a final concentration of 
150, 300 or 600 µg/ml; monosodium urate crystals were prepared from uric acid (Sigma 
Aldrich), resuspended in PBS at a final 50 mg/ml and were used at a final concentration of 
150, 300 or 600 µg/ml; Leu-Leu-OMe (Santa Cruz) was resuspended in 100% methanol at 
1 M and used at a final concentration of 0.5, 1 and 2 mM. 
2.1.5 Cell death inducers 
Death receptor inducers were prepared as follows: recombinant soluble Fas ligand (FasL; 
Enzo) was solubilised in sterile water at 100 mg/ml and used at a final concentration of 
100 ng/ml; murine TNF (Peprotech) was dissolved in sterile water at 50 mg/ml and used at 
a final concentration of 100 ng/ml; the IAP antagonist, Compound A (Cp A, a kind gift from 
the Walter and Eliza Hall Institute of Medical Research, Australia), was diluted in Opti-
MEM (Life Technologies) at 100 mg/ml and used at a final concentration of 500 ng/ml.  
2.1.6 Caspase inhibitors 
Caspase inhibitors were prepared as follows: z-VAD-fmk was solubilised in DMSO at 50 
mM and used at a final concentration of 50 µM; biotin-VAD-fmk was solubilised in DMSO 
at 10 mM and used at a final concentration of 10 µM. 
2.1.7 Antibodies for in vivo injection 
Antibodies used for in vivo injections were described in Chapters 3 and 4. 
2.1.8 Antibodies for flow cytometry 
Antibodies used for flow cytometry were described in Chapters 3 and 4. 
2.1.9 Antibodies for western blot 
Antibodies that were used in Chapter 5 that were not otherwise described in Chapters 3 
and 4 are listed in Table 2.1. 
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Table 2.1 Antibodies used for western blot. 
Antibody Specificity Antibody 
type 
Dilution Expected 
molecular 
weight (kDa) 
Source 
Primary antibodies 
α-c-IAP1 Human, 
mouse 
Rat 
monoclonal 
1:1000 62 Enzo 
α-c-FLIP Human, 
mouse 
Rat 
monoclonal 
1:500 55 (c-FLIPL), 
26 (c-FLIPs) 
Adipogen 
α-Bid Mouse Rat 
monoclonal 
1:1000 23 eBiosciences 
α-caspase-8 Mouse Rat 
monoclonal 
1:1000 55 (Full 
length); 46, 
28, 18 
(cleavage) 
Enzo 
α-TRIF Human, 
mouse, rat 
Rabbit 
polyclonal 
1:1000 76 Novus 
Biological 
α-ASC Human, 
mouse 
Rabbit 
polyclonal 
1:1000 20 Santa Cruz 
Secondary antibodies 
Goat α-rabbit 
IgG HRP 
Rabbit IgG - 1:5000 - Cell signaling 
Goat α-rat 
IgG HRP 
Rat IgG - 1:5000 - Cell signaling 
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2.2 Methods 
2.2.1 Bacterial preparation 
S. Typhimurium strains for in vitro and in vivo infection were prepared as stated in Chapter 
3. 
2.2.2 Bone marrow-derived macrophage cell culture  
Bone marrow-derived macrophages were prepared and cultured as described in Chapter 
3. 
2.2.3 Bone marrow neutrophil purification 
Bone marrow neutrophils were prepared and cultured as described in Chapter 3. 
2.2.4 Peritoneal-elicited neutrophil purification 
Neutrophils were purified from the peritoneal exudate of thioglycollate-challenged mice as 
described in Chapter 3. 
2.2.5 Human cell preparation 
Immune cells were fractionated from human blood as described in Chapter 3. 
2.2.6 Inflammasome activation assay 
Inflammasome activation assays were performed as described in Chapters 3 and 4. 
2.2.7 LPS transfection 
Cells were transfected with LPS in order to activate the cytosolic LPS receptor, caspase-
11. Cells were primed with 100 ng/ml ultrapure Escherichia coli K12 LPS for 6 h in Opti-
MEM. Cells were then washed once with Opti-MEM and the culture media replaced to 
remove residual LPS. 2 µg/ml LPS was transfected into the cytoplasm by application of 0.5 
µl Fugene (Promega) in a final volume of 200 µl Opti-MEM. Cells were incubated a further 
8 h before cell harvest. 
2.2.8 Gentamicin protection assay 
Intracellular bacterial loads in neutrophils and macrophages were quantified using 
gentamicin protect assay as described in Chapter 3. 
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2.2.9 Enzyme-linked immunosorbent assay (ELISA) 
The production of inflammatory cytokines IL-1α, IL-1β, IL-18 and TNF following cell 
stimulation was quantified using enzyme-linked immunosorbent assay (ELISA) as 
described in Chapters 3 and 4. IL-6 concentrations were quantified using matched-pair 
antibodies (BD Bioscience). Nunc MaxiSorp 96-well plates were coated with capture 
antibody (50 µL/well; diluted in 0.1 M NaHCO3) and incubated overnight at 4 oC. Plates 
were washed twice with PBST (PBS/0.05% Tween-20) to remove unbound antibody and 
blocked with 200 µL/well 10% FCS/PBS for 1 hour at 37 oC. Plates were washed twice 
with PBST, dried and 50 µL/well of cytokine standards or sample were added and 
incubated overnight at 4 oC. Unbound sample was removed from the plate by four washes 
in PBST. Detection antibody (100 µL/well; diluted in 10% FCS/PBS) was then added and 
incubated for 1 hour at 37 oC. Unbound detection antibody was removed by washing the 
plate six times in PBST. Extra-avidin peroxidase (Sigma Aldrich) was diluted 1:1000 in 
10% FCS/PBS, and 50 µL was added to each well and incubated at 37 ̊C for 30 mins. 
Plates were washed eight times in PBST before addition of 100 µL/well TMB substrate 
(Sigma Aldrich). The reaction was stopped when lower standards had developed using 
100 µL/well of 2 N H2SO4. Absorbance at 450 nm was measured using a Powerwave XS 
spectrophotometer (Bio Tek) and cytokine concentration in samples was calculated using 
data points generated from the standard curve. 
2.2.10 MTT reduction assay 
The colorimetric MTT assay measures cellular metabolic activity by monitoring cleavage of 
the tetrazolium salt 3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyl tetrazolium bromide (MTT) by 
the mitochondrial enzyme succinate dehydrogenase, forming an insoluble blue formazan 
product that indirectly indicates cellular viability. Neutrophils and macrophages were plated 
in Opti-MEM at 0.4 x 106 or 0.1 x 106 cells per well, respectively, in a final volume of 200 µl 
in a 96-well plate. Cell culture supernatant was removed after cell stimulation and replaced 
with 50 µl of MTT reagent at a final concentration of 1 mg/ml (diluted in Opti-MEM), and 
incubated for 1-2 h at 37 oC (the extent of formazan production can be visualised under a 
light microscope). MTT reagent was then replaced and with 200 µl isopropanol and 
incubated in the dark with gentle shaking in room temperature to dissolve the formazan. 
The absorbance of the solubilised formazan was measured at 570 nm using the 
Powerwave XS spectrophotometer (Bio Tek) 96-well plate reader. 
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2.2.11 Lactate Dehydrogenase (LDH) release assay 
Lactate dehyrodgenase (LDH) is a cytosolic enzyme that is released during cellular lysis 
and can be measured using a colorimetric assay that produces a red formazan product. 
The intensity of the final red formazan product can be used as an indirect indicator of 
cellular toxicity. LDH toxicity assays were performed as described in Chapter 3. 
2.2.12 Live cell imaging 
The ability of neutrophils to phagocytose silica particles was investigated by live cell 
imaging as described in Chapter 4. 
2.2.13 Flow cytometric analysis of propidium iodide uptake 
Propidium iodide is a cell-impermeable DNA-intercalating agent excluded from viable cells. 
Propidium iodide can be detected at 617 nm by flow cytometry, and is used to label dying 
cells. Neutrophils were plated on non-adherent 24-well tissue culture plastic (Nunc) and 
stimulated. Semi-adherent and floating cells were then harvested in ice-cold DPBS 
supplemented with 1% FCS and 5 mM EDTA, and collected by centrifugation at 500 g for 
5 min at 40C. Cells were resuspended in 100 µl ice-cold DPBS supplemented with 1% 
FCS, 5 mM EDTA and 1 µg/ml propidium iodide, and samples were acquired on a FACS 
Canto II (BD Bioscience) cytometer and analysed using FlowJo 9.4.4 (Tree Star). 
2.2.14 Gene profiling analysis 
NLRs were profiled for mRNA expression in human and murine immune cell fractions as 
described in Chapter 3. 
2.2.15 SDS-PAGE and immunoblotting 
Proteins from whole cell lysate and cell culture supernatant were separated using pre-cast 
4-12% or 12% polyacrylamide gels (Bio-rad) and analysed by immunoblotting as described 
in Chapters 3 and 4. 
2.2.16 ASC crosslinking  
Cell extracts were crosslinked in order to monitor ASC polymerisation following 
inflammasome stimulation. Neutrophils and macrophages were plated at 3 x 106/well and 
1.65 x 105/well, respectively, in order for ASC expression levels to be equivalent in 
untreated cell extracts (macrophages express ~18-fold more ASC protein on a per-cell 
basis, which approximately scales with cell volume). Following stimulation, cells were 
washed twice with 250 µl of ice-cold 50 mM HEPES and lysed in 250 µl ice-cold buffer (0.5 
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mM HEPES, 0.5% Triton X-100, 0.3% Benzonase, Roche general protease inhibitor) for 
10 min on ice. Cell lysates were centrifuged at 6000 g for 15 min at 4 oC, and the soluble 
fraction removed. The Triton X-100 insoluble cell pellet enriched with ASC polymers was 
resuspended in 200 µl 50 mM HEPES supplemented with 50 mM NaCl and 2 mM 
disuccinimidyl suberate (DSS; Thermo Scientific) and incubated for 45 min at 37 oC to 
cross-link ASC oligomers. The ASC polymer-enriched insoluble fraction was then isolated 
by centrifugation at 6000 g for 15 mins at 4 oC, and resuspended in 20 µl of 1x LDS 
loading buffer (Invitrogen). Samples were separated by gel electrophoresis (precast 4-12% 
polyacrylamide gel; Bio-rad), transferred to nitrocellulose membrane, and analysed by 
immunoblotting. 
2.2.17 Active caspase pulldown 
Cells were treated with biotin-VAD-fmk in order to label active caspases following 
inflammasome activation. 10 µM biotin-VAD-fmk (Santa Cruz) was added to 4 x 106 
neutrophils 30 min prior to cell stimulation. Cell extracts were then lysed in 200 µl ice-cold 
buffer (1% IPEGAL, 50 mM HEPES, 50 mM NaCl, 0.3% benzonase) for 10 min on ice. 
Paramagnetic streptavidin beads (Promega) were added to the cell culture supernatant or 
cell extract, and incubated overnight with gentle rotation at 4 oC. Beads were washed 
thrice in 500 µl buffer with increasing NaCl concentration (1% IPEGAL, 50mM HEPES plus 
150 mM, 300 mM, or 500 mM NaCl). Pellets were then resuspended in 20 µl 1x LDS 
buffer. Beads were boiled for 95 0C for 10 min and separated by centrifugation at 6000 g 
for 1 min and the soluble fraction containing the biotin-VAD-fmk-trapped proteins was 
separated by gel electrophoresis (precast 12% polyacrylamide gel; Bio-rad) before protein 
transfer to nitrocellulose, and immunoblot analysis. 
2.2.18 In vivo Salmonella challenge 
Mice were challenged with Salmonella as described in Chapter 3. 
2.2.19 Alum-induced peritonitis 
Alum was administered by intraperitoneal injection, and immune cell recruitment to the 
peritoneum was quantified as described in Chapter 3. 
2.2.20 Murine endotoxic shock 
Mice were challenged with 10 mg/kg poly(IC) i.p. in a total volume of 200 µl DPBS at 0700 
h. 6h later, mice were re-challenged, this time by intraperitoneal injection with 10 mg/kg 
Escherichia coli 0111:B4 LPS (Sigma Aldrich)  in a final volume of 200 µl DPBS. Poly(IC) 
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and LPS injection times were kept constant between experiments to account for murine 
circadian rhythm. Rectal temperature was monitored using a BART 12R-220 thermometer 
(World Precision Instruments) every 2 h for the first 10 h post-LPS challenge, and were 
monitored every 4-6 h thereafter. Mice were considered moribund and sacrificed 
immediately when their rectal temperature dropped below 240C or when they were unable 
to regain posture. 
2.2.21 Collection of mouse serum 
Serum was collected and analysed by ELISA to assess the production of proinflammatory 
cytokines in control and infected animals. Post-euthanasia, whole blood was collected by 
heart puncture using a 27-gauge needle. Whole blood was left to clot in room temperature 
for 45 min-1 h. The serum was separated by centrifugation at 1000 g for 10 mins at room 
temperature.  
2.2.22 Analysis of immune infiltrate by flow cytometry 
Immune cell recruitment to the peritoneum following intraperitoneal Salmonella challenge 
was analysed as described in Chapter 3. 
2.2.23 Analysis of cellular toxicity in vivo by flow cytometry 
Cellular toxicity in the immune cell infiltrate following Salmonella challenge was quantified 
as described in Chapter 3. 
2.2.24 Statistical analysis 
Statistically significant differences were calculated using Prism 6 (GraphPad software). For 
comparisons between two normally distributed data sets, an unpaired t-test with two-tailed 
distribution (Mann-Whitney t-test) was used. For comparisons between 3 or more samples 
across different time points, a two-way ANOVA was used. For all data contained in this 
thesis, statistically significant data is represented as *p<0.05, **p< 0.01, ***p<0.005.
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3. The neutrophil NLRC4 inflammasome selectively 
promotes IL-1β maturation without pyroptosis during 
acute Salmonella challenge 
 
 
 
 
 
The data presented here in Chapter 3 were previously published and were unformatted to 
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3.1 Summary 
The NLRC4 inflammasome drives potent innate immune responses against Salmonella, by 
eliciting caspase-1-dependent pro-inflammatory cytokine production (e.g. interleukin-
1β, IL-1β) and pyroptotic cell death. Macrophages are well established to trigger 
inflammasome-mediated host defense during acute Salmonella-induced peritonitis, 
however the potential contribution of other cell types was unclear. Here we demonstrate 
that neutrophils, typically viewed as cellular targets of IL-1β, themselves activate the 
NLRC4 inflammasome during acute Salmonella infection, and are a major cell 
compartment for IL-1β production during acute peritoneal challenge in vivo (106 
CFU/mouse). Importantly, we also find that neutrophils are resistant to pyroptosis, a 
unique specialization of the inflammasome pathway amongst cells so far described. 
NLRC4 pathway specialization allows neutrophils to sustain IL-1β production at a site of 
infection, without compromising the crucial inflammasome-independent antimicrobial 
effector functions that would be lost if neutrophils rapidly lysed upon caspase-1 activation. 
Inflammasome pathway specialization in neutrophils thus maximizes host pro-
inflammatory and antimicrobial responses during pathogen challenge.  
3.2 Introduction 
The innate immune system engages an array of pattern recognition receptors (PRR) to 
detect signals of host infection, tissue injury and cellular stress. Among these receptors 
are the Toll-like receptors, C-type lectins, cytoplasmic nucleic acid receptors (e.g. RIG-like 
helicases and HIN-200 proteins) and Nod-like receptors (NLRs). NLRs are activated by 
pathogen-associated molecules and host-derived alarmins indicating cellular injury or 
stress, and are potent mediators of inflammation. The human NLR family has 22 
members, and is defined by the presence of a central NACHT domain that triggers self-
oligomerization. A functional subgroup of the NLR family form high molecular weight 
complexes known as inflammasomes (e.g. NLRP1, NLRP3, NLRP6, NLRP12 and NLRC4) 
(2). 
 
Inflammasomes are ‘danger’ sensor complexes that trigger immune system activation via 
cytokine processing. Inflammasome activation involves oligomerization of the NLR 
scaffold, followed by recruitment, clustering and auto-activation of a pro-inflammatory 
caspase, caspase-1, usually via a protein adaptor ASC (2). Upon activation, caspase-1 
mediates the maturation and secretion of pro-inflammatory cytokines such as interleukin 
(IL)-1β and IL-18, and rapidly induces a lytic form of inflammatory cell death (pyroptosis). 
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These caspase-1 functions together mediate host-protective inflammatory and 
antimicrobial responses. IL-1β and IL-18 drive pro-inflammatory responses, including the 
recruitment and activation of phagocytes (4), whilst pyroptotic cell death releases 
intracellular pathogens into the extracellular environment, rendering them susceptible to 
neutrophil-mediated destruction (115). Specific Gram-negative bacteria encoding type 3 or 
4 secretion systems, such as Salmonella enterica serovar Typhimurium (S. Typhimurium, 
Stm) and Pseudomonas aeruginosa (P. aeruginosa) trigger activation of the NLRC4 
inflammasome (29, 51). NLRC4 activation by S. Typhimurium occurs upon cytosolic 
recognition of bacterial ligands (needle protein, PrgJ rod protein, bacterial flagellin) 
following their translocation into the host cell cytosol by the Salmonella pathogenicity 
island-1 type 3 secretion system (SPI1-T3SS) (45, 47, 54). NLRC4 activation by these 
ligands is mediated by NAIP co-receptors, also encoded within the NLR family (44, 45, 47, 
48). NLRC4 has a CARD domain and so can interact directly with pro-caspase-1 through 
homotypic CARD-CARD interactions, bypassing an absolute requirement for the ASC 
inflammasome adaptor. This ASC-independent NLRC4 inflammasome was reported to 
form a death complex that drives caspase-1-dependent macrophage lysis (8). However, 
maximal cytokine processing by the NLRC4 inflammasome in macrophages requires ASC 
(8).  
 
Although recent years have seen great progress in our understanding of the molecular 
mechanisms underlying NLRC4 inflammasome activation, several key questions regarding 
NLRC4 biology remain outstanding. One such question is the identity of the cell types 
responsible for initiating NLRC4 pathways during in vivo infection; most NLRC4 research 
to date has concentrated on macrophages and dendritic cells without clear data indicating 
these are the dominant cell types triggering NLRC4 activation, IL-1β/IL-18 production and 
pyroptosis in vivo. Another key question is the extent to which inflammasome-dependent 
processes (cytokine production versus cell death) are inter-regulated. Production of active 
IL-1β/IL-18 is controlled by caspase-1 at two levels: cytokine processing from the inactive 
precursor to the mature form, and cytokine release from the cytosol to the extracellular 
space. It is currently unclear whether the release of mature cytokine occurs solely via an 
active caspase-1-dependent unconventional secretion pathway (11) or whether passive 
release during caspase-1-dependent cell death contributes to cytokine export. It is thus 
presently unresolved whether pyroptotic cell death is actually necessary for full 
inflammasome-dependent cytokine production (through contributing to cytokine release) or 
alternatively, whether pyroptosis serves to limit cytokine production by preventing the 
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further processing of pro-caspase-1, pro-IL-1 and pro-IL-18 cytosolic pools. If the latter, 
this raises the further intriguing question of how inflammasome pathways trigger sustained 
cytokine production during in vivo infection and inflammatory disease, when 
inflammasome-activated cells would be expected to rapidly lyse, limiting their ability to 
produce further cytokines. 
 
Neutrophils are the first cells recruited in large quantities to a site of infection or injury, and 
inflammasome activity itself induces IL-1-dependent neutrophil influx in vivo. The 
possibility that neutrophils themselves are competent for inflammasome function and 
thereby contribute to IL-1-dependent amplification of neutrophil recruitment/activation and 
pathogen clearance has not been carefully investigated. Herein, we report that the NLRC4 
inflammasome is expressed by both human and mouse neutrophils, and that neutrophil 
NLRC4 selectively promotes S. Typhimurium-dependent cytokine processing, but not 
pyroptosis, in vitro and in vivo. This ability of neutrophils to produce caspase-1-dependent 
IL-1β without concomitant cell death is unique amongst NLRC4-signaling cells so far 
described, and for the first time explains the extended kinetics of inflammasome-
dependent IL-1β production during acute infection. Furthermore, our finding that 
neutrophils trigger caspase-1-dependent IL-1β without concomitant pyroptosis challenges 
the dogma that these inflammasome-dependent processes are always initiated together. 
Taken together, our results indicate that inflammasome pathway specialization in 
neutrophils allows their prolonged release of IL-1β, allowing a positive amplification loop of 
neutrophil recruitment and activation, without compromising the crucial inflammasome-
independent antimicrobial effector functions of neutrophils that would be lost if neutrophils 
were to rapidly lyse by pyroptotic cell death. Inflammasome pathway specialization in 
neutrophils thus maximizes host pro-inflammatory and antimicrobial responses during 
Salmonella challenge.  
3.3 Results 
3.3.1 Neutrophils express multiple NLRs 
Neutrophils express a wide variety of PRR (228) and are likely candidates for NLR 
function. However, the expression and potential function of most NLRs in neutrophils is 
unclear (228). To date, only one recent study has specifically shown a function for a 
neutrophil inflammasome, that of NLRP3, in mediating host inflammatory responses during 
in vivo infection (229). In order to define the neutrophil NLR repertoire, we examined the 
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mRNA expression of all 22 NLR family members amongst purified immune cell fractions 
from human blood. Human blood was separated into polymorphonuclear cell (PMN) and 
peripheral blood mononuclear cell (PBMC) fractions by discontinuous density 
sedimentation. The PMN and PBMC fractions were then further purified on the basis of cell 
surface markers. 15 of the 22 human NLRs are reliably detectable in such cells (Figure 
3.1A). Human neutrophils purified from the PMN fraction by CD16 positive selection 
express numerous NLRs, including the inflammasome scaffolds NLRP1, NLRP3, NLRP6, 
NLRP12 and NLRC4 (Figure 3.1A, Supplementary Figure 3.1). For example, NLRP3 
and NLRC4 mRNAs were expressed in purified human neutrophils at similar or greater 
levels than other cell types for which NLRP3 and NLRC4 function is well characterized, 
such as CD14+ monocytes, monocyte-derived macrophages (MDM) and monocyte-derived 
DCs (MDC) (Figure 3.1B, C), and NLRP12 mRNA showed a striking enrichment in 
neutrophils versus other white blood cell populations within the panel (Figure 3.1D). 
Mouse bone marrow neutrophils (BMN) also expressed Nlrp3, Nlrc4, and Nlrp1a at similar 
or greater levels to bone marrow macrophages (BMDM) and/or bone marrow dendritic 
cells (BMDC) (Figure 3.1E, F, Supplementary Figure 3.1). In human and murine 
macrophages, cell stimulation with the TLR4 agonist, lipopolysaccharide (LPS) 
upregulates the expression of Nlrp3 and Nlrc4 (230). In keeping with this, we observed 
LPS-dependent upregulation of Nlrp3 and Nlrc4 expression in murine neutrophils 
(Supplementary Figure 3.2). Constitutive and inducible expression of inflammasome-
forming NLRs in neutrophils suggests that like other PRR, inflammasomes may modulate 
neutrophil responses during inflammation. 
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Figure 3.1 Human and mouse neutrophils express multiple NLRs.  
(A) Heat map showing median-normalized qPCR profiles of all NLRs reliably detected in human blood cell 
populations or myeloid cell lines. Expression profile detail for (B) NLRP3, (C) NLRC4 and (D) NLRP12 in 
purified human leukocyte populations and cell lines. Neutrophil expression of (E) Nlrp3 and (F) Nlrc4 was 
confirmed in a panel of mouse tissues and purified cell populations. Data are mean + SD of technical 
replicates and are representative of three independent experiments. Human cells: polymorphonuclear 
fraction (PMN; containing neutrophils and eosinophils), neutrophils (CD16+ cells from PMN fraction, which 
excludes monocytes), bulk peripheral blood mononuclear cell fraction (PBMC), monocytes (CD14+ cells from 
PBMC fraction), monocyte-derived dendritic cells (MDC), monocyte-derived macrophages (MDM), T cells 
(CD3+), B cells (CD19+), NK cells (CD56+), and the monocytic cell lines THP-1, HL60 and U937. Mouse cells: 
bone marrow neutrophils (BMN), bone marrow-derived dendritic cells (BMDC), bone marrow-derived 
macrophages (BMDM), and splenic B and T lymphocytes. See also Figure S3.1 and S3.2. 
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3.3.2 The neutrophil NLRC4 inflammasome drives caspase-1 and IL-1β activation 
Neutrophil expression of NLRC4 mRNA suggested that neutrophils may participate in 
inflammasome-dependent antimicrobial responses against Salmonella. We investigated 
this possibility by infecting mature bone marrow neutrophils purified from wild-type (WT) 
and caspase-1/11 doubly-deficient (Ice-/-) mice. Neutrophils were primed with LPS to 
induce pro-IL-1β expression, prior to infection with varying doses of log-phase S. 
Typhimurium SL1344. BMDMs, which are well established to activate NLRC4-dependent 
pathways (8, 54), were prepared and treated in parallel for comparison. Treatment with 
LPS alone did not stimulate IL-1β secretion in either neutrophils or macrophages, but 5 h 
S. Typhimurium infection triggered robust IL-1β secretion in LPS-primed neutrophils 
(Figure 3.2A), similar to infected WT macrophages (Figure 3.2B). Salmonella-induced IL-
1β secretion in both neutrophils and macrophages was ablated in Ice-/- cells, indicating that 
IL-1β production was mediated by an inflammasome. Of note, the optimal dose of S. 
Typhimurium, and the timing of IL-1β secretion varied between neutrophils and 
macrophages.  
 
Maximal Salmonella-dependent cytokine production by the NLRC4 inflammasome in 
macrophages requires the ASC inflammasome adaptor (8). We found that ASC was also 
required for optimal Salmonella-dependent IL-1β production from neutrophils (Figure 
3.2C), similar to macrophages (Figure 3.2D). At higher multiplicities of infection, moderate 
ASC-independent IL-1β production was apparent for both neutrophils and macrophages, 
and we confirmed by immunoblotting that ASC-independent IL-1β was indeed the mature 
form (Figure 3.2E). As Salmonella-dependent IL-1β production was maximal in neutrophils 
and macrophages at distinct multiplicities of infection, for subsequent in vitro experiments 
we infected neutrophils and macrophages with Salmonella doses that yield robust IL-1β 
production (MOIs of 25 and 5, respectively). 
 
In macrophages, IL-1β production during acute Salmonella infection relies upon the 
Salmonella SPI1-T3SS needle (54), which translocates bacterial proteins into the 
macrophage cytosol for recognition by the NAIP co-receptors of the NLRC4 inflammasome 
(44, 45, 47, 48). NLRP3 is also reported to contribute to Salmonella sensing in unprimed 
macrophages at later time points of infection (111, 146); the late time course of NLRP3 
function in unprimed cells presumably reflects the functional requirement for infection-
induced NLRP3 upregulation. We thus examined whether similar host and pathogen 
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determinants underlie IL-1β production from neutrophils. We infected WT or 
inflammasome-deficient neutrophils and macrophages with S. Typhimurium or its isogenic 
mutant (ΔSPI1) and assayed IL-1β production at 5 h post-infection. The Salmonella SPI1-
T3SS translocon was required for IL-1β secretion from both macrophages and neutrophils 
(Figure 3.2E, Supplementary Figure 3.3A-B). As for macrophages, NLRC4 was 
essential for neutrophil IL-1β secretion at 5h post infection (Figures 3.2E, Supplementary 
Figure 3.3A-B). Western blot confirmed that IL-1β and caspase-1 are both efficiently 
processed, and their mature forms (IL-1β p17, caspase-1 p20) were released from WT but 
not Nlrc4-/- or caspase1/11-deficient Ice-/- neutrophils infected with WT S. Typhimurium 
(Figure 3.2E). We next examined whether neutrophils secrete other caspase-1-dependent 
cytokines upon NLRC4 activation. IL-18 secretion by Salmonella-infected neutrophils and 
macrophages followed a similar pattern to IL-1β production by these cells 
(Supplementary Figure 3.3B-C); however, LPS-primed neutrophils were poorer 
producers of IL-18, as compared to IL-1β. Consistent with previous reports (111, 146), we 
observed that Nlrp3 deficiency led to a modest but reproducible suppression of IL-1β and 
IL-18 production in LPS-primed neutrophils and macrophages at 5 h post-infection 
(Supplementary Figure 3.3A-D). In examining this further, we observed that NLRP3 
appeared to provide a supportive function to the NLRC4 inflammasome at 1 h post-
infection, but the contribution of NLRP3 to NLRC4-dependent IL-1β production diminished 
as the time course progressed (Supplementary Figure 3.3E). We confirmed that 
caspase-1l was dispensable for neutrophil IL-1β production (Supplementary Figure 3.3F) 
under our experimental conditions. Together, these data indicate neutrophils can trigger 
NLRC4 function, wherein NLRC4-dependent caspase-1 drives the production of 
inflammasome target cytokines. IL-1β was the dominant cytokine secreted by this pathway 
in neutrophils, perhaps due to stronger intracellular expression of this cytokine precursor 
as compared to pro-IL-18 in LPS-primed cells. 
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Figure 3.2 Neutrophil NLRC4 activation triggers caspase-1 and IL-1β  cleavage and secretion.  
(A, C, E left panel) bone marrow neutrophils or (B, D, E right panel) bone marrow-derived macrophages 
were primed with 100 ng/ml LPS for 4 h before infection with S. Typhimurium (Stm). Cells were infected with 
increasing doses of Stm and IL-1β secretion was measured by ELISA at (A, B) 1, 3 and 5h post-infection, or 
(C, D) 5h post-infection. (E) Cells were infected with Stm or its isogenic ΔSPI1 mutant (MOI of 25 or 5 for 
neutrophils and macrophages, respectively) and cell extracts and supernatants were harvested at 5 h post-
infection. Cleaved caspase-1 and IL-1β in cell supernatants (SN) and expression of pro-caspase-1, pro-IL-
1β, ASC and GAPDH (loading control) in cell extracts (XT) were detected by western blot. All ELISA data are 
mean + SD of technical triplicate cell stimulations. All data are representative of 3 independent experiments, 
except B-D data, which are representative of 2 independent experiments. See also Figure S3.3. 
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3.3.3 The neutrophil inflammasome is activated during in vivo infection 
We next examined whether, like bone marrow neutrophils challenged in vitro, neutrophils 
elicited and infected by Salmonella in vivo can produce inflammasome-dependent IL-1β. 
WT and Ice-/- mice were infected (i.p.) for 6 h with 106 CFU S. Typhimurium, after which 
elicited neutrophils were purified and cultured ex vivo in the presence of the membrane-
impermeable antibiotic, gentamicin, to eliminate extracellular bacteria. Despite only low 
levels of active cell infection at these time points (Figure 3.3A), WT neutrophils efficiently 
secreted IL-1β ex vivo (Figure 3.3B), and IL-1β secretion was abrogated in Ice-/- mice, 
indicating that neutrophil IL-1β secretion is inflammasome-dependent. Consistent with in 
vitro data (Supplementary Figure 3.3C), purified neutrophils infected in vivo produced 
minimal caspase-dependent IL-18 (Figure 3.3C).  
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Figure 3.3 Neutrophils infected with S. Typhimurium in vivo trigger inflammasome-dependent IL-1β  
secretion.  
Mice were challenged with S. Typhimurium (Stm) and sacrificed at 6 h post-infection. Ly6G+ neutrophils in 
the peritoneal exudate were purified by positive selection. (A) Neutrophil intracellular bacterial loads were 
analyzed at 30 mins post-purification. (B) In vivo elicited neutrophils were cultured ex vivo for 8 h, and 
supernatants were collected for (A) IL-1β and (B) IL-18 quantification by ELISA. Data are mean of 
neutrophils elicited from individual mice (8-10 mice per genotype) combined from two independent 
experiments.  
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3.3.4 Neutrophils are a major source of IL-1β during acute Salmonella infection 
Given that neutrophils possess a functional NLRC4 inflammasome (Figure 3.2), and 
neutrophils comprise a large component of the cellular infiltrate in many inflammatory 
settings, we hypothesized that the neutrophil compartment may be a significant contributor 
to IL-1β production during acute infection. We first measured the kinetics of immune cell 
recruitment during Salmonella-induced peritonitis. In uninfected mice, neutrophils 
(CD11b+Ly6C+Ly6G+) and monocytes (CD11b+Ly6C+Ly6G-) are barely detectable, and 
resident macrophages (CD11b+F4/80+) are the major CD11b+ myeloid cells in the 
peritoneal cavity (Figures 3.4A-B). Neutrophils were recruited as early as 1 h post 
infection and neutrophil numbers increased by 165-fold compared to uninfected mice at 6h 
(Figure 3.4B). Monocytes were recruited more slowly and weakly as compared 
neutrophils, showing significant recruitment at 4 h (11-fold) and 6 h (26-fold) as compared 
to uninfected mice (Figure 3.4B). In contrast, macrophage abundance in the peritoneal 
exudate declined throughout the infection time course, showing significantly decreased 
abundance at 4 and 6 h (Figures 3.4A-B), consistent with previous reports (231, 232). We 
also profiled the kinetics of intracellular pro-IL-1β expression in myeloid cell subsets over 
the same infection time course. Macrophages, monocytes and neutrophils all showed a 
rapid induction in intracellular pro-IL-1β expression in the first 2 h of S. Typhimurium 
challenge (Supplementary Figure 3.4A).  
 
To quantify the contribution of the neutrophil compartment to inflammasome-dependent IL-
1β production in vivo, we examined the effect of neutrophil depletion. 24 h after α-Ly6G 
antibody injection, mice were challenged with S. Typhimurium over 6 h. α-Ly6G 
administration efficiently depletes neutrophils (Figure 3.4C) without affecting the 
abundance of other myeloid cells (Supplementary Figures 3.4B-C), as shown previously 
(233, 234). Consistent with the strong expression of intracellular pro-IL-1β in macrophages 
(CD11b+F4/80+) 1 h post Salmonella challenge (Supplementary Figure 3.4A), IL-1β 
levels in the peritoneal lavage fluid dramatically increased at 1 h post-infection in both 
undepleted and neutrophil-depleted mice (Figure 3.4D), suggesting that resident 
peritoneal macrophages provide the initial wave of IL-1β during Salmonella challenge. 
However, IL-1β levels continued to increase by 2-fold between 1 h and 2 h in undepleted 
mice (coinciding with neutrophil recruitment, Figure 3.4B) whilst IL-1β levels remained 
unchanged in depleted mice (Figure 3.4D). IL-1β levels remained higher (3-fold) in 
undepleted mice as compared neutrophil-depleted mice at 6 h post-infection (Figure 
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3.4D). Importantly, neutrophil depletion did not affect monocyte/macrophage intracellular 
pro-IL-1β (Supplementary Figures 3.4D-E), indicating that neutrophil depletion did not 
indirectly influence IL-1β expression or secretion from monocyte/macrophages. 
Collectively, these data suggest that resident macrophages provide the first wave of IL-1β 
production within the first hour of infection, whereas newly-recruited neutrophils continue 
to produce IL-1β thereafter. Similar results were obtained 12h post-infection, where 
neutrophil depletion reduced IL-1β levels in the peritoneum by 60% (Supplementary 
Figures 3.4F-G) and in the serum by 50% (Figure 3.4E). These results, coupled with our 
earlier data showing that in vivo-challenged neutrophils efficiently produce IL-1β ex vivo, 
suggest that neutrophils are a major cellular compartment for IL-1β production from 1 to 12 
h post-infection. As expected given the known anti-microbial functions of neutrophils 
during Salmonella infection, neutrophil-depleted mice exhibited significantly higher 
bacterial burdens in both liver and spleen (Figures 3.4F-G). Neutrophil-derived IL-1β likely 
contributes to host defense, as IL-1β neutralization increased bacterial burden in the liver 
and spleen (Figure 3.4H-I). 
 
Consistent with our earlier observations that primed neutrophils are poor producers of IL-
18 (Figure 3.3B, Supplementary Figure 3.3), acute (1-6 h) infection did not induce IL-18 
levels in the peritoneum (Supplementary Figure 3.5A), and neutrophil depletion did not 
significantly affect IL-18 production after 12 h Salmonella challenge in vivo 
(Supplementary Figure 3.5B), despite modest IL-18 induction at this time point 
(Supplementary Figure 3.5C). Thus non-neutrophilic cells are the primary producers of 
IL-18 during acute Salmonella challenge.  
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Figure 3.4 Neutrophils are major producers of IL-1β  during acute Salmonella infection.  
(A) Flow cytometry plots and (B) absolute abundance of macrophages (CD11b+F4/80+), neutrophils 
(CD11b+Ly6C+Ly6G+) and monocytes (CD11b+Ly6C+Ly6G-) following infection with Stm. The statistical 
significance for each cell type at each time point was calculated relative to uninfected. (C-G) Mice were 
administered with isotype control (mock-depleted) or α-Ly6G antibody (neutrophil-depleted) for 24 h before 
infection with Stm. (C) Neutrophil abundance in the peritoneum and (D) IL-1β levels in the peritoneal lavage 
fluid up to 6 h post-infection. At 12 h post-infection (E) serum IL-1β was measured by ELISA, and pathogen 
loads in the (F) liver and  (G) spleen were quantified by serial dilution. (H-I) Mice were administered with 
isotype control or α-IL-1β neutralizing antibody for 16 h prior to infection with Stm. At 24 h post-infection, 
pathogen loads in the (H) liver and (I) spleen were quantified by serial dilution. Flow cytometry plot in (A) is 
representative of at least 4 independent experiments. Data are mean of (B-D) 3-8 individual mice per time 
point combined from 2-3 independent experiments, (E-G) 14-16 mice pooled from 3 independent 
experiments, or (H-I) 9-10 mice pooled from 2 independent experiments. See also Figures S3.4 and S3.5. 
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3.3.5 Neutrophils are resistant to pyroptosis in vitro and in vivo 
In addition to the regulation of inflammasome-dependent cytokines, a hallmark of NLRC4 
activation in macrophages and dendritic cells is the rapid induction of caspase-1-
dependent but cytokine-independent pyroptotic cell death (29). We thus examined whether 
Salmonella infection also triggered NLRC4-dependent neutrophil death in concert with 
cytokine regulation. As for previous experiments, we primed neutrophils and macrophages 
with LPS and then infected cells in vitro with increasing doses of S. Typhimurium. 
Surprisingly, NLRC4-dependent caspase-1 activation (Figure 3.2) did not trigger 
concomitant neutrophil death, as assessed by light microscopy (not shown) or by 
quantifying the release of intracellular lactate dehydrogenase (LDH) into the supernatant 
(Figure 3.5A). By contrast, macrophages underwent rapid caspase-1-dependent cell 
death upon S. Typhimurium infection (Figure 3.5B). Macrophage pyroptosis was evident 
as early as 1 h post-infection, whereas neutrophils showed no evidence of caspase-1-
dependent cell death as late as 5h (Figures 3.5A-B) or even 16h (Supplementary Figure 
3.6A) post-infection, despite clear neutrophil death when treated with an apoptotic trigger, 
staurosporine, at these time points (Supplementary Figure 3.6B). In keeping with the lack 
of inflammasome-dependent cell death in neutrophils, and the reported ASC-
independence of NLRC4/caspase-1-triggered pyroptosis in macrophages (8), Asc-
deficiency did not affect LDH release in neutrophils or macrophages at 5 h post-infection 
(Figures 3.5C-D). While NLRC4 and the Salmonella SPI1-T3SS were absolutely required 
for Salmonella-dependent cell death in macrophages, neither WT Salmonella nor its 
isogenic ΔSPI1 mutant triggered neutrophil cell death, and this was unaffected by 
knockout of inflammasome components (Supplementary Figure 3.6C-D). To test whether 
the ability of neutrophils to resist caspase-1-dependent cell death was a general feature of 
inflammasome pathways in this cell type, we examined pyroptotic cell death downstream 
of a non-NLR inflammasome. AIM2 is a cytosolic dsDNA sensor of the HIN200 family, and 
a potent driver of pyroptotic cell death in macrophages. While AIM2 activation by 
transfected DNA transfection enabled caspase-1 processing, it did not trigger caspase-1-
dependent neutrophil death (Figure 3.5E). Together, these in vitro data indicate that while 
NLRC4 activation in macrophages triggers rapid caspase-1-dependent cell death, 
neutrophils are resistant to this arm of caspase-1 signaling, despite the concomitant 
activity of other caspase-1 functions (e.g. IL-1β processing, Figure 3.2).  
 
Pyroptotic death is a host defense mechanism that restricts the ability of Salmonella to 
replicate intracellularly within macrophages (115). As neutrophils were resistant to 
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pyroptotic cell death, we hypothesized that the beneficial function of caspase-1 in 
suppressing intracellular pathogen loads in macrophages may be absent in neutrophils.  
We thus infected neutrophils and macrophages with increasing doses of Salmonella in 
vitro as for previous experiments (in the presence of gentamicin to neutralize extracellular 
bacteria), and monitored intracellular bacterial loads over a time course of in vitro infection 
(Figure 3.5F-G). In line with previous studies (54, 115), caspase-1deficiency dramatically 
increased the intracellular bacterial burden of macrophages (Figure 3.5G), coinciding with 
their inability to undergo cell death, and both caspase-1-dependent and -independent 
mechanisms contributed to suppressing intracellular pathogen loads by 16 h post-
infection. By contrast, the intracellular bacterial burden of neutrophils was not strongly 
affected by caspase-1 deficiency (Figure 3.5F). The intracellular loads of live bacteria 
were lower in neutrophils versus macrophages, likely reflecting their superior anti-microbial 
defense mechanisms, and we observed the presence of Salmonella in most neutrophils by 
microscopy (not shown). Surprisingly, both WT and Ice-/- neutrophils failed to suppress 
intracellular bacterial burden by 16 h post-infection. The inability of neutrophils to undergo 
pyroptosis may thus dramatically compromise their ability to defend against intracellular 
infection. 
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Figure 3.5 Neutrophils do not undergo Salmonella-dependent pyroptosis in vitro.  
Cytoplasmic LDH release into the supernatant, as compared to total intracellular LDH of uninfected cells was 
quantified as a measure of cell death. (A, C, F) bone marrow neutrophils and (B, D, G) bone marrow-derived 
macrophages were all primed for 4 h with LPS before infection with Stm. Cells were infected with increasing 
Stm doses and LDH release was measured at (A, B) 1, 3 and 5 h, or (C, D) 5 h post-infection. (E) Cells were 
LPS-primed for 3 h before lipofectamine transfection of calf thymus DNA. LDH release was measured at 6 h 
post transfection. Caspase-1 cleavage was measured in cell supernatants (SN) by immunoblotting, relative 
to expression of the GAPDH loading control in cell extracts (XT). (F-G) Cells were LPS-primed for 4 h and 
infected with Stm (MOI 5 or 25). Intracellular bacterial CFU of bone marrow neutrophils (F) and bone 
marrow-derived macrophages (G) were enumerated. Data are mean + SD of technical triplicate cell 
stimulations and are representative of (A-B) 3 or (C-G) 2 independent experiments. 
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To investigate whether in vivo challenged neutrophils are also resistant to pyroptosis, we 
infected WT and Ice-/- mice with S. Typhimurium i.p for 6 h, purified the in vivo-infected 
neutrophils and cultured them ex vivo for 8 h. Despite inflammasome-dependent IL-1β 
release (Figure 3.3A), caspase-1/11 deficiency did not affect the release of intracellular 
LDH (Figure 3.6A). To further investigate this phenomenon in a fully in vivo setting, we 
challenged mice with S. Typhimurium i.p. for 1.5 h. As inflammasome-dependent cell 
death triggers a rapid loss in plasma membrane integrity, pyroptotic cells can be identified 
with the membrane impermeable dye, 7-AAD (115). 18% of resident peritoneal 
macrophages were no longer viable at 1.5 h post-Salmonella challenge, but macrophage 
death was two-fold reduced in Ice-/- animals (Figure 3.6B). In contrast, 7-AAD uptake by 
neutrophils at the same time point was low, and slight differences in neutrophil death in 
WT versus Ice-/- animals were not statistically significant (Figure 3.6B). To ensure 
sufficient time for the activation of caspase-1-dependent programs in newly-recruited 
neutrophils, the experiment was repeated using an extended infection time course of 6 h. 
As for 1.5 h (Figure 3.6B), 7-AAD uptake remained low amongst neutrophils at 6 h post-
infection, and showed no significant difference between WT and Ice-/- neutrophils (Figure 
3.6C). In all, our in vitro and in vivo data indicate that while neutrophils drive substantial 
inflammasome-dependent IL-1β release, they possess a specialized inflammasome 
pathway that renders them resistant to pyroptotic cell death during challenge with 
Salmonella. 
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Figure 3.6 Neutrophils infected with Salmonella in vivo resist pyroptotic cell death.  
(A) Mice were challenged with Stm and Ly6G+ neutrophils in the peritoneal exudate at 5.5 h post-infection 
were purified by positive selection. In vivo elicited neutrophils were cultured ex vivo for 5 h in the presence or 
absence of 50 µM z-VAD-FMK, and assayed for LDH release. Data are mean of neutrophils elicited from 8 
individual mice combined from two independent experiments. (B, C) Percentage of 7-AAD+ cells amongst 
macrophages or neutrophils in the peritoneal exudate following Stm challenge for (B) 1.5 h or (C) 6 h, and 
representative flow cytometry plots. Data are mean of 8-9 individual mice combined from two independent 
experiments. 
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3.4 Discussion  
The NLRC4 inflammasome pathway is now well established to mediate host inflammatory 
and antimicrobial responses, leading to pathogen control and clearance. However, the key 
cell types responsible for initiating NLRC4 pathways during in vivo infection with 
Salmonella were unclear. During Salmonella intra-peritoneal challenge, peritoneal 
macrophages quickly respond to Salmonella challenge with NLRC4 inflammasome 
formation and caspase-1 activation, culminating in rapid caspase-1-dependent IL-1β 
production and pyroptotic cell death. However, despite rapid macrophage lysis (apparent 
as early as 1.5 h), peritoneal IL-1β levels continue to rise past 24 h post-infection, 
suggesting the possibility that other cells may be able to signal via inflammasomes at a 
site of infection. Neutrophils predominate the early inflammatory infiltrate, presenting these 
cells as excellent candidates for driving NLRC4-dependent IL-1β production. Neutrophils 
were previously reported not to trigger NLRC4 inflammasome-dependent pathways, 
because they did not undergo pyroptotic cell death when infected with typical NLRC4 
activators such as S. Typhimurium (53, 115), however, such studies did not assess the 
capacity for neutrophils to cleave caspase-1 or produce inflammasome-target cytokines.  
 
Here we provide the first demonstration that Salmonella infection indeed triggers 
neutrophil NLRC4-dependent caspase-1 activation and IL-1β production in vitro and that 
neutrophils are a major compartment for inflammasome-dependent IL-1β production in 
vivo. By specifically depleting neutrophils in vivo prior to infection with S. Typhimurium, we 
quantified the contribution of neutrophils to both the IL-1β response and pathogen burden 
during acute infection. Neutrophil depletion dramatically increased pathogen loads in liver 
and spleen, consistent with the important function of these cells in controlling murine 
Salmonella infection as is well established in intravenous, intraperitoneal and oral 
challenge models (115, 234-240). Our data suggest that after an initial burst of IL-1β 
release from resident macrophages, recruited neutrophils become the predominant source 
of secreted IL-1β from 1 to 12 h post-infection. Neutrophil-derived IL-1β is thus likely to 
mediate a positive amplification loop driving further neutrophil recruitment and activation, 
presenting a new auto-regulatory paradigm for these cells during pathogen control. Of 
note, similar pathways may control neutrophil function downstream of other neutrophil-
expressed inflammasomes, such as AIM2 and NLRP3. Three recent reports suggest that 
the NLRP3 inflammasome enables IL-1β  processing in neutrophils, in vitro (241, 242) and 
in vivo (229), while pyroptosis was not examined. We confirmed herein that, as for 
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macrophages as was previously published (111, 146), NLRP3 appears to collaborate with 
the NLRC4 inflammasome in neutrophils. The published literature for NLRP3 function in 
neutrophils, and our studies presented here characterizing neutrophil NLRC4, NLRP3 and 
AIM2 inflammasome function, collectively overturn the general assumption that neutrophils 
can only trigger IL-1β production via inflammasome-independent mechanisms such as Fas 
receptor ligation (243) or cleavage via granular proteases (244). Indeed, in the Salmonella 
model studied here, neutrophil-derived IL-1β was entirely dependent on inflammasome-
activated caspase-1. The inflammasome dependency of neutrophil IL-1β may depend on 
the microbial trigger, as neutrophils produced IL-1β independently of inflammasomes 
during P. aeruginosa infection (244). 
 
The contribution of IL-1β to host defense in murine Salmonella challenge is somewhat 
controversial. In oral infection models, deficiency in Il-1b or its receptor was associated 
with moderately increased susceptibility to Salmonella infection in BALB/c (234) or 
C57BL/6 (245) mice, although the latter is controversial (234). For intraperitoneal infection, 
IL-1β/IL-1R appears dispensable for pathogen control and mouse survival at 3 days post-
infection, while the important protective functions of IL-18 in host defense are evident at 
this time point (234, 245). Since IL-1β exerts a range of activities to promote neutrophil-
mediated pathogen clearance in a number of other bacterial infection models (4), and our 
data indicate that IL-18 levels are unchanged in the acute (0-6 h) phase of intraperitoneal 
challenge when neutrophils predominate, we investigated whether IL-1β contributes to 
pathogen control during acute infection. Indeed, significantly increased bacterial burdens 
were evident in the organs of IL-1β-neutralized mice at 12 h post-infection. In light of 
previous studies, our data suggest a model in which macrophage- and neutrophil-derived 
IL-1β supports host defense in the acute phase of infection, while IL-18 production 
becomes important for microbial control in the latter stages of infection.  
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The neutrophil NLRC4 pathway is unique amongst cells described to date. Despite clear 
NLRC4-dependent caspase-1 activation, neutrophils did not undergo pyroptotic cell death, 
in vitro or in vivo. The resistance of neutrophils to pyroptotic cell death appears to allow 
sustained IL-1β release, as compared to macrophages where cytokine production 
plateaued within 3 h, coinciding with cell lysis. While our observation of caspase-1-
dependent cytokine processing uncoupled from pyroptotic death is the first report of 
neutrophil signal specialization downstream of NLRs, specialization in other PRR signaling 
pathways (e.g. TLRs, CLRs) is already well documented (228). For example, while TLR4 
in macrophages elicits dual signaling pathways via MyD88 and TRIF, TLR4 solely signals 
through MyD88 in human neutrophils (246).  
 
Our in vivo data suggest a model in which resident macrophages and recruited neutrophils 
collaborate, together coordinating caspase-1-dependent inflammation and pathogen 
elimination. Resident peritoneal macrophages respond to infection by secreting a rapid 
burst of IL-1β within the first hour to initiate inflammation and neutrophil influx, while 
neutrophils are the dominant IL-1β-secreting cells from 1 to 12 h post Salmonella 
challenge. A recent study from Miao and co-workers posits that macrophage pyroptosis is 
an innate defense mechanism that prevents Salmonella replication within macrophages, 
and allows bacterial release for more effective killing by neutrophils (115). Since 
neutrophils are well established as the primary cells mediating Salmonella elimination, the 
lack of neutrophil pyroptosis we observe makes intuitive sense, as microbial destruction 
rather than cell lysis is the appropriate response for a neutrophil encountering Salmonella. 
If neutrophils could not resist pyroptosis, their ability to eliminate Salmonella through 
classic antimicrobial mechanisms (reactive oxygen species, degranulation, phagocytosis, 
etc.) would be severely compromised, leading to pathogen dissemination. While neutrophil 
NLRC4 pathway specialization is probably necessary to ensure pathogen clearance in the 
short term, the lack of a functional pyroptotic pathway in neutrophils, coupled with the 
extended lifespan of neutrophils in inflammatory microenvironments (147, 228), may 
ultimately render these cells susceptible to intracellular pathogens. Indeed, several reports 
suggest that Salmonella (247, 248) as well as other pathogens such as Neisseria 
gonorrhoeae (249), Staphylococcus aureus (250), Chlamydia pneumoniae (251), 
Burkholderia pseudomallei (53) and Anaplasma phagocytophilum (252) reside and 
replicate efficiently within neutrophils in vivo, and may use neutrophils to acquire nutrients, 
evade the immune system and disseminate to other tissues. Indeed, our observations from 
neutrophil infection in vitro suggest that their resistance to pyroptosis may contribute to the 
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inability of neutrophils to restrict intracellular Salmonella survival, similar to caspase-1-
deficient macrophages. 
 
The surprising lack of neutrophil pyroptosis has fundamental implications for our 
understanding of inflammasome pathways. Firstly, it suggests that the caspase-1-
dependent pathways mediating cytokine processing versus death are mechanistically 
separable, in support of an earlier proposal that two distinct caspase-1 activation states 
drive cytokine processing versus lytic death (8). Until caspase-1-dependent cell death 
programs are elucidated, the mechanism by which neutrophils resist this process will 
remain elusive, but a likely scenario is that a caspase-1 proteolytic substrate required for 
the initiation of lytic cell death is not expressed in neutrophils. The finding that neutrophils 
have uncoupled IL-1β release from pyroptotic cell death also unequivocally confirms the 
existence of caspase-1-dependent unconventional protein secretion pathways, refuting the 
alternative possibility that IL-1β is passively released during caspase-1-dependent cell 
death (253). Furthermore, the extended kinetics of IL-1β production in neutrophils as 
compared to macrophages suggests that pyroptotic cell death actually functions to curtail 
macrophage IL-1β processing and release. 
 
In summary, our data are the first to indicate that neutrophils posses a unique 
inflammasome pathway that resists caspase-1-directed lytic cell death, thereby permitting 
extended cytokine production. Our finding that neutrophils are major contributors to 
inflammasome-dependent IL-1β during acute Salmonella infection may actually 
underestimate the importance of neutrophil inflammasomes in human infection and 
disease, as neutrophils are grossly under-represented in murine as compared to human 
blood (254).  NLRP3/12 dysfunction is associated with genetic and acquired human 
inflammatory diseases, including hereditary fever syndromes and gout (2), and these 
diseases are currently attributed to inflammasome dysfunction in 
monocytes/macrophages, in which cytokine production is intrinsically linked to cell death. 
This raises the intriguing question of why IL-1β production and inflammation are not self-
limiting in these diseases, as one might expect IL-1β release to be transient if IL-1β-
producing cells rapidly lyse. Our demonstration that human neutrophils express a range of 
inflammasome scaffolds, and that neutrophil IL-1β production proceeds without restriction 
by inflammasome-dependent cell death pathways, suggests that neutrophils may be 
critical cellular drivers of pathogenic IL-1β in human inflammatory disease. 
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3.5 Experimental Procedures 
3.5.1 Bacterial strains 
S. Typhimurium SL1344 strains were grown at 37oC in Luria-Bertani medium at 200 rpm. 
The SL1344 ΔSPI1 (ΔInvA) mutant was previously described (145). Overnight bacteria 
were diluted 1:40 and grown for 3 h to induce expression of the SPI1-T3SS. Antibiotics 
used were 20 µg/ml streptomycin and 50 µg/ml gentamicin. 
3.5.2 Mice 
Mice were backcrossed at least 10 times to C57BL/6 and all experiments were conducted 
with age- and sex-matched mouse cohorts. C57BL/6, Nlrc4-/-  (29), Nlrp3-/- (40), Asc-/- (29), 
Ice-/- (226) and Casp11-/- (227) mice were housed in specific pathogen-free facilities at the 
University of Queensland. All protocols were approved by the Animal Ethics Committee at 
the University of Queensland.  
3.5.3 Preparation of human and mouse cells 
Fresh human peripheral blood was subject to discontinuous density sedimentation 
(Histopaque 1119 and 1077, Sigma) to separate neutrophils and eosinophils (densities 
>1.077 g/ml; polymorphonuclear PMN fraction) from cells with lower densities (peripheral 
blood mononuclear cells, PBMC). CD16+ neutrophils were further purified from the 
polymorphonuclear fraction, and CD14+ monocytes, CD4+ T cells, CD19+ B cells and 
CD56+ NK cells were purified from the mononuclear fraction by magnetic-assisted cell 
sorting (MACS), according to standard protocols (Miltenyi Biotec). All MACS-purified cell 
preparations were assayed for purity by flow cytometry. Monocyte-derived DCs and 
monocyte-derived macrophages were differentiated for 7 days with GM-CSF (100 ng/ml) 
plus IL-4 (25 ng/ml), or M-CSF (100 ng/ml), respectively (all Immunotools). Preparations of 
CD16+, CD14+ and CD3+ cells achieved 97-99% purity, while less abundant cell types 
were enriched (55% CD19+ B cells; 70% CD56+ NK cells). All mouse tissues for mRNA 
profiling were prepared as single cell suspensions. Bone marrow cells and splenocytes 
were subject to erythrocyte lysis prior to fractionation. Splenocytes were stained with B220 
and CD3, and B and T lymphocytes were enriched using standard MACS techniques with 
anti-fluorochrome beads (Miltenyi Biotec). Bone marrow and elicited neutrophils were 
purified by surface labeling using α-Ly6G-FITC (NIMP-R14 or 1A8), and purified by MACS 
with α-FITC beads. MACS-purified fractions were assayed for cell purity by flow cytometry. 
Bone marrow and elicited neutrophil populations achieved >98% purity. Splenic B and T 
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cells were typically enriched to 88% and 64% purity, respectively. Bone marrow-derived 
macrophages and dendritic cells were differentiated as previously described (255, 256). 
3.5.4 mRNA expression profiling 
Human and mouse mRNA expression profiling by quantitative PCR was performed 
normalized to a human and mouse reference gene (HPRT) as previously described (255). 
All primer sequences are available on request. Primer pairs were designed to flank exon-
exon junctions to avoid amplification of contaminating genomic DNA, and primer pair 
efficiencies were quantified and used in calculations to generate cDNA profiles. 
3.5.5 Neutrophil and macrophage in vitro infection assays 
BMN and BMDM were prepared as described above. BMNs were used for experiments on 
the day of purification and were plated in RPMI-1640 supplemented with 10% FCS and 10 
mM HEPES (all Life Technologies), and 0.4 µg/mL aprotinin (Sigma) at a density of 3.3 
x106 cells/ml, except experiments with ΔSPI1 bacteria that were plated at 2 x 107 
neutrophils/ml. Differentiated BMDM were cultured at a density of 0.8 x 106 cells/ml in 
RPMI-1640 supplemented with 10% FCS, 1x Glutamax (Life Technologies), and 104 
units/ml recombinant human M-CSF (a gift from Chiron). BMN or BMDM were primed with 
100 ng/ml ultrapure E. coli K12 LPS (Invivogen) for 4 h to induce the expression of pro-IL-
1β. BMN and BMDM were infected at the indicated MOI and centrifuged immediately at 
700 g for 10 min at room temperature. Cells were incubated at 37 oC for 25 min to allow 
phagocytosis of extracellular bacteria. Complete media was then replaced with Opti-MEM 
(Life Technologies) supplemented with 50 µg/ml gentamicin (Life Technologies) for the 
remainder of the assay to kill extracellular bacteria. Cells were then further incubated for 
the indicated times before harvesting cell-free supernatants and cell extracts for cytokine 
production. Cell-free supernatants were analyzed at the indicated time points post-
infection for LDH release.  
3.5.6 Intracellular bacterial survival 
BMN and BMDM were infected as described above with the following modifications. 25 
min after centrifugation, cells were washed thrice with complete media containing 200 
µg/ml gentamicin and cultured for a further 30 min to kill extracellular bacteria. 
Subsequently, cells were cultured in complete media containing 20 µg/ml gentamicin for 
up to 16 h. 
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3.5.7 In vivo infection and neutrophil depletion 
Neutrophils were depleted by i.p. administration of 0.1 mg α-Ly6G antibody (endotoxin-
free 1A8 clone, BioXcell), or mock-depleted by i.p. administration of 0.1 mg isotype control 
antibody (endotoxin-free 2A3 clone, BioXcell). 24 h after antibody injection, mice were 
challenged with i.p. 1 x 106 CFU log-phase S. Typhimurium SL1344. For IL-1β 
neutralization experiments, mice were administered 0.1 mg of IL-1β neutralizing antibody 
(endotoxin-free B122 clone, BioXcell) or isotype antibody (endotoxin-free, polyclonal 
hamster IgG, BioXcell) i.p. 16 h prior to Salmonella challenge.  Mice were sacrificed at 1-
24 h post-infection as indicated and the peritoneal cavity was flushed with 10 ml of DPBS. 
Cytokine levels and cellularity in the peritoneal lavage fluid were analyzed by ELISA and 
flow cytometry, respectively. Liver and spleen were homogenized and bacterial loads were 
determined using serial dilution. To culture in vivo challenged neutrophils ex vivo, 
neutrophils were purified from the peritoneal exudate using α-Ly6G MACS and cultured at 
2 x 105 cells/well for a further 8 h in 125 µl Opti-MEM supplemented with 50 µg/ml 
gentamicin. Bacterial loads were quantified by serial dilution following 0.5 h incubation with 
50 µg/ml gentamicin. 
3.5.8 Flow cytometry 
Myeloid cells were identified using α-CD11b (Pac Blue-conjugated, M1/70, BioLegend), 
macrophages were labeled with α-F4/80 (APC-conjugated, BM8, BioLegend), and 
neutrophils and monocytes were discriminated by α-Ly6G (FITC, PeCy7 or PE-conjugated 
1A8, BioLegend) and α-Ly6C (PE-conjugated, HK1.4, BioLegend) staining. T cells were 
labeled with α-CD3 (APC/Cy7-conjugated, 17A2, BioLegend) and B cells were labeled 
with α-B220 (FITC-conjugated, RA3-6B2). Intracellular pro-IL-1β was detected using the 
NJTEN3 antibody clone (eBioscience). Dead cells were labeled with 7-AAD (Becton 
Dickinson). Cell profiles were acquired using a Canto II (Becton Dickinson) and analyzed 
using FlowJo software (Tree Star). 
3.5.9 Inflammasome and pyroptosis assays 
IL-1β (R&D Systems) and IL-18 (MBL, eBioscience) levels in cell-free supernatants and 
serum were analyzed by ELISA. For AIM2 inflammasome activation studies, neutrophils 
(106) were transfected with 0.125 µg calf thymus DNA using Lipofectamine 2000. Western 
blots were performed as previously described (256). In brief, cell-free supernatants were 
precipitated with chloroform and methanol, subject to SDS-PAGE, transferred to 
nitrocellulose membrane and immunoblotted using standard methods. Antibodies included 
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IL-1β (polyclonal goat, R&D Systems), caspase-1 (Casper-1, Adipogen), ASC (polyclonal 
rabbit, Santa Cruz), and GADPH (polyclonal mouse, BioScientific). Cytotoxicity was 
analyzed by lactate dehydrogenase release (TOX7-1KT, Sigma). 
3.5.10 Statistical analysis 
Statistical analyses were performed using non-parametric Mann-Whitney t-test or a two-
way ANOVA using Prism Graphpad software. Data were considered significant when p ≤ 
0.05 (*), 0.005 (**), 0.001(***) and 0.0001(****). 
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3.6 Supplementary figures 
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Supplementary Figure  3.1 Expression profile detail for NLRs expressed in purified human and 
mouse leukocyte populations, cell lines and tissues, related to Figure 3.1.  
mRNA expression of (A) NLRP1, (B) NLRP2, (C) NLRP4, (D) NLRP6, (E) NOD1, (F) NOD2, (G) NOD3, (H) 
NOD4, (I) NOD5, (J) NAIP, and (K) CIITA was quantitated by qPCR in primary human blood populations: 
polymorphonuclear fraction (PMN; containing neutrophils and eosinophils), neutrophils (CD16+ cells from 
PMN fraction, which excludes monocytes), bulk peripheral blood mononuclear cell fraction (PBMC), 
monocytes (CD14+ cells from PBMC fraction), CD14+ monocyte-derived dendritic cells (MDC), CD14+ 
monocyte-derived macrophages (MDM), CD3+ T cells, CD19+ B cells and CD56+ NK cells. The myeloid cell 
lines, THP-1, HL60 and U937 were also included on the panel. Data are mean + SD of technical triplicates 
and is representative of three experiments with independent blood donors. NLRs that were highly expressed 
in human neutrophils were examined for expression in mouse immune cell subsets and tissues by qPCR: (L) 
Nlrp1a, (M) Nlrp6, (N) Nod2, and (O) Nod5. mRNAs for the inflammasome components (P) Asc and (Q) 
Casp1 were also measured in parallel. Cell populations are: BMN, bone marrow neutrophils; BMDC, bone 
marrow dendritic cells left untreated or treated overnight with TNF (25 ng/ml) or LPS (50 ng/ml); BMDM, 
bone marrow derived macrophages; B cells, B220+ splenocytes; T cells, CD3+ splenocytes. Data are mean + 
SD of technical triplicates and are representative of three independent experiments. 
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Supplementary Figure 3.2 Neutrophil Nlrp3 and Nlrc4 expression is induced by LPS, related to Figure 
3.1.  
BMN were treated with an increasing dose of LPS for 4 h and mRNA expression was quantified by qPCR. 
Data are mean + SD of technical triplicates.  
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Supplementary Figure  3.3 NLRP3 collaborates with the NLRC4 inflammasome during Salmonella 
infection, related to Figure 3.2.  
BMNs or BMDMs were treated with 100 ng/ml LPS before infection with S. Typhimurium (Stm) or its isogenic 
ΔSPI1 mutant.  Neutrophils (A, C, F) and macrophages (B, D) were infected (MOI of 25 or 5 for neutrophils 
and macrophages, respectively) for 5 h and IL-1β (A-B, F) and IL-18 (C-D) release were measured by 
ELISA. (E) Neutrophils were infected with increasing doses of Stm and IL-1β secretion was measured by 
ELISA at 1, 3 and 5 h post-infection. Data are (A-B) mean + SD of technical triplicate cell stimulations and 
are representative of (A) 3 or  (B) 2 individual experiments, (C) mean + SEM of 3 independent experiments, 
(D) mean + SD of technical triplicate cell stimulations and are representative of 3 independent experiments, 
(E) mean + SD of technical triplicate cell stimulations and are representative of 2 independent experiments, 
(F)  mean + SD of technical triplicate cell stimulations. 
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Supplementary Figure 3.4 Neutrophil depletion does not affect the abundance or intracellular pro-IL-
1β expression of macrophages or monocytes, related to Figure 3.4.  
(A) Mice were challenged with i.p. Stm and the peritoneal exudate was collected up to 6 h post-infection. 
Expression of intracellular pro-IL-1β in myeloid cells was measured by flow cytometry (mean fluorescence 
intensity). Data are mean ± SEM of 3-4 individual mice per time point combined from 2 independent 
experiments. (B-G) Mice were administered with isotype control (mock-depleted) or α-Ly6G antibody 
(neutrophil-depleted) for 24 h before infection with Stm. The abundance of (B) macrophages and (C) 
monocytes in the peritoneal exudate at 12 h post-infection was assessed by cell counting and flow 
cytometry. Data are mean of 14-16 mice pooled from 3 independent experiments. The intracellular 
expression of pro-IL-1β in peritoneal exudate (D) macrophages and (E) monocytes over a time course of 
infection was assessed by flow cytometry. Data are mean ± SEM of 3-5 individual mice per time point 
combined from 2 independent experiments. (F) Neutrophil abundance and (G) IL-1β levels in the peritoneal 
lavage fluid were also measured at 12 h post-infection. Data are mean of 14-16 mice pooled from 3 
independent experiments. 
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Supplementary Figure 3.5 IL-18 is produced from 6-12 h post infection by non-neutrophilic cells, 
related to Figure 3.4. 
Peritoneal IL-18 levels in mice (A-B) administered isotype versus α-Ly6G antibody for 24 h or (C) not 
administered antibody before Stm challenge for (A) 0-6 or (B, C) 12 h before quantitation of peritoneal IL-18 
by ELISA. Data are mean ± SEM of (A) 3-5 individual mice per time point, combined from 2 independent 
experiments, mean of (B) 14-16 mice pooled from 3 independent experiments, or (C) 3 individual mice. 
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Supplementary Figure 3.6 Neutrophils are resistant to pyroptotic cell death, related to Figure 3.5.  
(A) BMNs were plated in complete media and primed for 4 h with LPS or left untreated before infection with 
increasing doses of Stm for 16 h. (B) BMNs were treated with increasing concentrations of staurosporin to 
trigger apoptotic cell death, for 5 h and 16 h. (C-D) Cells were primed for 4 h with LPS and infected with Stm 
or its isogenic mutant (MOI of 25 or 5 for neutrophils and macrophages, respectively) and LDH release was 
measured at 1 h post-infection. Cytoplasmic LDH release into the supernatant, as compared to total 
intracellular LDH, was quantified as a measure of cell death. (A-B) Data are mean + SD of quadruplicate cell 
stimulations or (C-D) mean + SD of technical triplicate cell stimulations and are representative of 3 
independent experiments. 
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4. The neutrophil NLRP3 inflammasome is activated by 
soluble but not particulate or crystalline agonists 
 
The data presented here in Chapter 4 were submitted for consideration as a short 
communication to the European Journal of Immunology on 22 July 2015. 
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4.1 Abstract 
Neutrophils express pattern recognition receptors (PRR), and regulate immune responses 
via PRR-dependent cytokine production. An emerging theme is that neutrophil PRRs often 
exhibit cell type-specific adaptations in their signalling pathways, which prompted us to 
examine NLRP3 inflammasome signalling in neutrophils, as compared to macrophages 
where NLRP3 function is well established. Here, we demonstrate that while neutrophils 
can indeed signal via the NLRP3 inflammasome, neutrophil NLRP3 selectively responds to 
soluble agonists but not particulate/crystalline agonists that trigger macrophage 
phagolysosomal rupture. In keeping with this, the lysosomotropic peptide Leu-Leu-OMe 
stimulated only weak neutrophil NLRP3-dependent IL-1β production, suggesting that 
lysosomal rupture is not a strong stimulus for NLRP3 activation in neutrophils. We 
validated our in vitro findings for poor neutrophil NLRP3 responses to particles in vivo, 
where we demonstrated that neutrophils do not significantly contribute to alum-induced IL-
1β production in vivo. In all, our studies highlight that myeloid cell identity and the nature of 
the danger signal can strongly influence signalling by a single PRR, thus shaping the 
nature of the resultant immune response. 
 
4.2 Introduction 
Inflammasomes are cytoplasmic multi-protein complexes that drive the maturation of 
specific interleukin-1 (IL-1) family cytokines and induce an inflammatory form of cell death 
called pyroptosis. Inflammasomes consist of a sensor protein (e.g. a Nod-like receptor 
(NLR) protein), the caspase-1 protease, and often contain the common inflammasome 
adaptor, ASC (2). The NLRP3 inflammasome is of particular importance because it has 
the capacity to sense a wide variety of structurally unrelated molecules, including whole 
pathogens, bacterial toxins, metabolic products, insoluble molecules (particles, crystals 
and protein aggregates), and alarmins released from damaged tissues. Consequently, the 
NLRP3 inflammasome is central to host defence but also mediates pathological immune 
responses in numerous inflammatory and metabolic disorders such as Alzheimer’s 
Disease, silicosis, asbestosis and gout (2). How a single protein responds to such a 
diverse range of agonists remains an enigma. Many studies posit that these distinct 
agonists elicit convergent cell stress signals that trigger NLRP3 activation and 
inflammasome assembly. Proposed mechanisms include K+ efflux (20), lysosomal rupture 
by crystals, particles and protein aggregates (19), reactive oxygen species production (18) 
and calcium mobilisation (25). However, the precise nature of the NLRP3-activating stress 
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signal, and the mechanism by which NLRP3 senses such a signal, remains obscure. Also 
unclear is how a single receptor signalling module can tailor an in vivo immune response 
that is appropriate to such diverse cues such as tissue injury, infection, metabolic stress or 
environmental irritants; one possibility is that distinct NLRP3 agonists trigger NLRP3 
signalling in different immune cell suites. 
 
While the biology of NLRP3 has been widely studied in macrophages and dendritic cells, 
increasing evidence suggests that these cells are not the sole cell types driving NLRP3-
dependent responses in vivo. Two recent studies demonstrated that neutrophils are major 
contributors to NLRP3-dependent IL-1β production during murine infection with 
Staphylococcus aureus (229) and Streptococcus pneumoniae (257). NLRP3 signalling 
pathways are poorly characterised in neutrophils, and it is increasingly appreciated that 
immune signalling pathways often display cell type-specific effects. For example, we 
recently reported that neutrophils selectively trigger caspase-1-dependent cytokine 
processing but not pyroptosis following NLRC4 activation by Salmonella (Chapter 3), 
while in macrophages, the NLRC4 inflammasome drives both cytokine processing and 
pyroptosis. Here, we investigated NLRP3 signalling in neutrophils, with the hypothesis that 
like NLRC4, the NLRP3 pathway may exhibit neutrophil-specific adaptations. In doing so, 
we demonstrate that soluble but not particulate or crystalline NLRP3 agonists trigger 
NLRP3-dependent responses in neutrophils. Our findings highlight cell type specificity in 
the ability to respond to individual NLRP3 agonists, and provide a possible mechanism by 
which NLRP3-dependent immune responses are tailored to the specific danger 
encountered. 
4.3 Results and discussion 
4.3.1 The neutrophil NLRP3 inflammasome selectively responds to soluble agonists 
The neutrophil NLRP3 inflammasome is reported to trigger caspase-1-dependent IL-1β 
cleavage and release following infection with whole pathogen (S. aureus and S. 
pneumoniae) or bacterial pore-forming toxins (229, 241, 257). However, it was unclear 
whether other compounds established to activate NLRP3 in macrophages, such as 
insoluble compounds that cause phagolysosomal rupture, also activate NLRP3 in 
neutrophils. We investigated this possibility by stimulating purified bone marrow 
neutrophils and bone marrow-derived macrophages (BMDM) with a range of NLRP3 
agonists. Cells were stimulated with lipopolysaccharide (LPS) to upregulate NLRP3 and 
pro-IL-1β prior to challenge with NLRP3 agonists (230, 258). The bacterial pore-forming 
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toxin and potassium ionophore, nigericin, triggered IL-1β secretion from both wild type 
(WT) neutrophils and macrophages (Figure 4.1A-C). IL-1β production by neutrophils 
required an inflammasome, as IL-1β secretion was significantly reduced in caspase-1/11-
deficient Ice-/- neutrophils (Figure 4.1A), similar to Ice-/- macrophages (Figure 4.1B). 
Moreover, caspase-1/11 deficiency ablated IL-1β processing by neutrophils (Figure 4.1C). 
Other soluble activators of the NLRP3 inflammasome (e.g. extracellular ATP, R837) also 
triggered NLRP3/caspase-1-dependent IL-1β release in neutrophils (Supplementary 
Figure 4.1A-B), as for macrophages (27, 259). In macrophages and dendritic cells, a 
range of insoluble compounds can also trigger NLRP3 activation by rupturing 
phagolysosomes (16, 19). We next investigated if this pathway is also active in 
neutrophils. Surprisingly, neither alum nor silica particles, nor MSU crystals, triggered 
caspase-1-dependent IL-1β secretion from neutrophils (Figure 4.1D-F), while all elicited 
strong caspase-1-dependent IL-1β secretion from macrophages as anticipated (Figure 
4.1G-J). Thus, neutrophils can mount robust NLRP3 inflammasome responses to soluble 
but not insoluble NLRP3 agonists. 
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Figure 4.1 Neutrophils produce mature IL-1β  in response to soluble but not particulate/crystalline 
agonists of the NLRP3 inflammasome.  
Bone marrow neutrophils (A, C, D-F) or bone marrow-derived macrophages (B, G-I) were primed with 100 
ng/ml LPS for 4 h before challenge with nigericin (Nig) (A-B: 0, 1.25, 2.5, 5 µM; C: 5 µM), alum (D, G: 0, 150, 
300, 600 µg/ml), silica (E, H: 0, 150, 300, 600 µg/ml) or MSU (F, I: 0, 150, 300, 600 µg/ml). IL-1β secretion 
was measured by ELISA at 1, 3, 5 h (A-B) or 7 h post challenge (D-I). (C) Neutrophil supernatants (SN) and 
cell extracts (XT) were harvested at 5 h post-nigericin treatment, and examined by western blot. All ELISA 
data are mean + SD of technical triplicate cell stimulations, and are representative of 3 independent 
experiments. 
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4.3.2 The phagolysosomal rupture pathway is a weak stimulus for neutrophil NLRP3  
Insoluble NLRP3 agonists trigger NLRP3 activation in macrophages by destabilising 
phagolysosomes (19). The observed lack of inflammasome activation in neutrophils 
stimulated with insoluble NLRP3 agonists could either reflect ineffective phagocytosis of 
these stimuli, or a deficiency in the NLRP3-activating phagolysosomal rupture pathway. 
We first investigated the cellular uptake of silica particles by live cell imaging. Neutrophils 
were incubated with silica in the presence of the fluid phase marker, Dextran, over 2 h. 
Silica particles were detected in Dextran-positive compartments (Figure 4.2A, 
Supplementary Figure 4.2), indicating that neutrophils phagocytose these particles, as 
for MSU crystals (260). We next examined the lysosomal rupture pathway in neutrophils 
versus macrophages by treating the cells with the small lysosomotropic peptide L-leucyl-L-
leucine methyl ester (Leu-Leu-OMe) to induce phagolysosomal damage (19). 
Phagolysosomal integrity can be measured using acridine orange (AO), which fluoresces 
red in the low pH of lysosomes (19). AO fluorescence was 3-fold higher in bone marrow 
macrophages compared to neutrophils (Figure 4.2B-C), suggesting that macrophages 
harbour a larger, or more acidic, lysosomal compartment than neutrophils. Leu-Leu-OMe 
treatment triggered a loss of AO fluorescence in both cell types (Figure 4.2B-C), although 
the effect was much more prominent in macrophages. The loss of AO fluorescence 
correlated inversely with IL-1β secretion for both neutrophils and macrophages (Figure 
4.2D-E). However, IL-1β production in response to Leu-Leu-OMe was weak in neutrophils, 
while producing a robust IL-1β response in macrophages. This indicates that while Leu-
Leu-OMe can elicit phagolysosome rupture and resultant IL-1β production in neutrophils, 
this pathway is a very weak stimulus for neutrophil NLRP3 activation as compared to 
macrophages.  
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Figure 4.2 The phagolysosomal rupture pathway is a weak stimulus for neutrophil IL-1β  production.  
(A) Bone marrow neutrophils were exposed to silica (15 µg/ml) for 2 h in the presence of Dextran555 (200 
µg/ml) and silica internalisation was analysed by confocal microscopy. Brightfield image shows refractive 
silica particles with one particle (arrow) co-localising with the fluid phase marker, dextran.  Scale bar = 5 µM. 
(B, D) Bone marrow neutrophils or (C, E) bone marrow-derived macrophages were primed with 100 ng/ml 
LPS for 4 h before exposure to increasing doses of Leu-Leu-OMe (0, 0.5, 1, 2 mM). Acridine orange (AO) 
staining and IL-1β secretion was measured at 7 h by flow cytometry and ELISA, respectively. (B-E) Data are 
mean + SD of technical triplicate cell stimulations, and are representative of (A) 2 or (B-E) 3 independent 
experiments. 
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4.3.3 Neutrophil depletion does not alter IL-1β production in alum-induced 
peritonitis  
We, and others, demonstrated that neutrophils are a major cellular compartment for 
caspase-1-dependent IL-1β production during in vivo bacterial infection (229, 257). Given 
our surprising observation that alum did not trigger IL-1β production by the neutrophil 
NLRP3 inflammasome in vitro (Figure 4.1D), we anticipated that, unlike the case for in 
vivo bacterial challenge (229, 257), neutrophils would not be a significant cellular source of 
IL-1β during alum-induced peritonitis. To examine this hypothesis, we administered 
C57BL/6 mice with an isotype control antibody or an α-Ly6G (1A8) antibody to specifically 
deplete neutrophils (Chapter 3). At 16 - 24 h post-depletion, mice were challenged with 
350 µg alum for 6 h and peritoneal IL-1β levels were quantified. Alum triggered neutrophil 
recruitment and IL-1β production in mock-depleted mice (Figure 4.3A), but neutrophil 
depletion did not affect peritoneal IL-1β levels (Figure 4.3B). This indicates that, as 
anticipated, neutrophils are not a significant cellular source of IL-1β in this setting.  
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Figure 4.3 Neutrophils do not significantly contribute to IL-1β production during alum challenge in 
vivo.  
Mice were i.p injected with 100 µg of α-Ly6G (1A8) or isotype antibody. After 16-24 h, mice were challenged 
i.p with 350 µg alum for 6 h. (A) Absolute abundance of CD11b+Ly6C+Ly6G+ neutrophils, and (B) peritoneal 
IL-1β levels in the peritoneal exudate. Data are 4-5 mice per condition, combined from 2 independent 
experiments. Statistical analyses were performed using the non-parametric Mann-Whitney t-test. Data were 
considered significant when p ≤ 0.05 (*). 
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4.4 Concluding remarks 
Neutrophils have been traditionally viewed as anti-microbial effector cells, but an emerging 
literature documents the wide diversity of neutrophil functions, including their role as 
important modulators of inflammation (261). The NLRP3 inflammasome is a key pathway 
for eliciting inflammatory responses, but the circumstances in which neutrophils contribute 
to NLRP3-driven inflammation were poorly characterised. Here we challenged neutrophils 
with a panel of 7 different NLRP3 agonists that trigger NLRP3 activation by 
phagolysosomal rupture (MSU, Alum, Silica, Leu-Leu-OMe) or by mechanisms 
independent of phagolysosomal rupture (nigericin, ATP, R837). Human and mouse 
neutrophils express NLRP3 (Chapter 3), and in keeping with this, we and others (241) 
observe robust NLRP3-dependent responses to soluble agonists (e.g. nigericin, ATP, 
R837) that signal the presence of infection or tissue damage. Surprisingly, we discovered 
that the neutrophil NLRP3 inflammasome was poorly responsive to insoluble NLRP3 
agonists such as alum, silica and MSU that trigger macrophage NLRP3 activation via 
phagolysosomal rupture. Neutrophils were likewise poorly responsive to the 
lysosomotropic peptide Leu-Leu-OMe, suggesting that lysosomal rupture is not a 
prominent pathway for NLRP3 activation in neutrophils. Accordingly, we found that 
neutrophils did not significantly contribute to IL-1β production during alum-induced 
peritonitis. This is in sharp contrast with in vivo bacterial challenge models, where 
neutrophils were major producers of IL-1β (229, 257) (Chapter 3) and thereby drove an 
amplification loop to ensure large numbers of activated neutrophils were recruited to 
resolve the infection (Chapter 3). 
 
Given the diversity of NLRP3 activating signals, a key outstanding question is how the 
immune system tailors an in vivo response that is appropriate to each stimulus. For 
example, in scenarios where neutrophil-mediated clean up is important (e.g. infection, 
injury), one might expect that the immune response will be dominated by neutrophils, while 
this may be less important in other scenarios of NLRP3 activation, such as metabolic 
stress (e.g. MSU) or exposure to environmental irritants (e.g. alum, silica). Our data 
broadly support such a model, as intraperitoneal Salmonella infection was a more potent 
stimulus for neutrophil recruitment than alum injection (Figure 4.3 and Figure 3.4B). The 
finding that neutrophils produce IL-1β in response to NLRP3 agonists indicative of infection 
or injury, but not those signalling metabolic stress or irritant exposure, suggests a possible 
mechanism by which immune responses are tailored according to stimulus; neutrophil-
derived IL-1β and the ensuing positive feedback loop of neutrophil recruitment and 
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activation likely allows for a strong neutrophil response when it is appropriate, but this 
positive feedback loop is not engaged to prevent collateral damage in circumstances 
where neutrophil function is less important. Our proposed model is noteworthy from a 
clinical perspective, as the NLRP3 pathway contributes to the adjuvant activity of alum 
(262), and is central to a number of inflammatory disorders triggered by insoluble 
aggregates, such as gout and silicosis. Our data suggest that other cell types (e.g. 
macrophages, dendritic cells) are responsible for driving inflammasome-mediated 
inflammatory responses in these settings.  
 
Our finding that the signalling pathways eliciting NLRP3 activation in macrophages are not 
always conserved in neutrophils emphasises the strong influence of cell identity on innate 
immune signalling pathways. Instances of such cell type-specificity in signalling pathways 
are already appreciated within the myeloid compartment; for example, neutrophils exhibit 
various cell type-specific adaptations to the Toll-like receptor signalling pathways 
described for macrophages (228). We speculate that cell type-specific tailoring of immune 
signalling networks may be common, and warrants further investigation to gain a more 
nuanced mechanistic understanding of immune response sculpting in health and disease. 
4.5 Materials and methods 
4.5.1 Mice 
C57BL/6 and Ice-/- (226) mice were housed in specific-pathogen-free facilities at the 
University of Queensland. Ice-/- mice were backcrossed at least ten times to C57BL/6, and 
all experiments were conducted with age- and sex-matched mouse cohorts. The University 
of Queensland’s animal ethics committee approved all experimental protocols. 
4.5.2 Primary cell culture and inflammasome assays 
Bone marrow neutrophils were surface labelled using α-Ly6G-FITC (1A8, Biolegend), and 
purified by MACS with α-FITC beads. MACS-purified fractions were assayed for cell purity 
(>98%) by flow cytometry. Macrophages were differentiated from bone marrow as 
previously described (255). Bone marrow neutrophils were always used for experiments 
on the day of purification and were plated in OPTI-MEM (Life Technologies) supplemented 
with 0.4 µg/mL aprotinin (Sigma) at a density of 3.3 x106 cells/ml, except in Figure S2B 
where 5 x106 cells/ml were used. Bone marrow-derived macrophages were cultured at a 
density of 1 x 106 cells/ml in OPTI-MEM (Life Technologies) supplemented with 100 ng/ml 
units/ml recombinant human M-CSF (ImmunoTools). To activate the NLRP3 
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inflammasome, neutrophils and macrophages were primed with 100 ng/ml ultrapure E. coli 
K12 LPS (Invivogen) for 4 h to induce the expression of pro-IL-1β before stimulation with 
NLRP3 agonists. IL-1β levels in cell-free supernatants were analysed by ELISA 
(eBioscience). Cytotoxicity was measured by intracellular LDH release (Promega). Cell 
culture supernatants were precipitated with chloroform and methanol as previously 
described (256), and western blots on cell extracts and precipitated supernatants were 
performed using standard procedures (256). Antibodies included IL-1β (polyclonal goat, 
R&D Systems), caspase-1 (Casper-1, Adipogen), ASC (polyclonal rabbit, Santa Cruz), and 
tubulin (B-5-1-2, Sigma).  
4.5.3 Live cell imaging of neutrophil uptake of silica 
Purified neutrophils were plated on Poly-L-Lysine (Sigma) treated Mat-tek dishes for live 
cell imaging experiments. Cells were incubated with silica (15 µg/ml) particles and Dextran 
(200 µg/ml; 10,000 MW, Alexa Fluor® 555).  After 2 hours incubation, cells were washed 
three times with warm OPTI-MEM (Life Technologies) and imaged live using a Zeiss 710 
confocal microscope. 
4.5.4 Acridine orange labelling and flow cytometry 
Lysosomes were loaded with acridine orange as previously described (19). In brief, cells 
were incubated with acridine orange (Santa Cruz, 1 µg/ml) for 15 min and washed thrice 
prior to stimulation with Leu-Leu-OMe. Lysosomal rupture was quantified using flow 
cytometry at a loss of emission at 600 – 650 nm. Data were acquired on BD Canto II and 
were analysed with FlowJo software (Tree Star). 
4.5.5 Neutrophil depletion and in vivo alum challenge 
Neutrophils were depleted or mock-depleted by i.p. administration of 100 µg α-Ly6G 
antibody (endotoxin-free 1A8 clone, BioXcell) or isotype control anti- body (endotoxin-free 
2A3 clone, BioXcell). 16-24 h post depletion, mice were challenged with i.p with 350 µg 
alum (Pierce) and sacrificed after 6 h. The peritoneal cavity was flushed with 10 ml of ice-
cold DPBS. Collected cells were analysed for neutrophil abundance by flow cytometry, and 
cell-free supernatants were subject to IL-1β ELISA. 
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4.6 Supplementary figures 
 
 
 
 
 
 
 
 
 
 
 
Supplementary Figure 4.1 Neutrophils produce mature IL-1β  in response to soluble agonists of the 
NLRP3 inflammasome.  
(A) Bone marrow neutrophils were primed with 100 ng/ml LPS for 4 h before challenge with R837 (0, 5, 10, 
20 µg/ml) and IL-1β secretion was measured by ELISA at 3, 5, and 7 h post-challenge. Data are mean + SD 
of technical triplicate cell stimulations, and are representative of 3 independent experiments. (B) Wild type 
versus Nlrp3-/- neutrophils were primed with 100 ng/ml LPS for 3 h and challenged with 5 mM ATP for 1 h. 
Supernatants (SN) and cell extracts (XT) were harvested and examined for pro-IL-1β and pro-caspase-1 
cleavage by western blot.  
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Supplementary Figure 4.2 Neutrophils internalise silica particles.  
Neutrophils were incubated with silica (15 µg/ml) for 2 h. Uncropped brightfield image shows refractive silica 
particles within neutrophils.  
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5. Neutrophils resist multiple caspase-8-dependent cell 
death pathways 
5.1 Introduction 
The NLRP3 inflammasome is of particular medical importance because it triggers 
inflammatory responses to a wide variety of structurally unrelated molecules, including 
whole pathogens, bacterial toxins, protein aggregates, metabolites, environmental irritants 
and cellular danger signals released as a consequence of infection or tissue damage (2). 
A key molecular function of the NLRP3 inflammasome is to recruit pro-caspase-1 to the 
ASC polymer for cluster-induced auto-activation, and thereby facilitate caspase-1-
dependent programs (e.g. cytokine processing, pyroptosis). Recent studies have revealed 
an additional function for the NLRP3 inflammasome; the ASC polymer also recruits pro-
caspase-8, driving caspase-8 activation and apoptotic cell death in macrophages (69, 70). 
NLRP3/caspase-8-dependent macrophage apoptosis occurs more slowly than caspase-1-
dependent pyroptosis, and is posited to be a backup mechanism to ensure the suicide of 
infected cells if caspase-1 function is absent (e.g. in cells that do not express caspase-1, 
or if caspase-1 function inhibited by pathogen virulence factors) (69, 70). 
 
Inhibitor of apoptosis proteins (IAPs) are potent inhibitors of pro-apoptotic proteins, and 
also regulate the transcription of pro-survival proteins. Blocking or depleting IAPs thus 
significantly increases the propensity of a cell to undergo cell death. IAP depletion triggers 
multiple intracellular signalling complexes that culminate in caspase-8-dependent 
apoptosis (Figure 5.1). In some cells, IAP antagonism triggers NF-κB activation, leading to 
autocrine TNF signalling (263). TNF signalling in IAP-depleted cells triggers the formation 
of an intracellular signalling complex consisting of RIPK1, TRADD, FADD and caspase-8. 
This caspase-8 activating platform is termed ‘complex II’ and triggers caspase-8 
dependent apoptosis (Figure 5.1A) (198). In other cell types, IAP depletion may also 
trigger caspase-8-dependent apoptosis that is independent of TNF signalling. Caspase-8-
mediated apoptosis in this case requires the formation of a complex II-like platform called 
the ‘ripoptosome’, consisting of RIPK1, FADD and caspase-8, which triggers caspase-8-
dependent apoptosis (Figure 5.1B) (264, 265). In cells such as macrophages, IAP 
depletion in conjunction with TLR4 signalling leads to TRIF-dependent activation of RIPK3 
to trigger ripoptosome-mediated apoptosis (Figure 5.1C) (88). Interestingly, cell death is 
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not prevented if caspase function is blocked in IAP-depleted cells. Instead, cells switch to 
another form of lytic cell death that is dependent on RIPK3 and MLKL, and is termed 
‘necroptosis’ (Figure 5.1A-C) (266). 
  
Intriguingly, recent reports have revealed that ripoptosome and necrosome signalling in 
macrophages triggers NLRP3 inflammasome activation and IL-1β maturation, and that 
IAPs suppress this process (74, 88, 267). Genetic ablation or pharmacological inhibition of 
IAPs in LPS-primed macrophages triggered RIPK3-dependent caspase-8 activation via the 
ripoptosome (74, 264), and ensuing caspase-1-independent IL-1β maturation (74) and 
NLRP3 function (88). If caspase-8 function was suppressed in addition to IAP ablation, 
RIPK3 instead triggered MLKL-dependent necroptosis and NLRP3 signalling (88). It 
seems likely that in both RIPK3-mediated pathways, the NLRP3 inflammasome is 
assembled as a consequence of falling intracellular K+ levels during apoptotic or 
necroptotic cell death. 
 
We have previously demonstrated that neutrophils do not undergo caspase-1-dependent 
pyroptosis downstream of NLRC4 inflammasome activation by Salmonella (Chapter 3). 
The data presented in this chapter aimed to investigate possible cross-talk between RIPK3 
cell death and NLRP3 inflammatory pathways in neutrophils, with the hypothesis that, 
similar to previous chapters, innate immune signalling pathways may be specialised in 
neutrophils. Here, we demonstrate that neutrophils resist all known forms of NLRP3-
dependent cell death. In addition, our data suggest that differential TLR signalling in 
neutrophils allows neutrophils to resist RIPK3-dependent cell death and inflammatory 
responses.  
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Figure 5.1 Different cell death pathways engaged in IAP-depleted cells.  
(A) IAP depletion can trigger autocrine TNF production and complex II-dependent caspase-8 activation. (B) 
IAP depletion can trigger caspase-8 activation and apoptosis through the ripoptosome, with apoptosis 
occurring independently of TNF signalling. (C) TLR-TRIF signalling can trigger RIPK3-dependent caspase-8 
activation via the ripoptosome. In all cases, caspase-8 inhibition leads to the assembly of the necrosome, 
resulting in RIPK3-dependent MLKL phosphorylation and necroptosis. 
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5.2 Results 
5.2.2 NLRP3 activation triggers ASC oligomerisation, caspase-1 processing and IL-
1β maturation but not pyroptosis or apoptosis in neutrophils 
We and others reported that the NLRP3 agonist, nigericin, stimulates NLRP3-dependent 
IL-1β production in neutrophils (Chapter 4 and (241)), but the NLRP3 signalling pathway 
and its cellular outcomes have not been closely examined in neutrophils. In macrophages, 
NLRP3 signals by triggering the polymerisation of the inflammasome adaptor protein, 
ASC. We first examined whether nigericin elicits ASC polymerisation in neutrophils, as for 
macrophages. LPS-primed bone marrow neutrophils (BMN) and bone marrow-derived 
macrophages (BMDM) were stimulated with nigericin, and cellular extracts were 
fractionated into Triton X100 soluble and insoluble fractions (containing monomeric and 
polymeric ASC, respectively). The Triton X100 insoluble fractions were then subject to 
disuccinimidyl suberate (DSS) to crosslink ASC oligomers (268, 269). Treatment with LPS 
alone triggered minimal ASC polymerisation in both neutrophils and macrophages (Figure 
5.2A). Nigericin treatment of LPS-primed cells triggered ASC polymerisation in both cell 
types, although ASC polymerisation occurred more slowly in neutrophils compared to 
macrophages, as ASC remained largely in the Triton X-100 soluble fraction in neutrophils 
up to 3 h post-nigericin treatment, when it underwent a major redistribution to the Triton X-
100 insoluble, ASC polymer fraction (Figure 5.2A). In contrast, in macrophages much of 
the cellular ASC redistributed from the cytoplasmic Triton X-100 soluble to the insoluble 
fraction within 1 h of nigericin treatment, and ASC redistribution appeared complete by 3 h 
post-nigericin stimulation (Figure 5.2A). Consistent with the delayed polymerisation of 
ASC, nigericin-stimulated caspase-1 processing and IL-1β maturation occurred more 
slowly in neutrophils compared to macrophages (Figure 5.2A).  
 
Having established that neutrophil NLRP3, like macrophage NLRP3, triggers the 
polymerisation of ASC and downstream caspase-1 and IL-1β processing, the cellular 
outcomes of neutrophil NLRP3 inflammasome activation were next examined. In 
macrophages, the ASC polymer facilitates caspase-1 and caspase-8 activation for the 
initiation of pyroptosis and apoptosis, respectively. LPS-primed wild type (WT), Nlrp3-/-, 
Asc-/- and Ice-/- neutrophils and macrophages were stimulated with nigericin over 5 h, and 
cell death and viability were measured by intracellular LDH release, MTT reduction and 
propidium iodide (PI) uptake. Substantial macrophage cell death was apparent at high 
doses of nigericin as early as 3 h in WT macrophages, reflecting caspase-1-dependent 
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pyroptosis, while WT neutrophil viability remained relatively high even at 5 h post-nigericin 
(Figure 5.2B-E). Nlrp3-/- and Asc-/- macrophages were protected from nigericin-induced 
cell death at all time points, while caspase-1-deficient Ice-/- macrophages lost viability at 5 
h  (Figure 5.2C, E), reflecting NLRP3/ASC/caspase-8-dependent apoptotic death (69, 70). 
Importantly, genotype had no apparent effect on neutrophil cytotoxicity or viability following 
nigericin treatment even after 5 h (Figure 5.2B, D), indicating that neutrophils did not 
undergo any form of NLRP3 inflammasome-dependent cell death. To ensure that the lack 
of NLRP3-dependent cell death in neutrophils was not a consequence of delayed 
signalling kinetics, WT, Nlrp3-/- and Ice-/- neutrophils were stimulated with nigericin in the 
presence or absence of the pan-caspase inhibitor z-VAD-fmk for 7 h and the loss of 
membrane integrity was measured by PI uptake in these cells. At this time point, a high 
proportion (~80%) of nigericin-stimulated neutrophils were positive for PI, but this 
proportion was not affected by LPS pre-treatment or neutrophil genotype (Figure 5.2F). 
Caspase inhibition by z-VAD-fmk modestly reduced PI uptake in nigericin-treated 
neutrophils of all genotypes, but greatly reduced PI uptake in Fas-treated neutrophils 
(Figure 5.2F), indicating that while Fas and nigericin do trigger neutrophil cell death, and 
nigericin-stimulated cell death is partially dependent on apoptotic caspases, nigericin-
induced cell death occurs via mechanisms independent of the NLRP3 inflammasome. In 
these experiments, z-VAD-fmk was added to the cell culture media at the same time as 
LPS and FasL to prevent FasL-induced caspase activation, however, z-VAD-fmk may alter 
LPS-priming of NLRP3 responses. To circumvent this possibility, z-VAD-fmk will be added 
to the cells 30 min prior to nigericin stimulation and not throughout the LPS priming 
process in future experiments. Taken together, these data indicate that while part of the 
macrophage NLRP3 signalling pathway is mirrored in neutrophils (i.e. ASC polymerisation, 
caspase-1 processing and IL-1β maturation), neutrophils are resistant to all forms of 
NLRP3-mediated cell death. 
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Figure 5.2 NLRP3 triggers ASC polymerisation, and caspase-1 and IL-1β  processing but not cell 
death in neutrophils.  
(A) BMN and BMDM were primed with 100 ng/ml LPS for 4 h and then stimulated with 5 µM nigericin for 1, 
3, or 5 h. At the indicated time points, cells were lysed and the Triton X-100 insoluble fraction (TX100insol) 
was crosslinked with DSS. Soluble and insoluble cell fractions (TX100sol, TX100insol), and cell supernatants 
(SN) were subject to western blot for ASC, cleaved caspase-1 (p20) and mature IL-1β (p17). Cell numbers 
for neutrophils (3 x 106) and macrophages (1.65 x 105) were optimised such that total ASC abundance was 
equivalent between samples (right: input). (B, D) BMN or (C, E) BMDM were primed with 100 ng/ml LPS and 
treated with a dose range of nigericin for 3 or 5 h. (B-C) Cytoplasmic LDH release into the supernatant or (D-
E) MTT reduction was quantified as a measure of cell death/viability. (F) BMN were left untreated or primed 
with 100 ng/ml LPS in the presence or absence of 50 µm z-VAD-fmk. PI uptake at 7 h post-nigericin was 
quantified by flow cytometry. Data are mean + SD of technical triplicate cell stimulations and are 
representative of (A-C) four or (D-F) two independent experiments. 
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5.2.3 The neutrophil NLRP3 inflammasome recruits and activates caspase-8, but 
does not facilitate caspase-8 self-processing 
In macrophages, NLRP3 drives apoptotic cell death by recruiting caspase-8 to the ASC 
polymer for caspase-8 activation (69, 70). Hypothesising that neutrophil protection from 
NLRP3/ASC/caspase-8-dependent cell death may be due to inefficient caspase-8 
activation by neutrophil NLRP3/ASC, pro-caspase-8 recruitment to the ASC speck was 
next examined. LPS-primed neutrophils were stimulated with nigericin over 5 h in the 
presence of z-VAD-fmk to prevent caspase-8 proteolysis and release from the ASC 
polymer. The Triton X-100 insoluble fraction was separated from the soluble fraction by 
centrifugation, to enrich for polymeric ASC. Caspase-8 was not present in the Triton X-100 
insoluble fraction in untreated and LPS-primed neutrophils. Nigericin treatment triggered 
caspase-8 redistribution into the ASC polymer-containing insoluble fraction (Figure 5.3A). 
As caspase-8 appeared to be recruited to the neutrophil NLRP3 inflammasome, possible 
mechanisms suppressing caspase-8 activity were next investigated. c-FLIP is a caspase-8 
homologue that lacks the caspase catalytic cysteine, and heterodimerises with pro-
caspase-8 to inhibit specific caspase-8 functions (270). c-FLIP exists as long and short 
splicoforms (c-FLIPL and c-FLIPs). At high c-FLIP concentrations, both c-FLIP isoforms 
outcompete pro-caspase-8 for binding to its signalling complex and thereby limit caspase-
8 auto-proteolysis. However, at low cellular concentrations, c-FLIPL can enhance specific 
pro-caspase-8 activities, as the protease-dead domain of c-FLIPL is able to allosterically 
activate pro-caspase-8 (197). However, the c-FLIPL/caspase-8 heterodimer cleaves a 
narrower range of substrates compared to a caspase-8 homodimer (197). c-FLIP 
localisation was next examined, with the hypothesis that c-FLIP may be recruited to the 
neutrophil NLRP3 inflammasome alongside caspase-8 to suppress caspase-8-dependent 
apoptosis. Interestingly, nigericin triggered the redistribution of both c-FLIP isoforms, c-
FLIPL and c-FLIPs, to the Triton X-100 insoluble fraction (Figure 5.3A). These data broadly 
suggest that both caspase-8 and c-FLIP are recruited to the inflammasome upon 
neutrophil nigericin treatment, and caspase-8 auto-proteolysis on the neutrophil NLRP3 
inflammasome may be suppressed by c-FLIP. Further experiments using Nlrp3-/- and Asc-/- 
neutrophils will confirm that pro-caspase-8 and c-FLIP recruitment to the Triton X-100 
insoluble fraction indeed reflects recruitment to the inflammasome, and c-FLIP silencing 
experiments will reveal possible functions for c-FLIP in inhibiting NLRP3/caspase-8-
dependent apoptosis. 
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A caspase activity probe was next employed to clarify whether inflammasome-recruited 
caspase-8 gains enzymatic activity in neutrophils. Biotin-VAD-fmk is a biotinylated 
substrate mimic that binds irreversibly to the active site of caspases, and can thereby be 
used in conjunction with streptavidin-coupled beads to isolate activated caspases for 
identification by western blot. Caspase-1-deficient Ice-/- neutrophils were used for these 
studies in order to more clearly observe caspase-8-dependent processes, which occur 
more slowly than pyroptosis (69, 70). Surprisingly, given that neutrophils did not undergo 
inflammasome-mediated apoptosis (Figure 5.2B-F), pro-caspase-8 was indeed detected 
in the pulldown fraction upon neutrophil nigericin stimulation. Intriguingly, active caspase-8 
was detected in the cell supernatant, but not in the ASC polymer-containing cell extracts. 
The active species pulled down by this approach were full-length (55 kDa) pro-caspase-8 
and a larger caspase-8 species of approximately 75 kDa (Figure 5.3B). The latter may 
reflect caspase-8 post-translational modification, which can reportedly positively or 
negatively regulate caspase-8 activity (271-273). In this experiment, biotin-VAD-fmk was 
applied 30 min prior to cell stimulation with nigericin, and so it remains possible that biotin-
VAD-fmk prevented pro-caspase-8 self-processing upon the ASC speck. To test whether 
inflammasome-recruited caspase-8 undergoes auto-processing or supports substrate 
cleavage in neutrophils, LPS-primed neutrophils were exposed to nigericin for 5 h without 
the addition of a caspase inhibitor, and cell extracts and supernatants were analysed by 
immunoblot. Nigericin triggered the release of full-length caspase-8 into the cell 
supernatant, but caspase-8 cleavage was not apparent in any neutrophil fraction (Figure 
5.3C). In contrast, nigericin triggered robust caspase-8 processing in Ice-/- macrophages 
(Figure 5.3C). Under certain conditions, c-FLIPL can stabilise the pro-caspase-8 active site 
loop to form an enzymatically-active heterodimer with limited substrate repertoire (197, 
215, 270, 274). Because both c-FLIP isoforms were enriched in the Triton X-100-insoluble 
ASC polymer fraction following nigericin treatment (Figure 5.3A), possible correlations 
between c-FLIP expression levels and caspase-8 processing were next investigated, as 
high c-FLIP levels might explain altered caspase-8 processing in neutrophils. Nigericin 
stimulation did not influence c-FLIPL expression in neutrophils, and c-FLIPs was barely 
detected in cell extracts under all tested conditions. In contrast, nigericin induced a marked 
reduction of c-FLIPL in macrophages, while c-FLIPs was not detected (Figure 5.3C). In all, 
these data suggest a likely role for c-FLIP in limiting caspase-8 cleavage upon the NLRP3 
inflammasome in neutrophils, thereby suppressing inflammasome-mediated apoptotic cell 
death. Future experiments will knock down c-FLIP expression in neutrophils using siRNA, 
in order to assess whether this increases neutrophil susceptibility to NLRP3-dependent 
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apoptosis. Alternatively, c-FLIPL will be overexpressed in Ice-/- macrophages in order to 
block NLRP3/caspase-8 dependent apoptosis. 
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Figure 5.3 Nigericin triggers pro-caspase-8 recruitment to the ASC speck, pro-caspase-8 activity, but 
not pro-caspase-8 processing.  
(A) BMN were primed with 100 ng/ml LPS for 4 h in the presence or absence of 50 µM zVAD-fmk co-
administration, before stimulation with 5 µM nigericin for 1, 3, 5 h. At the indicated time points, cells were 
lysed and the Triton X-100 insoluble (TX100insol) and soluble fractions were analysed by western blot. (B) 
LPS-primed Ice-/- neutrophils were stimulated with 5 µM nigericin for 5 h in the presence of 10 µM biotin-
VAD-fmk (added 30 min prior to nigericin). Western blot detected biotin-VAD-trapped and untrapped 
caspase-8 in the supernatant (SN) and cell extracts (XT). (C) LPS-primed Ice-/- BMN and BMDM were 
treated with 5 µM nigericin for 5 h and the cell extracts (XT) were analysed by western blotting. Blots are 
representative of (A) a single experiment or (B-C) 3 independent experiments. 
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5.2.4 LPS/Cp A does not trigger RIPK3/caspase-8-dependent apoptosis or NLRP3 
signalling in neutrophils 
The surprising finding that neutrophils resist NLRP3/caspase-8-dependent cell death 
prompted us to investigate whether other caspase-8 signalling platforms are also deficient 
in neutrophils. The ripoptosome consists of RIPK1, FADD, caspase-8, and under some 
conditions, the caspase-8 inhibitor, c-FLIP (264, 265). Both c-FLIP isoforms were reported 
to limit caspase-8 auto-processing upon the ripoptosome, and thereby inhibit caspase-8-
dependent cleavage of apoptotic substrates (264, 265). If c-FLIP is absent, ripoptosome-
recruited pro-caspase-8 undergoes complete auto-proteolysis and is able to cleave its full 
range of substrates to drive the apoptotic program. Caspase-8 function in the context of 
the ripoptosome was next examined in neutrophils, as ripoptosome assembly in 
macrophages triggers apoptosis and NLRP3 signalling (74, 275). Neutrophils were treated 
with the IAP antagonist, Compound A (Cp A), to induce ripoptosome assembly (74, 264, 
265). Surprisingly, Cp A treatment was a weak stimulus for neutrophil death (Figure 5.4A), 
but elicited robust macrophage death (Figure 5.4B). LPS pre-treatment did not enhance 
cell death levels in Cp A-treated neutrophils (Figure 5.4A), but accentuated Cp A-
mediated macrophage cytotoxicity (Figure 5.4B). Enhanced cell death in LPS-treated 
macrophages is due to TLR4-mediated RIPK3 activation, which enhances ripoptosome-
dependent apoptosis (88). The lack of Cp A-induced cell death in IAP-inhibited neutrophils 
suggested the possibility that in these cells, Cp A may not induce autocrine TNF signalling. 
Indeed, exogenous TNF enhanced Cp A-mediated death in neutrophils but LPS pre-
treatment had no effect on Cp A-induced neutrophil cytotoxicity (Figure 5.4A). In all this 
suggests that IAP-depletion licenses neutrophils to undergo TNF-dependent apoptosis, 
demonstrating that the ripoptosome can indeed be formed and trigger apoptosis in 
neutrophils. However, IAP depletion did not license neutrophils for LPS-mediated 
RIPK3/ripoptosome-driven cell death. By contrast, macrophages were susceptible to both 
cell death pathways.  
 
Since Cp A did not elicit cell death in LPS-primed neutrophils (Figure 5.4A), we 
hypothesised that IAP inhibition would be similarly unable to drive caspase-8- and 
NLRP3/caspase-1-dependent pro-IL-1β processing in neutrophils. Indeed, Cp A did not 
trigger IL-1β secretion from either WT or caspase-1-deficient Ice-/- LPS-primed neutrophils, 
while nigericin induced IL-1β secretion from LPS-primed WT neutrophils (Figure 5.4B). In 
contrast, and as expected (74), Cp A triggered robust IL-1β secretion from LPS-primed WT 
macrophages (Figure 5.4C), reflecting RIPK3/caspase-8-dependent IL-1β processing and 
Neutrophils resist multiple caspase-8 dependent cell death pathways 
 111 
RIPK3/caspase-8-dependent NLRP3 activation (88). IAP inhibition triggers ASC 
polymerisation in LPS-stimulated macrophages and dendritic cells (267), however, it was 
unclear whether IAPs directly regulate ASC polymerisation, or this occurs as a secondary 
outcome of ripoptosome/caspase-8-driven NLRP3 activation. To investigate this, ASC 
polymerisation in LPS/Cp A-stimulated neutrophils and macrophages was monitored using 
the DSS crosslinking protocol. Nigericin stimulated ASC polymerisation in LPS-primed 
neutrophils, while Cp A did not trigger neutrophil ASC polymerisation regardless of LPS 
priming (Figure 5.4E). In contrast, Cp A triggered ASC polymerisation in macrophages, 
and LPS pre-treatment boosted this effect (Figure 5.4E). These data are consistent with 
NLRP3 activation following LPS/Cp A treatment in macrophages but not neutrophils 
(Figure 5.4C-E), and suggest that IAPs do not directly regulate ASC polymerisation, but 
instead, the reported ASC polymerisation in LPS-treated IAP-deficient macrophages and 
dendritic cells occurs as a consequence of ripoptosome/caspase-8-dependent NLRP3 
signalling. If this is the case, the NLRP3 inhibitor, MCC950, should block ASC 
oligomerisation in LPS/Cp A-treated macrophages, and future experiments will be carried 
out to verify this. As anticipated given the dual pathways (caspase-8 versus caspase-
8/NLRP3/caspase-1) mediating IL-1β production downstream of the ripoptosome (88), 
caspase-1 deficiency only partially suppressed Cp A-induced IL-1β secretion from LPS-
primed macrophages (Figure 5.4D-E). The lack of cell death and mature IL-1β release in 
LPS/Cp A-stimulated neutrophils suggests that this treatment regimen may fail to trigger 
pro-caspase-8 processing in neutrophils. 
 
We therefore next investigated the cleavage status of pro-caspase-8 in neutrophils and 
macrophages exposed to LPS/Cp A versus a positive control for caspase-8 processing, 
FasL. Expression of full-length caspase-8 was unaffected by Cp A treatment in neutrophils 
(Figure 5.4F). Cp A did not elicit caspase-8 cleavage, while FasL triggered robust 
caspase-8 processing as observed by the loss of full-length pro-caspase-8 in the 
neutrophil cell extracts and the appearance of caspase-8 cleavage fragments in the 
supernatant (Figure 5.4F). In line with the lack of Cp A-induced caspase-8 proteolysis, 
expression of the caspase-8 substrate, Bid, was unchanged following Cp A treatment, 
while FasL triggered a loss of full-length Bid in the neutrophil cell extracts (Figure 5.4F). In 
contrast in LPS-primed macrophages, Cp A triggered a loss of full-length pro-caspase-8 
and appearance of processed caspase-8 in the cell extracts and supernatants (Figure 
5.4F), as well as IL-1β processing (Figure 5.4E). Similarly, Bid cleavage was readily 
observed in both Cp A and FasL-treated macrophages (Figure 5.4F).  
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c-FLIP hemizygosity enhances ripoptosome/caspase-8-mediated IL-1β processing in 
macrophages (276), so high c-FLIP expression may underlie the lack of pro-caspase-8 
cleavage in neutrophils exposed to LPS/Cp A. LPS treatment induced c-FLIPL expression 
both cell types (Figure 5.4F), consistent with the view that LPS is a pro-survival signal 
(Chapter 3). c-FLIPs was barely detected in all treatments in either cell type. FasL induced 
c-FLIPL degradation in both neutrophils and macrophages, and accordingly, both cell types 
underwent caspase-8 cleavage and death (Figure 5.4F). Importantly, Cp A treatment did 
not affect c-FLIPL expression in neutrophils, but led to a complete loss of cellular c-FLIPL in 
macrophages, suggesting a possible role for c-FLIPL in regulating caspase-8 auto-
processing and substrate repertoire in these cells. In all, the lack of cell death and mature 
IL-1β release in LPS/Cp A-stimulated neutrophils suggested at least three possible 
explanations: (1) the ripoptosome complex failed to be assembled in these cells; (2) 
caspase-8 was not activated because the ripoptosome was not recruited by TRIF to the 
TLR signalling complex; or (3) c-FLIPL was recruited to the TRIF-associated ripoptosome, 
and suppressed caspase-8 pro-apoptotic functions. Preliminary experiments to investigate 
the latter two possibilities were commenced, but full investigations were not possible due 
to time constraints. Future experiments will investigate each other these possible 
scenarios in detail.  
5.2.5 Neutrophils appear unable to signal via TRIF  
In macrophages, LPS treatment in IAP-depleted cells triggers ripoptosome-dependent cell 
death, IL-1β processing and NLRP3 activation (74, 88). This process requires signalling 
through the TLR3 and TLR4 adaptor TRIF, which recruits and activates RIPK3 kinase 
through homotypic RHIM-RHIM interactions (88). Interestingly, human neutrophils weakly 
express TRIF, and were unable to trigger TRIF-dependent signalling pathways such as the 
production of type I interferon following LPS engagement (246). TRIF signalling in murine 
neutrophils was therefore next investigated, as absent or altered TRIF signalling may 
provide a mechanism for the absence of caspase-8-dependent outputs (cell death, IL-1β 
maturation, NLRP3 activation) following LPS/Cp A treatment in neutrophils (Figure 5.4). 
TRIF was readily detected in neutrophil cell lysates (Figure 5.5A). Interestingly, the 
synthetic TLR3 agonist, poly(IC), appeared to provided a survival signal to neutrophils, 
similar to LPS (Chapter 3), as indicated by an increase in the level of tubulin loading 
control (Figure 5.5A), which may indicate that murine neutrophils can signal through 
TLR3, although this remains to be formally investigated. Having established that murine 
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neutrophils express TRIF, we next investigated whether LPS- or poly(IC)-treated 
neutrophils could signal via TRIF, by measuring proinflammatory cytokine production. TNF 
production can occur via the TRIF-dependent or -independent pathways downstream of 
TLR4 (277), but all cytokine production downstream of TLR3 depends upon TRIF. LPS 
triggered TNF (Figure 5.5B) but not IL-6 (not detected, data not shown) production in 
murine neutrophils, while poly(IC) did not trigger detectable levels of secreted TNF (Figure 
5.5B) or IL-6 (not detected, data not shown). In all, these data suggest that murine 
neutrophils may trigger only a subset of the full spectrum of macrophage TLR/TRIF 
signals, as previously suggested for human neutrophils (246). Future experiments will 
assess the TRIF-dependent signalling events (e.g. IFN-β gene expression) following 
stimulation with various TLR ligands to confirm if LPS-dependent TRIF signalling is indeed 
deficient or altered in neutrophils.  
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Figure 5.4 LPS-primed neutrophils do not trigger RIPK3-dependent inflammatory responses upon 
functional blockade of IAPs.  
(A) BMN or (B) BMDM were left untreated or treated with 500 nM Cp A in the presence or absence of 100 
ng/ml LPS or 100 νg/ml TNF for 6 h. Cytoplasmic LDH release into the supernatant, as compared to total 
intracellular LDH of untreated cells was quantified as a measure of cell death. (C-F) BMN or BMDM were 
primed for 3 h with 100 ng/ml LPS before stimulation with 500 nM Cp A for 6 h. Cells were treated with 100 
ng/ml FasL for 9 h. (C-D) IL-1β secretion was quantified by ELISA. (E) ASC oligomers in the Triton X-100 
insoluble (TX100insol) fraction and cleaved caspase-1 (p20) and mature IL-1β (p17) in the cell supernatant 
were detected by western blotting. (F) Caspase-8, c-FLIP and Bid in the cell extracts (XT) and supernatants 
(SN) were detected by western blotting. GAPDH was used as loading control. (A, C, D) Data are mean + 
S.E.M of three independent experiments, performed each in triplicate cell stimulations. (B) Data are mean + 
SD of technical triplicates, and representative of two experiments. (E-F) Western blots are representative of 
three independent experiments. 
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Figure 5.5 Murine neutrophils express TRIF, but may not signal via TRIF-dependent pathways.  
Neutrophils were left untreated or stimulated with 100 ng/ml LPS or 50 µg/ml poly(IC) for 10 h. (A) TRIF 
expression in the whole cell lysate was detected by western blotting, versus a tubulin loading control. (B) 
TNF production was measured by ELISA. Data are mean SD of technical triplicate from a single experiment. 
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5.2.5 TNF but not LPS triggers RIPK3-dependent necroptosis in neutrophils  
The earlier observation that TNF plus Cp A triggered neutrophil death, but not Cp A alone 
or in combination with LPS (Figure 5.4A), suggested that TNF/Cp A-induced cell death in 
neutrophils most likely occurred through Complex II, while Cp A plus LPS was not a strong 
stimulus for neutrophil ripoptosome signalling. To examine whether neutrophils can 
undergo necroptotic cell death, neutrophils were treated with TNF in the presence of Cp A 
and the pan-caspase inhibitor Q-VD-OPh (QVD), and cellular toxicity was measured by PI 
uptake after 24 h. 30% of untreated neutrophils were PI positive after culture for 24 h, 
reflecting basal apoptosis. In line with earlier observations (Figure 5.4A), Cp A or TNF 
alone had little effect on cell viability but in combination synergised to induce cell death in 
both the presence and absence of caspase inhibition (Figure 5.6). TNF/Cp A-induced 
cytotoxicity was unaffected by Ripk3 deficiency, suggesting that in the absence of caspase 
inhibition, neutrophils underwent Complex II-dependent apoptosis. However, Ripk3 
deficiency protected neutrophils during TNF/Cp A/QVD-induced cell death (Figure 5.6), 
indicating that neutrophils underwent TNF-dependent necroptosis when caspase-8 
function was inhibited. When a similar experiment was repeated in which TNF was 
substituted for LPS, neutrophils did not undergo cell death after any combination of Cp A, 
LPS and QVD, while Cp A/LPS and CpA/LPS/QVD did kill macrophages (88). Taken 
together, these data suggest that TNF but not LPS can trigger cell death pathways in IAP-
depleted neutrophils. 
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Figure 5.6 Cp A sensitises neutrophils to TNF-induced, RIPK3-independent death, while caspase 
inhibition triggers RIPK3-dependent necroptosis.  
Bone marrow neutrophils were purified by cell sorting, and PI uptake was measured 24 h after cell exposure 
to TNF (100 ng/ml), Cp A (500 nM), QVD (20 µM) or combinations therein. Data are mean + SD of technical 
triplicate cell stimulations from a single experiment. This experiment was performed by Motti Gerlic (Walter 
and Eliza Hall Institute), who kindly granted permission for this data to be presented in this thesis. 
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5.3 Discussion 
Previous data presented in this thesis demonstrated that NLRC4/caspase-1 activation in 
neutrophils selectively drives cytokine processing but not pyroptosis in neutrophils, and 
that this pathway specialisation is critical for in vivo defence against Salmonella (Chapter 
3). The data presented in the current chapter extends these findings, demonstrating that 
neutrophil NLRP3 activation also does not elicit caspase-1-dependent pyroptosis, or 
indeed caspase-8-dependent apoptosis, in line with emerging data that this myeloid subset 
often exhibits specialised inflammatory signalling pathways. Neutrophil resistance to 
NLRP3/caspase-8-dependent cell death correlated with a lack of nigericin-stimulated pro-
caspase-8 processing, and may reflect inhibition of pro-caspase-8 processing and 
apoptosis-initiating function by c-FLIP isoforms. Future experiments will use siRNA to 
silence c-FLIP expression in neutrophils, or use myeloid-specific conditional c-FLIP 
knockout neutrophils, to determine whether c-FLIP inhibition of pro-caspase-8 underlies 
the inability of neutrophils to undergo NLRP3-dependent apoptosis. The mechanism by 
which neutrophils avoid NLRP3/caspase-1-directed pyroptosis remain unclear, but may 
reflect reduced or absent expression of the unknown cell machinery required for pyroptosis 
execution. 
 
As for previous results for neutrophil NLRC4, the inability of neutrophils to undergo NLRP3 
inflammasome-dependent pyroptotic and apoptotic cell death likely represents an 
advantage to the host in specific circumstances. A key in vivo function of the NLRP3 
inflammasome is to recruit neutrophils to a site of infection or injury, in order to clear 
infection or engulf cell debris. In these settings, neutrophils sensing NLRP3-activating 
stimuli are likely also exposed to inflammatory mediators such as IL-1β that prolong 
neutrophil lifespan (228). The inability of neutrophils to undergo NLRP3-dependent cell 
death, coupled with increased lifespan at sites of inflammation, may represent a 
mechanism by which neutrophil function is ensured until the cause of inflammation is 
resolved, at which time neutrophils will be allowed to undergo their underlying apoptotic 
program. If NLRP3 agonists could induce neutrophil death, this would compromise 
neutrophil antimicrobial mechanisms (e.g. ROS, neutrophil extracellular traps, granules) 
and phagocytic function at sites of injury or infection. The lack of inflammasome-mediated 
cell death in neutrophils may however pose a disadvantage under some circumstances; 
for example, it may result in increased susceptibility to specific neutrophil-trophic 
intracellular pathogens. For example, Anaplasma phagocytophilum and Leishmania major 
avoid immune surveillance by replicating within neutrophils, and conversely, neutrophil 
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depletion protected animals from Anaplasma phagocytophilum (278) and Leishmania 
major (279) infection. Interestingly, Leishmania major activates the inflammasome (280), 
and so one might predict that infected mice would show improved survival if neutrophils 
were able to trigger inflammasome-dependent cell death, similar to the improved survival 
of neutrophil-depleted as compared control mice (279, 281). Another setting in which the 
inability of neutrophils to undergo inflammasome-mediated cell death might contribute to 
pathology is in inflammatory disease, as the sustained viability of inflammasome-activated 
neutrophils may result in prolonged neutrophil cytokine production. NLRP3 dysregulation is 
associated with hereditary fever syndromes and acquired pathologies such as arthritis (2). 
As neutrophils make up more than 70% of white blood cells in the human circulation (228), 
and NLRP3-dependent inflammatory responses from neutrophils are not restricted by 
inflammasome-dependent cell death, neutrophils may be a key cell type for driving 
NLRP3-dependent pathologies through sustained IL-1β production in humans. The next 
chapter in this thesis investigates potential roles for neutrophils in mediating pathological 
inflammasome responses to bacterial LPS in mice, in order to provide proof-of-concept 
that neutrophil inflammasomes can drive human inflammatory diseases. 
 
The surprising inability of neutrophils to undergo inflammasome-mediated apoptotic and 
pyroptotic pathways led us to investigate whether neutrophils could die via other 
inflammatory cell death pathways elicited during infection, such as ripoptosome- or 
necrosome-induced cell death downstream of LPS/TLR4 or TNF/TNFR signalling. TNF 
alone did not induce neutrophil cell death, but IAP inhibition sensitised the cells to RIPK3-
independent cell death, likely mediated by TNF-induced complex II signalling to the 
caspase-8-driven apoptotic program. If caspase-8 function was inhibited by QVD, 
neutrophils instead underwent RIPK3-depedent necroptotic cell death. Intriguingly, LPS 
did not appear to induce any form of cell death in IAP-inhibited neutrophils, and 
correspondingly, Cp A/LPS did not trigger neutrophil NLRP3 signalling (Figure 5.4C and 
(88)). At least three possible reasons may account for the lack of ripoptosome- and 
necrosome-mediated cell death in LPS-stimulated neutrophils: (1) IAP depletion may not 
induce ripoptosome complex assembly in neutrophils, similar to observations in some 
cancer cells, such as chronic lymphocytic leukaemia (282); (2) High expression of c-FLIP 
isoforms in neutrophils may block these cell death modalities; or (3) TLR4 signalling in 
neutrophils may be unable to engage ripoptosome-mediated responses, due to deficient or 
altered TRIF signalling. To investigate if IAP depletion triggers ripoptosome formation in 
neutrophils, reciprocal co-immunoprecipitation experiments for components of the 
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ripoptosome (e.g. RIPK1, FADD and caspase-8) will be performed in Cp A-treated 
neutrophils. Such experiments will be performed using macrophages as a positive control, 
as macrophages are well established to signal via the ripoptosome in response to Cp 
A/LPS exposure. If the ripoptosome is indeed assembled in neutrophils, the role of c-FLIP 
in suppressing apoptosis and necroptosis will then be investigated. Gene silencing 
(siRNA) approaches will knock down the expression of both c-FLIPL and c-FLIPs isoforms, 
as both isoforms can block RIPK1/3-mediated cell death (264, 265). These experiments 
may be technically challenging, as neutrophils are highly apoptotic cells, and because c-
FLIP suppresses caspase-8-mediated apoptosis. To circumvent these potential issues, 
neutrophils will be cultured in the presence of growth factors (e.g. G-CSF) during gene 
silencing and stimulation. Alternatively, experiments may be conducted using myeloid-
specific c-FLIP-deficient cells. In macrophages, TLR4 activates RIPK3 via TRIF-RIPK1 
interaction, leading to ripoptosome-mediated cell death and NLRP3 signalling (88). The 
possibility that TLR4 signalling does not activate the ripoptosome in IAP-inhibited 
neutrophils because of altered TRIF signalling in these cells will be a key focus of future 
investigations. TLR4-stimulated human neutrophils are unable to induce expression of 
type I IFN, possibly due to an inability to engage the TRIF signalling pathway (246). TRIF 
is a signalling adaptor that is recruited to TLR4 in the endosome following TLR4 
internalisation. Importantly, internalisation of the TLR4:LPS complex into endosomes 
requires the TLR4 co-receptor, CD14 (277).  Human neutrophils display ~20-fold fewer 
CD14 molecules on their cell surface compared to blood monocytes (283, 284); so 
decreased neutrophil CD14 expression may block neutrophil TRIF signalling and 
consequent RIPK1/3-mediated cell death pathways. We will investigate this possibility by 
profiling the expression of TRIF-dependent target genes such as IFN-β downstream of 
LPS stimulation in murine neutrophils. If indeed neutrophils do not trigger TRIF-dependent 
target genes, expression of cell surface CD14 will be investigated and LPS-mediated 
internalisation of TLR4 will be monitored. We anticipate that TLR4 will remain on the cell 
surface following LPS engagement cells such as neutrophils that weakly express CD14, 
while cells such as macrophages that express high levels of CD14 will internalise LPS-
TLR4 as previously shown (277). 
 
Apoptosis is traditionally regarded as an immunologically silent form of cell death; so it is 
intriguing that ripoptosome-dependent apoptosis triggers proinflammatory NLRP3 
signalling in macrophages. It remains unclear what advantage this gives to the host, and 
likewise, what advantage is offered from neutrophil protection from such pathways. These 
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observations for macrophages contribute to an emerging literature suggesting that 
apoptosis induced by cellular stress or microbial infection can trigger pathways that 
propagate inflammation through the production of proinflammatory cytokines. For example, 
in the presence of LPS, FasL triggered apoptosis and concomitant IL-1β release in specific 
cell types, including neutrophils (243, 285, 286). Similarly, endoplasmic reticulum stress 
can also trigger apoptosis with accompanied IL-1β release (287). Apoptosis is a key innate 
immune mechanism to protect against viral infection, and is launched in infected cells via 
depletion of endogenous IAPs. Since viral infection often triggers IAP depletion and TLR3-
TRIF-dependent signalling, RIPK3-mediated cell death and NLRP3 activation in this 
scenario likely provides important antiviral innate immune responses in macrophages. 
While neutrophils are traditionally viewed as mediators of anti-bacterial defences, 
emerging studies suggest that neutrophils can enhance antiviral responses as they 
express a number of intracellular nucleic acid sensors that can signal independently of 
TRIF such as AIM2 (Chapter 3), RIG-1 and MDA5 (288), and neutrophils can cast NETs 
to entrap human immunodeficiency virus-1 (HIV-1) (289). Therefore, it seems likely that 
RIPK3-dependent cell death pathways are switched off in neutrophils in order to prolong 
neutrophil viability at a site of infection.  
 
In conclusion, this chapter demonstrates that NLRP3 activation in neutrophils triggers ASC 
polymerisation, caspase-1 cleavage and secretion of mature IL-1β. Unlike macrophages, 
however, neutrophils do not die via NLRP3/caspase-1 and NLRP3/caspase-8 pathways. 
Neutrophils also appeared to be protected from other cell death pathways induced by 
inflammatory stimuli in macrophages. Unlike macrophages, IAP depletion did not trigger 
neutrophil death, but IAP depletion did sensitise neutrophils to TNF-mediated apoptosis. 
Intriguingly, LPS exposure did not trigger death in IAP-depleted neutrophils, regardless of 
the presence or absence of caspase inhibition. In all, these data highlight the important 
influence of cell identity on immune signalling pathways, even within closely related 
myeloid cells. These cell type-specific signalling adaptations have likely evolved to provide 
a coordinated inflammatory response in vivo. 
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6. The neutrophil caspase-11 inflammasome in 
endotoxin shock 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The PhD candidate led the experimental design and interpretation of data. However, due 
to the laborious nature of the experiments, all data presented in this chapter were acquired 
in conjunction with Dr Dave Boucher (50%). 
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6.1 Introduction	  
Cells of the innate immune system express a wide range of PRRs to detect the presence 
of microbial infection (1). One mechanism by which immune cells sense Gram-negative 
bacteria is by detecting LPS (also known as endotoxin), a major constituent of the Gram-
negative bacterial cell wall. TLR4 is a well-characterised cell surface receptor that 
recognises extracellular LPS (290-292). TLR4 ligation triggers the induction of 
proinflammatory gene expression, including proinflammatory cytokines such as IL-6 and 
TNF (293), and components of the inflammasome signalling pathway such as NLRP3, IL-
1β and caspase-11 (227, 230, 258). A recent report identified a second LPS receptor, 
caspase-11 (81). Unlike TLR4, caspase-11 is located in the cell cytoplasm, and so detects 
cytosolic LPS from intracellular bacteria. LPS binding appears to cluster caspase-11, 
triggering proximity-induced caspase-11 autoactivation (81). In macrophages, active 
caspase-11 drives pyroptotic cell death, leading to the passive release of alarmins such as 
IL-1α and HMGB1, and also directs NLRP3/caspase-1-dependent IL-1β secretion through 
an ill-defined mechanism termed “non-canonical NLRP3 activation” (76) that involves 
caspase-11-dependent K+ efflux (82, 86, 294).  
 
Sepsis is life-threating condition characterised by a complex systemic hyperinflammatory 
response that can lead to multi-organ failure if the host fails to control infection (295). 
Sepsis-induced sustained inflammatory dysregulation can progress to septic shock upon 
circulatory decompensation (i.e. hypotension) (296). While both TLR4 and caspase-11 
pathways contribute to microbial clearance during infection, excessive activation of either 
pathway during murine experimental LPS challenge drives endotoxic shock, a systemic 
hyperinflammatory syndrome resembling clinical signs of septic shock in humans (77, 78, 
291, 292, 296). Indeed, Tlr4-deficient and Casp11-deficient mice were both protected 
during challenge with a single high dose of LPS (up to 54 mg/kg) (77, 78, 292), but the 
precise pathways controlling pathogenic inflammation in this model are still incompletely 
understood. A 1995 study demonstrated that Ice-/- mice were resistant to challenge with a 
single high dose of LPS, similar to Tlr4-/- mice (226). Until recently, these mice were 
considered to be Casp1 knockouts. Given that Ice-/- mice secreted significantly lower 
amount of IL-1β following LPS challenge, it was concluded that Ice-/- mice were protected 
from LPS lethality due to their inability to trigger caspase-1-dependent IL-1β secretion 
(226). Later studies showed that that caspase-1 activation required the assembly of an 
inflammasome complex (57), which suggested the existence of an unknown 
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inflammasome that assembles upon cytosolic LPS recognition. In 2011, Kayagaki and co-
workers demonstrated that the commonly used caspase1-deficient Ice-/- mouse strain carry 
a passenger mutation in the Casp11 locus, suggesting possible roles for caspase-11 in 
many of the phenotypes previously attributed to caspase-1, including endotoxin sensitivity 
(76). Subsequent studies used Tlr4-/- mice to investigate the role of caspase-11 in 
endotoxin sensitivity, in order to examine caspase-11 functions in isolation to LPS/TLR4-
dependent signalling. Because caspase-11 is not constitutively expressed in most cell 
types but can be induced by TLR ligation, Tlr4-/- mice were first pre-administered the TLR3 
ligand, poly(IC), to induce the expression of caspase-11. Remarkably, subsequent LPS 
challenge in poly(IC)-primed Tlr4-/- mice caused 100% lethality within 60 h, while more 
than 60% of Casp11-deficient mice were protected for 4 days or more during poly(IC)/LPS 
challenge. However, these studies did not investigate LPS sensitivity in the caspase-1/11-
double deficient Ice-/- mice, and so it remained unclear whether there was an additional 
protection from the loss of caspase-1 (77, 78).  
 
In addition to the poly(IC)/LPS model, mounting evidence also supports a pathological role 
for caspase-11 in the single high dose LPS challenge model. Kayagaki and co-workers 
demonstrated that Ice-/- mice reconstituted for Casp11 function by BAC transgenesis 
(Casp1-/-Casp11Tg) became susceptible to single dose LPS challenge (76). Given that 
LPS-TLR4 signalling upregulates not only Casp11 expression, but also expression of 
NLRP3 and pro-IL-1β (227, 258), this raises the question of whether caspase-11-driven 
lethality in this study is mediated by caspase-11-dependent pyroptosis and subsequent 
alarmin release, or by non-canonical NLRP3 activation and ensuing cytokine release. It 
also questions to what extent the resistance conferred by Tlr4 knockout is attributable to 
deficient caspase-11 pathways during LPS challenge. Kayagaki et al. posited that 
caspase-11-dependent pyroptosis, and not non-canonical NLRP3 pathways, were likely 
responsible for LPS-induced lethality (76, 77). However, one of these studies showed that 
Casp1-/-Casp11Tg, Nlrp3-/- and Asc-/- mice all showed significant protection during LPS 
challenge relative to WT mice (76), suggesting the possibility that the non-canonical 
NLRP3/ASC/caspase-1 pathway may also contribute to LPS-induced lethality via IL-1β or 
IL-18 production. In line with this, other studies supported a pathogenic role for IL-1 
signalling in LPS-induced lethality as IL-1 receptor 1 (IL-1R1) deficiency or treatment with 
exogenous IL-1 receptor antagonist (IL-1Ra) protected animals from LPS-induced lethality 
(297-299). Subsequent studies using Il1β-/- mice revealed that IL-1β deficiency only 
partially protected mice during LPS challenge, while neutralisation of IL-18 in Il1β-/- mice 
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provided additional resistance (300). This suggests that IL-1β and IL-18 synergise to 
contribute to endotoxic shock. IL-1α is an alarmin released by pyroptotic cells that also 
signals through IL-1R1, although unlike IL-1β, it is not cleaved by caspase-1. Whether IL-
1α also contributes to shock is currently unclear. 
 
To my knowledge, no studies have yet directly assessed the impact of non-canonical 
NLRP3/caspase-1 activity in the poly(IC)/LPS challenge model. If cytokines indeed 
mediate pathogenic caspase-11 responses during endotoxic shock, then it is yet unclear 
which cytokines are responsible for driving lethality, and which cell types produce these 
cytokines. As outlined above, potential culprits are IL-1β and IL-18 released via non-
canonical NLRP3 function, and/or IL-1α released upon NLRP3-independent cell lysis. This 
thesis previously demonstrated that neutrophils do not undergo NLRC4, NLRP3 or AIM2-
dependent pyroptosis (Chapters 3 and 5) or inflammasome-mediated apoptosis (Chapter 
5) but are a major cellular source of IL-1β during acute Salmonella infection (Chapter 3). 
Given that a key feature in LPS shock is neutrophilia (301), and neutrophils can produce 
substantial and sustained IL-1β, we hypothesised that caspase-11-activated neutrophils 
may present a sustained cellular source of pathogenic IL-1β that contributes to caspase-
11-dependent LPS lethality.  Thus, this chapter presents preliminary investigations into the 
potential contributions of the neutrophil caspase-11 inflammasome, and neutrophil-derived 
IL-1β, to endotoxin sensitivity. 
6.2 Results 
6.2.1 LPS transfection triggers caspase-11 activation in neutrophils  
Previous data from the Schroder laboratory demonstrated that caspase-11 is constitutively 
expressed in bone marrow neutrophils (data not shown), suggesting the potential for 
neutrophils to contribute to caspase-11-driven inflammation. To examine whether 
neutrophils can signal via the caspase-11 inflammasome, we first purified bone marrow 
neutrophils from wild type (WT), Casp11-/-, Ice-/- (Casp1/11-/-) and Nlrp3-/- mice. These cells 
were primed with LPS for 4 h to upregulate the expression of NLRP3 and the caspase-1 
substrate pro-IL-1β (230, 258). Subsequently, the cell culture media was replaced to 
remove residual LPS, and cells were transfected with ultrapure E. coli K12 LPS to the 
cytosol by chemical transfection to activate caspase-11. Macrophages, which are well 
established to activate caspase-11 upon LPS transfection (76), were prepared and 
stimulated in parallel as positive controls. The level of IL-1β secreted into the cell culture 
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supernatant was quantified by ELISA at 8h post-transfection as an output for caspase-11 
activation. LPS priming alone was ineffective for triggering IL-1β secretion from neutrophils 
and macrophages (Figure 6.1A, B), but LPS transfection for 8 h triggered robust IL-1β 
secretion in neutrophils (Figure 6.1A), similar to macrophages (Figure 6.1B). Mechanisms 
underlying IL-1β production from neutrophils were the same as macrophages, as IL-1β 
secretion from both cell types was suppressed in Casp11-/-, Nlrp3-/- and Ice-/- cells (Figure 
6.1A, B). These data for neutrophils and macrophages are consistent with the prevailing 
paradigm that intracellular LPS activates the caspase-11 inflammasome, and triggers IL-
1β production via non-canoncial NLRP3/caspase-1 activity. We presume that IL-1β 
production in WT neutrophils stimulated with intracellular LPS was accompanied by IL-1β 
maturation and caspase-1 processing, but this will need to be formally examined in future 
investigations. 
6.2.2 Neutrophils are resistant to caspase-11-mediated pyroptosis 
Another hallmark of caspase-11 activation is the initiation of the caspase-11-dependent, 
caspase-1-independent pyroptosis (76). Given that LPS transfection triggered robust 
caspase-11-dependent IL-1β secretion from neutrophils (Figure 6.1A), their potential to 
undergo caspase-11-mediated pyroptosis was next investigated. Neutrophils and 
macrophages of different genotypes were prepared as above, and the release of 
intracellular LDH was measured as an indicator of lytic cell death. LPS priming delivered a 
survival signal to neutrophils (Figure 6.2A) as previously reported (Chapter 3 and 5). 8 h 
LPS transfection did not induce LDH release from wild type neutrophils, and LDH release 
was not clearly altered by Casp1/Casp11, Casp11 or Nlrp3 deficiency in these cells 
(Figure 6.2A), despite clear caspase-11-dependent IL-1β secretion at this time point 
(Figure 6.1A). This was in striking contrast to WT macrophages, which underwent 
caspase-11-dependent cell death (Figure 6.2B) concomitant to IL-1β secretion (Figure 
6.1B) upon intracellular LPS delivery. Thus, LPS transfection in neutrophils selectively 
triggers non-canonical NLRP3/caspase-1-dependent IL-1β production but not caspase-11-
dependent pyroptosis. 
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Figure 6.1 LPS transfection triggers caspase-11 activation in neutrophils.  
(A) Bone marrow neutrophils or (B) bone marrow-derived macrophages were primed with 100 ng/ml LPS for 
4 h and washed. 2 µg/ml ultrapure LPS E.coli K12 was then transfected using Fugene. IL-1β secretion was 
quantified by ELISA at 8 h post-transfection. Data are mean + range of duplicate cell stimulations and are 
representative of 3 independent experiments. 
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Figure 6.2 Neutrophils do not undergo caspase-11-mediated pyroptosis.  
(A) Bone marrow neutrophils or (B) bone marrow-derived macrophages were primed with 100 ng/ml LPS for 
4 h and washed. 2 µg/ml ultrapure LPS E.coli K12 was then transfected using Fugene. Intracellular LDH 
release was quantified as a measurement of cell death at 8 h post transfection, and expressed as a 
percentage of the total intracellular LDH of untreated cells. Data are mean + range of duplicate cell 
stimulations and are representative of 3 independent experiments. 
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6.2.3 NLRP3 contributes to lethality during in vivo poly(IC)/LPS challenge 
The possibility that NLRP3 signalling contributes to LPS lethality in the poly(IC)/LPS 
challenge model was next examined by challenging WT and Nlrp3-/- mice with a non-lethal 
dose of poly(IC) (10 mg/kg) followed by 10 mg/kg of E. coli 0111:B4 LPS. Mouse rectal 
temperature and survival was monitored over 72 h. Consistent with previous reports, low 
dose of poly(IC) or LPS treatment alone did not induce hypothermia or septic shock-like 
symptoms (Figure 6.3A, B) (77, 78). However, LPS challenge in poly(IC)-primed mice 
triggered hypothermia in  both WT and Nlrp3-/- animals up to 10 h post LPS challenge 
(Figure 6.3C). Interestingly, NLRP3 deficiency protected mice from further hypothermia, 
and rectal temperature recovered progressively towards 72 h (Figure 6.3C). In keeping 
with this, Nlrp3-/- mice displayed a significantly smaller change in body temperature 
compared to wild type animals (Figure 6.3D). Importantly, 100% of Nlrp3-/- mice were 
protected from poly(IC)/LPS-induced lethality, while all WT mice succumbed, by 24 h 
(Figure 6.3E), suggesting that NLRP3 is an important driver of caspase-11-mediated 
endotoxin shock. 
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Figure 6.3 NLRP3 deficiency protects mice from caspase-11-mediated endotoxin shock.  
Mice were injected with (A) 10 mg/kg of E. coli 0111:B4 LPS or (B) 10 mg/kg of poly(IC) and monitored for 
signs of endotoxemia up to 24 h. (C-E) Mice were injected i.p with 10 mg/kg of poly(IC) for 6 h followed by a 
subsequent i.p injection with 10 mg/kg E. coli 0111:B4 LPS, and monitored for signs of endotoxemia. Mice 
were considered moribund and sacrificed immediately when rectal temperature fell below 24 oC or when 
mice were unable to regain their posture. (C) Rectal temperature of poly(IC)-primed mice following LPS 
challenge. The statistical significance for Nlrp3-/- was calculated relative to WT mice up to 20 h post-LPS 
challenge. (D) Percentage change in rectal temperature in panel (A) at 10 h post-LPS challenge. (E) Kaplan-
Meier survival curve for LPS challenge in poly(IC)-primed mice. (A-B) 2 mice or (C-E) 4 mice were used per 
group, and data are representative of a single experiment. 
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6.2.4 Neutrophil depletion reduces susceptibility to caspase-11-dependent 
endotoxemia in vivo 
The contribution of neutrophil caspase-11 function to endotoxic shock in vivo was next 
investigated. Mice were administered a neutrophil-specific α-Ly6G antibody to transiently 
deplete neutrophils in vivo, or alternatively, an isotype control antibody (as for Chapter 2). 
16 to 20 h after antibody injection, mice were challenged as before with poly(IC) and LPS 
to activate caspase-11. LPS challenge in poly(IC)-primed mice triggered hypothermia in 
both WT and Casp11-/- mice, regardless of neutrophil depletion (Figure 6.4A). Although 
Casp11-/- mice were as susceptible as wild type mice to hypothermia at early stages 
(Figure 6.4A, B), Casp11-/- mice did not succumb to LPS lethality (Figure 6.4C) and rectal 
temperature recovered over the course of 72 h (Figure 6.4A). Similar to caspase-11 
deficiency, neutrophil depletion protected WT mice from hypothermia (Figure 6.4B), with 
mice recovering quickly from 8 h post-LPS challenge, while neutrophil-sufficient WT mice 
remained hypothermic until they became moribund and were sacrificed at 33 h post-LPS 
(Figure 6.4A). Moreover, neutrophil depletion conferred protection from LPS lethality, with 
100% of neutrophil-sufficient WT mice becoming moribund within 32 h, while only 34% of 
neutrophil-depleted animals succumbed by 72 h post-LPS challenge (Figure 6.4C). 
Poly(IC)/LPS-induced death in this setting is mediated by caspase-11-dependent 
responses, as Casp11-/- mice were protected during poly(IC)/LPS challenge (Figure 6.4C). 
Importantly, neutrophil depletion had no effect on hypothermia or survival rates in Casp11-
/- mice, suggesting that neutrophils contribute to these responses via caspase-11 function 
(Figure 6.4A-C). To investigate mechanisms underlying the protective effect of neutrophil 
depletion, cytokine levels in serum were quantified at 4 h post LPS challenge in poly(IC)-
treated mice, with and without prior neutrophil depletion. TNF production is elicited by 
TLRs independently of inflammasomes, and TNF levels were unaffected by neutrophil 
depletion (Figure 6.4D), suggesting that both groups of mice responded equally to acute 
poly(IC)/LPS challenge. Because neutrophils contributed to pathological inflammation in 
poly(IC)/LPS-challenged mice, and caspase-11 activation in neutrophils triggers NLRP3-
dependent IL-1β but not cell lysis and ensuing alarmin (e.g. IL-1α) release (Figure 6.1A 
and 6.2A); we hypothesised that neutrophils contribute to septic shock via production of 
IL-1β but not IL-1α. We thereby predicted that neutrophil depletion would specifically 
reduce serum IL-1β levels, however, we observed no significant effect of neutrophil 
depletion on either serum IL-1α (Figure 6.4E) or IL-1β  (Figure 6.4F) at 4 h post LPS 
challenge in poly(IC) primed mice. This was very surprising as IL-1β drives hypothermic 
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responses (302), and neutrophil depletion protected 66% of wild type animals from 
poly(IC)/LPS-induced lethality (Figure 6.4C), and markedly protected against hypothermia 
(Figure 6.4A). The protective effect of caspase-11 deficiency or neutrophil depletion on 
body temperature was most evident at later stages of challenge (e.g. 18-31 h), thus, it is 
likely that neutrophil caspase-11-dependent IL-1β secretion becomes prevalent at later 
stages of challenge. Additional kinetic experiments to address this were not performed as 
part of this thesis, due to time constraints. Taken together, these results suggest that 
pathological immune responses in poly(IC)/LPS challenge model are mediated in three 
distinct phases: (1) in the acute phase (0-4 h post-challenge), caspase-11-independent 
mechanisms, possibly involving TNF, initiate hypothermic responses; (2) in the 
intermediate phase (4-8 h post-challenge) caspase-11-dependent pyroptotic cell death 
releases alarmins, thereby exacerbating hypothermia and septic shock-like symptoms; and 
(3) in the late phase (>8 h), non-canonical NLRP3 dependent pathways (e.g. neutrophil-
derived IL-1β secretion) further amplify inflammation and ultimately lead to mortality. 
Although neutrophil depletion conferred protection in the caspase-11-mediated 
endotoxemia model used here, the mechanisms responsible remain to be definitively 
established. Neutrophil-mediated cytokine production at later time points of challenge will 
thus be a key focus of future investigations. 
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Figure 6.4. Neutrophil depletion protects mice from caspase-11-mediated endotoxic shock.  
Mice were administered a single injection of 100 µg α-Ly6G or isotype antibody. 16 to 20 h later, mice were 
administered 10 mg/kg of poly(IC) for 6 h, followed by 10 mg/kg E. coli 0111:B4 LPS, and monitored for 
signs of endotoxemia. Mice were considered moribund and sacrificed immediately when rectal temperature 
dropped below 24oC or when mice were unable to retain their posture. (A) Rectal temperature of poly(IC)-
primed mice following LPS challenge. The statistical significance for WT mice was calculated relative to 
neutrophil-depleted WT mice up to 32 h post-LPS challenge. (B) Percentage change in rectal temperature of 
panel (A) at 10 h post-LPS challenge. (C) Kaplan-Meier survival curve for LPS challenge in poly(IC)-primed 
mice. (D-F) Serum cytokine levels of wild type mice with and without neutrophil depletion. (A-B) Data are 
from 5 mice per group, and are representative of 3 independent experiments. (C) Data are pooled from 2 
independent experiments and contain 7 to 10 mice per group. (D-F) Data are means from serum collected 
from individual mice (5 mice per group). 
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6.2.5 Adoptive transfer of B220- bone marrow cells 
In order to formally establish that caspase-11 function in neutrophils drives endotoxic 
shock responses in vivo, future experiments will adoptively transfer wild type versus 
Casp11-/- (CD45.2) donor neutrophils into congenic CD45.1 wild type hosts, or congenic 
CD45.1 wild type donor neutrophils into (CD45.2) wild type versus Casp11-/- hosts, prior to 
poly(IC)/LPS challenge. Preliminary experiments attempting systemic neutrophil adoptive 
transfer using tail vein injection were unsuccessful; and colleagues from the University of 
Queensland observed that donor neutrophils were cleared in the lung at 2-4 h post-
transfer (unpublished data; personal communications with Marion Brunk). To circumvent 
this issue, future experiments will deliver donor neutrophils by intraperitoneal injection. In 
an initial trial experiment, B220+ B cells were depleted from total CD45.2 donor bone 
marrow cells. 1 x 107 B220-depleted, unlabelled donor bone marrow cells were transferred 
via i.p. injection into CD45.1 recipient mice that were previously administered with an α-
Ly6G antibody to deplete endogenous neutrophils. Flow cytometry was used to examine 
whether donor cells were recoverable from the recipient animal 6 h after poly(IC) priming, 
before proceeding with LPS challenge. Although CD45.2+ donor cells were indeed 
recovered from poly(IC) challenged mice (Figure 6.5A), the majority of CD45.2+ cells were 
Ly6C+Ly6G- monocytes rather than CD11b+Ly6G+ neutrophils (Figure 6.5A-B). Apoptotic 
neutrophils can home to the bone marrow (303), but in this case donor CD45.2+Ly6G+ 
neutrophils were not present in the bone marrow (Figure 6.5B). The possibility that the 
unlabelled α-Ly6G antibody used for neutrophil depletion may have masked the α-Ly6G 
antibody epitope was investigated, but this possibility was excluded by alternative gating 
methods (CD11b+SSChi, data not shown). It is likely that under this experimental regimen, 
the α-Ly6G antibody used to deplete recipient mice of neutrophils was still circulating at 
the time of neutrophils transfer, leading to donor neutrophil lysis. Future experiments will 
either optimise the timing or dose of antibody administration, or will utilise neutrophil-
sufficient recipient mice. 
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Figure 6.5 Adoptive transfer of B220- bone marrow cells.  
Recipient CD45.1 mice were given a single i.p. injection of α-Ly6G (100 µg) 72 h prior to adoptive transfer. 1 
x 107 B220- CD45.2 donor bone marrow cells were injected i.p. into CD45.1 recipient mice. Mice were 
challenged 1 h later with 10 mg/kg of poly(IC) and sacrificed at 6 h post-challenge. Flow cytometry analysis 
of the cellularity of the (A) peritoneal exudate cells and (B) bone marrow from the CD45.1 recipient mouse. 
Profiles are representative of data from 3 individual mice. 
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6.3 Discussion  
The caspase-11 inflammasome is an important mediator of antimicrobial responses to 
cytoplasmic bacteria (75); however, excessive signalling through this pathway drives lethal 
endotoxemia (77, 78). A previous study demonstrated that Casp1/11-deficient Ice-/- mice 
reconstituted with a Casp11 transgene using a bacterial artificial chromosome (Casp1-/-
Casp11Tg) were substantially more susceptible to LPS-induced lethality than Ice-/- mice, 
while mortality in Casp11-/- mice was significantly delayed relative to WT (76). On the basis 
of these observations, it was suggested that caspase-1-dependent cytokines (IL-1β and IL-
18) are not important mediators of caspase-11-dependent septic shock (77). However, this 
conclusion needs to be revisited, as transcriptional regulation and expression of the 
Casp11 transgene may not reflect endogenous Casp11 in wild type mice, because the 
gene context (e.g. chromatin structure, enhancer environment, etc) is fundamentally 
changed, despite retaining the natural Casp11 proximal promoter. In support of this, the 
same study demonstrated that Casp1-/-Casp11Tg, Nlrp3-/- and Asc-/- mice all showed 
significant protection during LPS challenge relative to WT mice (76), suggesting that the 
non-canonical NLRP3/ASC/caspase-1 pathway may also contribute to LPS-induced 
lethality. It is also important to highlight that the role of poly(IC) priming was not 
investigated in the previous study, and was only regarded as a means to induce caspase-
11 expression. But poly(IC) stimulation also induces the expression of NLRP3, and the 
caspase-1 substrate pro-IL-1β in immune cells (304, 305). In support of poly(IC) 
upregulating the NLRP3/caspase-1/IL-1β signalling axis, our data demonstrate that Nlrp3 
deficiency protected poly(IC)-primed mice during LPS lethality, suggesting that the 
NLRP3-dependent cytokines, IL-1β and IL-18, are likely candidates for driving endotoxin 
shock following poly(IC)/LPS challenge. At this stage, we are unable to speculate whether 
IL-1β or IL-18, or the combination of both cytokines, are likely to drive septic shock-like 
symptoms, as both cytokines were previously implicated in LPS shock models (297-300). 
If further experiments suggest that excessive cytokine production through the 
NLRP3/caspase-1 axis indeed contributes to caspase-11-mediated endotoxic shock, this 
will open up new therapeutic avenues for the treatment of endotoxin shock, for example, 
the small molecule NLRP3 inhibitor, MCC950 (123).  
 
If NLRP3-dependent cytokines drive lethal septic shock responses in vivo, then the cellular 
source of such cytokines needs to be formally established. Monocytes/macrophages are 
clear candidates, but other cell types should also be considered. Because neutrophilia is a 
hallmark of sepsis (301), and neutrophils secrete IL-1β in a manner not curtailed by 
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inflammasome-mediated cell death, this presents neutrophils as a likely and perhaps 
major cellular source of IL-1β during in vivo lethal endotoxemia. Neutrophil-derived IL-18 
will also be investigated, however, neutrophils were weak producers of IL-18 downstream 
of NLRC4 (Chapter 3), suggesting that if IL-18 indeed contributes to endotoxic shock, it is 
likely derived from other cellular sources. Supporting our hypothesis for pathogenic 
neutrophil caspase-11 function in endotoxic shock, neutrophil depletion strongly protected 
wild type mice during poly(IC)/LPS challenge, while neutrophil depletion did not significant 
impact Casp11-/- mice; this indicates that the protective effect of neutrophil depletion lies 
within the caspase-11 pathway. Surprisingly, while neutrophil depletion protected 66% of 
mice from lethality, it did not significantly alter serum IL-1β levels at 4 h post-LPS 
challenge. Since IL-1β is a key regulator of the hypothermic response (302), and that 
neutrophil depletion protected mice from hypothermia at 8 h post-LPS challenge and later, 
this suggests that neutrophil-derived IL-1β levels may peak at a later stage of LPS 
challenge. Future experiments will investigate the time course of neutrophilia and serum 
IL-1β profiles in the poly(IC)/LPS challenge model, and assess serum IL-1β  levels and 
cleavage status in control and neutrophil depleted mice at later stages of poly(IC)/LPS 
challenge. We will also purify and culture in vivo-challenged neutrophils ex vivo, to 
demonstrate that these neutrophils secrete IL-1β via NLRP3-dependent means. As a 
complementary approach, we will quantify the expression of intracellular pro-IL-1β in the 
inflammatory infiltrate of WT and caspase-11-deficient animals by flow cytometry. If 
neutrophil caspase-11 function indeed contributes to IL-1β   production during LPS 
challenge, we expect a concomitant loss of intracellular pro-IL-1β  expression in vivo, and 
a corresponding release of IL-1β ex vivo, in WT but not Casp11-deficient neutrophils 
following poly(IC)/LPS challenge.  
 
The protective effect of neutrophil depletion during poly(IC)/LPS challenge suggests two 
possible scenarios by which neutrophils may contribute to LPS-induced lethality: (1) 
caspase-11 function in neutrophils may drive pathogenic IL-1β production through non-
canonical NLRP3 activation, or (2) caspase-11-independent neutrophil functions such as 
NET formation may promote caspase-11 signalling in other cells (306-308). Therefore, 
additional experiments are required to definitively establish whether neutrophils influence 
caspase-11 pathways in a cell-autonomous fashion (i.e. caspase-11 signalling in 
neutrophils drives septic shock). An elegant approach for delineating in vivo caspase-11 
functions in neutrophils would be to use a neutrophil-specific conditional Casp11 knockout. 
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However, genetic approaches for neutrophil-specific gene knockout are not currently 
available (233); the widely used ‘neutrophil-specific’ LysMCre line for Cre-mediated gene 
deletion also targets macrophages and other myeloid cells, as the LysM promoter is active 
throughout the myeloid compartment (309). An alternative method for defining the role of 
caspase-11 in neutrophils is to perform adoptive transfer experiments with wild type versus 
Casp11-/- donor neutrophils and recipient mice, and assessing their responses upon LPS 
challenge. This thesis presents data from preliminary experiments aimed at establishing 
such a protocol for neutrophil adoptive transfer, but this trial unfortunately failed to recover 
any donor neutrophils from the recipient animal following poly(IC) challenge. At least three 
possible explanations may explain the lack of donor CD45.2+CD11b+Ly6G+ neutrophils 
recovered from recipient mice. Firstly, and perhaps most likely, residual circulating α-Ly6G 
antibodies in recipient mice may have caused the transferred neutrophils to lyse. Future 
experiments will use recipient mice that have not been exposed to the α-Ly6G antibody, or 
will optimise the time between application of the α-Ly6G antibody and injection of CD45.2+ 
cells, to allow sufficient time for the α-Ly6G antibody to be cleared from the circulation. 
Secondly, the transferred neutrophils may have been phagocytosed by resident peritoneal 
macrophages upon injection, as the presence of a large number of neutrophils is 
uncommon in tissues during the steady state. This is however unlikely, as phagocytosis of 
neutrophils generally occurs after the exposure of ‘eat-me’ signals that are usually only 
expressed on apopototic neutrophils (310). Thirdly, the process of neutrophil enrichment 
and adoptive transfer in this experiment may have activated the neutrophils, triggering 
neutrophil cell death. Future experiments will examine the expression of cell surface 
activation and apoptotic markers (e.g. CD62L, annexin V) and plasma membrane integrity 
(e.g. propidium iodide staining) on purified neutrophils prior to adoptive transfer. Additional 
experiments will be performed to optimise the neutrophil adoptive transfer protocol and to 
assess the contribution of neutrophil-intrinsic caspase-11, caspase-1 and NLRP3 
pathways, and the cytokines IL-1α, IL-1β and IL-18 in driving lethal endotoxin shock. We 
will also monitor the fitness of poly(IC)/LPS-challenged wild type, IL-1α-/-, IL-1β -/- and IL-
1R-/- animals to assess possible IL-1 synergies in septic shock. 
 
Caspase-11 is not constitutively expressed in most cell types in vivo. Casp11 expression is 
upregulated following interferon (IFN) signalling (79, 227), which occurs downstream of 
TLR engagement by LPS or poly(IC). Since caspase-11 activation during bacterial 
infection requires type I IFN signalling (80), this suggests that individuals with pre-existing 
infections or autoimmune diseases are likely to exhibit sensitised caspase-11 activation 
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pathways, and perhaps be more susceptible to caspase-11-mediated pathologies during 
bacterial infection, compared to otherwise healthy individuals. In line with this, individuals 
with autoimmune diseases such as systemic lupus erythematosus (311) or viral infection 
are often predisposed bacterial infection and its associated septic shock (312). In fact, 
38% of sepsis cases in the United States were caused by viral infection followed by 
secondary Gram-negative bacterial superinfection (312) and recent autopsy investigations 
revealed that the leading cause of death in the 1918 ‘Spanish flu’ pandemic was due to 
influenza A virus plus bacterial co-infection (313). Since poly(IC) is a synthetic RNA 
analogue that mimics viral infection, and that it triggers TLR signalling and induces 
autocrine and paracrine IFN signalling, the poly(IC)/LPS challenge model provides a 
system to study functional links between IFN and septic shock during human diseases 
such as bacterial superinfection. 
 
Because TLR4-deficient mice were resistant to high dose LPS challenge, and LPS 
administration as low as 4 ng/kg in healthy human subjects triggered cardiovascular 
dysfunction similar to that observed during septic shock (314), various approaches to 
neutralise extracellular LPS or TLR4 were designed as potential therapies to ameliorate 
septic shock. However, these neutralising antibodies lacked efficacy in numerous large-
scale clinical trials (315). It is not entirely clear how to interpret this lack of efficacy, as it 
raises three distinct possibilities: (1) LPS-independent mechanisms drive septic shock in 
human patients (e.g. TLR signalling by other microbial structures); (2) LPS signalling is not 
neutralised by anti-LPS or anti-TLR4 antibodies. For example, such antibodies may not 
access intracellular compartments to neutralise LPS signalling via endosomal (e.g. TLR4) 
or cytosolic (e.g. caspase-4/5) receptors; and/or (3) Neutralising antibodies were not 
administered early enough in disease progression to effectively block the clinical signs of 
septic shock. 
 
It should be noted that the murine models of endotoxic shock presented in this chapter 
hold some limitations for understanding the corresponding human pathology. First, there is 
no direct one-to-one ortholog of Casp11 in humans. Humans instead encode two 
orthologs, CASP4 and CASP5 (83). Caspase-4 and -5 do however share the same LPS-
binding properties of caspase-11, and cytosolic bacterial infection in human myeloid cells 
triggers caspase-4/5-dependent cell death and caspase-4/NLRP3-dependent cytokine 
secretion (85, 86). Importantly, transgenic animals encoding human caspase-4 were 
hypersensitive to LPS challenge, implying that caspase-4, like caspase-11, may also be 
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involved in endotoxin sensitivity in humans. Second, the reliance of murine models to 
understand human diseases, in particular, endotoxin shock, has been frequently 
questioned because mice are significantly more resistant to LPS challenge than humans 
(316), and the LPS concentration in human plasma does not necessarily correlate with 
mortality in human septic shock patients (317, 318). In addition, transcriptional analysis of 
murine and human samples during endotoxin shock revealed poor correlation between the 
two species, further questioning the relevance of modelling human endotoxin shock using 
mice challenged with LPS (319). However, subsequent re-analysis of the same gene 
expression data set by two independent groups using different methodologies revealed 
contrary results, that is, that gene expression during inflammatory diseases such as 
endotoxin shock were indeed correlated between human patients and mouse models (320, 
321). It should also be highlighted that septic shock patients are frequently cytopenic or 
pan-cytopenic (322). The use of unfractionated leukocytes for the aforementioned 
transcriptional analyses thus confounds data interpretation, as leukocyte composition is 
likely to be significantly altered between sepsis patients and healthy controls. The profiling 
of highly purified immune cell subsets would be a more elegant approach for interrogating 
the transcriptional changes associated with human septic shock.  While we acknowledge 
that murine models of endotoxin shock may not completely represent mirror human sepsis, 
they do provide a tractable system for examining inflammatory signalling pathways, their 
cellular players, and downstream pathology. 
 
In summary, the work presented in this chapter demonstrates that neutrophil LPS 
transfection triggers caspase-11-dependent IL-1β secretion but not pyroptosis in vitro. It 
also demonstrates that NLRP3 and caspase-11 functions are important drivers of LPS-
induced lethality in poly(IC)-primed mice. Lastly, this chapter demonstrates a novel role for 
neutrophils in poly(IC)/LPS-induced lethality in WT but not Casp11-deficient mice. These 
data support a model in which neutrophils drive pathological immune responses during 
endotoxin shock via caspase-11/NLRP3-driven cytokine production. This hypothesis will 
be the focus of future studies that will define the precise role of neutrophils during murine 
septic shock. 
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7. Final discussion 
Inflammasome activation in all cell types studied prior to this thesis triggers a burst of IL 
1β/18 production that is accompanied by rapid cellular lysis. Given this literature, one 
might expect that inflammasome-dependent cytokines would only be produced transiently 
in vivo. However, IL-1β levels remain elevated over extended periods during infection and 
inflammatory disease (323, 324). This suggests that cytokine production and cell death 
occur in repeated waves of inflammasome signalling by incoming cells, or alternatively, 
that some cell types are protected from inflammasome-mediated death, allowing them to 
sustain inflammasome-dependent cytokine production within inflammatory foci. A major 
biological function of IL-1β is to recruit neutrophils to a site of inflammation and activate 
them to engulf invading pathogens or remove cellular debris (4). Human neutrophils were 
reported to regulate their own recruitment and activation by secreting IL-8 upon pathogen 
recognition (325), and so this thesis investigated whether neutrophils utilise the 
inflammasome-IL-1β signalling axis as a similar auto-regulatory strategy. Previous studies 
had discounted possible functions for neutrophil inflammasomes, after observing that 
human and murine neutrophils did not undergo pyroptosis when infected with NLRC4 
activators such as S. Typhimurium and Burkholderia pseudomallei (53, 115), and reporting 
that neutrophils contributed to IL-1β processing through caspase-1-independent 
mechanisms such as Fas ligation (243) or pro-IL-1β cleavage by neutrophil granular 
proteases (324, 326-328). Collectively, these reports led to an assumption that neutrophils 
do not themselves signal via inflammasomes and are thus merely cellular targets of 
inflammasome-derived IL-1β. We and others observed that neutrophils express multiple 
NLRs including NLRC4 and NLRP3, and other critical components of the inflammasome 
signal transduction pathway such as the ASC inflammasome adaptor, and the zymogen 
pro-caspase-1, indicating that neutrophils may be able to sense inflammasome-activating 
stimuli (241, 242, 257). Indeed, this thesis demonstrates that neutrophils can signal via 
NLRC4, NLRP3, AIM2 and caspase-11 inflammasomes, although the cellular outcomes of 
signalling are distinct as compared macrophages. 
 
A surprising but major finding of this thesis is that inflammasome activation in neutrophils 
selectively triggered caspase-1-dependent cytokine maturation without concomitant 
pyroptotic death. Neutrophil protection from caspase-1-driven pyroptosis appears to be a 
universal mechanism, as activation of the four major inflammasomes (NLRC4, NLRP3, 
AIM2 and caspase-11) failed to trigger neutrophil lysis. Macrophage inflammasomes also 
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recruit and activate caspase-8, and trigger apoptotic cell death if pyroptosis is blocked by 
caspase-1 deficiency or inhibition (69, 70). Interestingly, neutrophils also resisted 
inflammasome-dependent apoptosis following NLRP3 activation. Although it was not 
formally tested in this thesis, the failure of neutrophils to undergo inflammasome-
dependent apoptosis is anticipated to also apply to other inflammasomes (e.g. AIM2, 
NLRC4), and provides a likely explanation for why neutrophils but not Ice-/- macrophages 
remained viable after prolonged (16 h) Salmonella infection (Chapter 3, Supplementary 
Figure 3.6A). The primary known function of pyroptosis is to prevent intracellular 
pathogens from establishing a replicative niche, and to expose these microbes to 
neutrophil-mediated destruction (115). So the unique ability of neutrophils to resist 
inflammasome-mediated cell death is likely critical for enabling these cells to perform their 
classical antimicrobial functions (e.g. phagocytosis, production of ROS, NETs and 
antimicrobial peptides), while simultaneously driving an IL-1β-mediated auto-regulatory 
loop to ensure further neutrophil recruitment and activation. In addition to inflammasome-
dependent cell death, neutrophil protection from TLR4/RIPK3-dependent apoptosis and 
necroptosis also likely represents a mechanism to ensure neutrophil viability for IL-1β 
production and antimicrobial defence during in vivo microbial infection. While the inability 
of neutrophils to undergo inflammasome-dependent cell death may facilitate host defence 
in the short term, it may ultimately render these cells susceptible to infection by specific 
intracellular microbes. Indeed, neutrophils are a replicative niche for several intracellular 
pathogens such as Salmonella, Anaplasma phagocytophilum, Leishmania and Neisseria 
(248, 249, 279, 329, 330). In fact, a key virulence strategy of Anaplasma phagocytophilum 
is to induce the production of the neutrophil chemoattractant IL-8 (KC in mice) to recruit 
further neutrophils for infection (331). It will be of great interest in future investigations to 
determine whether professional intra-neutrophil pathogens such as Anaplasma 
phagocytophilum and Neisseria trigger inflammasome functions in neutrophils, and if so, 
whether the auto-regulatory IL-1β feedback loop provided by neutrophils increases host 
susceptibility to these microbes. 
 
An emerging concept in the disciplines of inflammation and regulated cell death is the 
striking similarities in receptor domain structure, organisation and activation mechanisms 
between the two pathways (89). For example, the organisation and activation mechanism 
of the NLRC4 inflammasome is highly reminiscent of the APAF-1 apoptosome (332). Both 
NLRC4 and APAF-1 contain N-terminal CARD domains and central nucleotide-binding 
domains. Following activation, both APAF-1 and NLRC4 oligomerise through their 
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nucleotide-binding domain, which directs the recruitment of caspases through CARD-
CARD interactions to drive proximity-induced caspase activation (333). Another similarity 
between some forms of regulated cell death signalling and inflammasomes is the 
requirement for a signalling adaptor (89). Signalling via the extrinsic apoptosis pathway 
(e.g. by Fas/FasL), and some inflammasomes requires a protein adaptor (FADD and ASC, 
respectively) to bridge receptor-caspase interactions. Perhaps a more important function 
of such signalling adaptors is to present clustered sites for caspase binding, thereby 
increasing the local caspase concentration to force caspase self-activation (334).  
 
C-FLIPL is a protease-dead homolog of caspase-8 and is a key regulator of caspase-8-
dependent cell death (196). At high cellular concentrations, c-FLIPL competes with pro-
caspase-8 for recruitment to signalling complexes, and consequently limits caspase-8 
auto-processing and activity. At low cellular concentrations however, the protease-dead 
domain of c-FLIPL can allosterically activate pro-caspase-8, although the c-FLIPL/pro-
caspase-8 heterodimer cleaves a narrower range of substrates compared to caspase-8 
homodimers (197, 274). Importantly, the c-FLIPL/caspase-8 heterodimer cleaves RIPK3 to 
prevent necroptosis (215). A straightforward explanation for why neutrophils do not 
undergo pyroptosis may be that the caspase-1-regulated pyroptotic effector is not 
expressed in these cells. However, it is also possible that neutrophils express a c-FLIPL-
like molecule to regulate the substrate repertoire of caspase-1 in neutrophils, akin to the c-
FLIPL/caspase-8 model for suppressing apoptosis and necroptosis. Work from others in 
our laboratory indicated that caspase-12 is highly expressed in murine neutrophils but only 
weakly expressed in murine macrophages (data not shown). Caspase-12 is highly 
homologous to caspase-1 (335), and caspase-12 overexpression suppresses caspase-1-
dependent IL-1β processing (336), but pyroptosis was not examined in that study (336). 
One possibility is that a caspase-12/caspase-1 heterodimer can support IL-1β processing 
(albeit less efficiently than a caspase-1 homodimer) but cannot cleave the substrate that 
executes pyroptosis. If indeed caspase-12 blocks the induction of neutrophil death, one 
would expect inflammasome activation to trigger pyroptosis in caspase-12-deficient 
neutrophils. Thus, future experiments will investigate whether overexpression of caspase-
12 in macrophages supresses pyroptosis induction whilst supporting sustained IL-1β 
production.  
 
Prior studies revealed that pro-caspase-1 self-cleavage was not required for the induction 
of pyroptosis while caspase-1 processing in the interdomain linker (p20↓p10) was 
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necessary for caspase-1-dependent cytokine processing in CARD-containing 
inflammasomes (e.g. NLRC4). On the basis of this observation, it was proposed CARD-
containing inflammasome scaffolds can form two distinct caspase-1-activing platforms in 
macrophages, one that does not contain ASC and one that does, and these mediate 
pyroptosis or cytokine processing, respectively (8). However, an inability of neutrophils to 
form the death-inducing inflammasome complex cannot explain why neutrophils do not 
undergo pyroptosis, as similar observations were made for the NLRP3 inflammasome that 
is believed to support cytokine processing and cell death from a single complex. It is 
possible, however, that the caspase-1 species that triggers macrophage lysis is not 
generated in stimulated neutrophils, for example, due to differences in ASC speck 
structure in neutrophils. 
 
The surprising lack of inflammasome/caspase-8-dependent apoptosis in neutrophils was 
likely due to inefficient caspase-8 processing. High expression of the caspase-8 inhibitor, 
c-FLIPL or c-FLIPs, in neutrophils compared to macrophages may provide a simple 
explanation for why caspase-8 was not processed in neutrophils. Another possible 
explanation is that the physical properties of ASC polymers may be different in neutrophils 
as compared macrophages, and this influences the ability of inflammasome-recruited pro-
caspase-8 (or indeed pro-caspase-1) to self-process. Whilst NLRP3 activation triggered 
rapid redistribution of soluble ASC into a single large ASC focus in macrophages, ASC 
polymerisation in neutrophils appeared delayed and less efficient. Importantly, NLRP3 was 
reported to trigger multiple ASC clusters in neutrophils (257), while ASC collapses into a 
single focus in macrophages. Coupled with the fact that neutrophils express approximately 
18-fold less ASC on a per cell basis (Chapter 5), this raises the likelihood that ASC foci 
are smaller in neutrophils relative to macrophages, and so likely possess different physical 
characteristics. This may influence the ability of neutrophil ASC foci to provide binding 
sites with optimal orientation for caspase-8 clustering and allosteric activation.  
 
Interestingly, neutrophils also appear to be protected from LPS-mediated necroptosis, 
possibly as a mechanism to sustain neutrophil viability for antimicrobial defence. Our 
preliminary data suggest that altered or deficient TLR4 signalling via the TRIF-dependent 
pathway may allow neutrophils to avoid LPS-mediated necroptosis. If this is the case, it 
indicates that the advantages conferred to the host immune response by resisting 
neutrophil cell death outweigh the possible benefits of neutrophil production of TRIF-
dependent cytokines (e.g. type I IFN). Interestingly, neutrophils appear to express high 
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levels of specific interferon-inducible genes, such as pro-caspase-11, under homeostatic 
conditions; this suggests that perhaps these cells have evolved mechanisms independent 
of autocrine type I IFN signalling to upregulate key host defence genes. The interferon-
inducible guanylate-binding proteins (GBPs) are other important players in the caspase-11 
pathway. In macrophages, GBPs mediate the lysis of the pathogen-containing vacuole 
(PCV), exposing bacteria to the cytosol for recognition by caspase-11 (80). It will be of 
great interest in future investigations to examine whether exposure of phagosomal bacteria 
into the cytoplasm similarly requires GBP functions in neutrophils. 
 
Bacterial infection induces a form of cell death in neutrophils called ‘NETosis’ (178). 
Neutrophils undergoing NETosis release various cellular contents, including DNA, 
histones, proteases and antimicrobial peptides. These molecules form a web to entrap 
extracellular pathogens and are collectively termed ‘Neutrophil Extracellular Traps’ (NETs).  
A single study demonstrated that cells undergoing NETosis remain viable up to 24 h (337) 
and others suggested that neutrophils undergoing NETosis retain their ability to migrate 
and phagocytose pathogens (338), and that the process of NETosis does not release 
intracellular LDH (178, 339). Interestingly, many processes that trigger inflammasome 
function also are also inducers of NETosis, such as TLR engagement, induction of ionic 
efflux and ROS production (178, 337). Therefore, the lack of inflammasome activation by 
insoluble and particulate NLRP3 agonists may be a consequence of neutrophils 
undergoing NETosis. In fact, a single study suggested that MSU-induced NETosis serves 
an important mechanism to supress inflammation by entrapping and digesting cytokines 
and chemokines (340). The calcium-dependent enzyme, protein arginine deiminase 4 
(PAD4), is a key regulator of NETosis (341). Interestingly, PAD4 contains a putative 
caspase-1 cleavage site (personal communication with Dr Dave Boucher), suggesting a 
possible mechanism where by caspase-1 activation might actually suppresses NETosis 
via PAD4 proteolytic inactivation. 
 
Alternatively, it is possible that inflammasome-dependent IL-1β  triggers NET formation at 
a site of infection as an additional antimicrobial defence strategy to classic neutrophil 
functions. IL-1β signalling enhances NETosis (93) and patients with Familial 
Mediterranean Fever often release IL-1β-decorated NETs during disease attacks (342). 
Interestingly, NETs were recently shown to serve as an endogenous danger signal that 
primes the expression of NLRP3 and pro-IL-1β in macrophages during atherosclerosis 
(343). Increasing studies are now suggesting that neutrophils are a heterogeneous 
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population and various subtypes exist in vivo (344). It may be possible that specific 
neutrophil subsets avoid cell death to sustain viability during infection, while others 
undergo NETosis to entrap pathogens that are too large to be engulfed (345), or to signal 
to other immune cells such as macrophages. Collectively, these data suggest the 
possibility that in some circumstances, inflammasome-dependent IL-1β may trigger 
neutrophil recruitment, classic neutrophil antimicrobial functions, but also NET release. In 
these settings, NETs would serve as an additive antimicrobial mechanism, and also as an 
inflammasome-priming signal for newly recruited monoctyes and macrophages. 
 
An emerging concept from this thesis is that pattern recognition receptor signalling 
pathways are not always conserved between cell types, including between closely-related 
subsets of the myeloid lineage. We propose that cell type-specific specialisation of 
inflammatory signalling pathways allows the immune system to tailor an in vivo response 
so that it is appropriate to each stimulus. In support of this, neutrophil inflammasome 
signalling and the ensuing amplification loop of neutrophil recruitment and activation was 
only triggered under scenarios where neutrophil-mediated clean up are important (infection 
and tissue injury; Salmonella, LPS, nigericin, ATP), while exposure to metabolic stress 
signals (MSU), or irritants (alum, silica) did not trigger neutrophil inflammasome function. 
This indicates that neutrophils are unlikely to be a source of pathogenic IL-1β during 
inflammatory diseases such as silicosis and gout, but may contribute via sustained IL-1β 
production to pathology in inherited diseases such as those driven by gain-of-function 
mutations in NLRP3 (128) or NLRC4 (134-136), or heritable diseases of NLRP12 
dysfunction (129). Another scenario where neutrophil inflammasome function may be 
pathogenic is during endotoxic shock, a condition that is often accompanied by 
neutrophilia (301). This thesis reported that neutrophil LPS transfection triggered caspase-
11-dependent IL-1β secretion without concomitant cell death in vitro, and in vivo neutrophil 
depletion was protective for caspase-11-driven endotoxic shock. Interestingly, neutrophil 
depletion was recently proposed as a possible treatment for human septic shock (346). 
Further experiments will be required to establish whether the protective effect of neutrophil 
depletion on LPS-induced lethality occurred as a direct consequence of blocking cell-
autonomous neutrophil caspase-11 signalling in mice. 
 
Two recent studies demonstrated that ASC polymers released during macrophage 
pyroptosis further propagate inflammation by triggering inflammasome activation in 
neighbouring cells. These studies showed that phagocytosis of extracellular ASC polymers 
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triggered lysosomal rupture and NLRP3-independent ASC polymerisation and caspase-1 
activation in recipient macrophages (347, 348). It is unclear how such processes will be 
halted in vivo, if engulfment of extracellular ASC polymers is always destined to trigger 
inflammasome signalling in a recipient cell, leading to release of further ASC polymers into 
the extracellular space, in a vicious inflammatory cycle. This thesis demonstrated that in 
neutrophils (1) ASC polymerisation occurs relatively slowly, (2) caspase-1 does not trigger 
pyroptosis, and (2) the lysosomal rupture pathway is a poor stimulus for NLRP3 activation; 
in all, this presents neutrophils as possible cellular candidates for suppressing 
inflammation driven by extracellular ASC polymers. However, it is unclear at present 
whether neutrophils are able to digest these protein aggregates. Future experiments will 
examine whether extracellular ASC polymers trigger caspase-1 activation and IL-1β 
release in neutrophils, and if indeed ASC polymers do not trigger neutrophil caspase-1 
activation, ASC-deficient neutrophils will be exposed to purified ASC polymers to reveal 
whether neutrophils can degrade exogenous ASC, by western blotting and microscopy. 
 
IL-1β, -18 and -37 are unusual cytokines that lack signal peptides and are secreted in an 
unconventional, ER/Golgi-independent manner (349). As inflammasome activation in 
macrophages elicits near-concurrent secretion of mature IL-1β and cell lysis, it is often 
proposed that inflammasome-dependent cytokines are passively released during 
pyroptotic cell death (253, 350). The discovery that caspase-1 activation downstream of 
NLRC4, NLRP3, AIM2 and caspase-11 in neutrophils selectively triggers cytokine 
maturation but not pyroptotic death refutes this possibility, and unequivocally confirms that 
cytokine secretion and pyroptotic cell death can be uncoupled. In line with this, 
ripoptosome-dependent release of caspase-8-processed IL-1β occurs before the loss of 
membrane integrity (74), indicating that cell lysis is not required for unconventional 
cytokine export.  
 
In summary, this thesis demonstrates that neutrophils exhibit specialised inflammasome 
signalling pathways, and these signalling modifications are likely to allow sculpting of the 
resultant immune response in vivo. Interestingly, neutrophils only produced 
inflammasome-dependent IL-1β after exposure to stimuli that mimic infection or injury, and 
this provided a feed-forward loop of neutrophil recruitment and activation; this is likely to 
represent a mechanism by which specific inflammasome agonists can elicit a neutrophil-
dominated response. Neutrophils appear to be resistant to multiple forms of microbe-
induced cell death, and IL-1β provides a neutrophil survival signal (96). Such mechanisms 
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likely provide these cells with sufficient time to perform their important phagocytic and/or 
antimicrobial functions at a site of injury or infection, after which neutrophil pro-survival 
factors decline, and the recruited neutrophils can undergo their underlying apoptotic 
program during the resolution phase of inflammation. However, prolonged neutrophil 
presence and inflammatory function may also drive pathologies such as endotoxin shock. 
So detailed knowledge of neutrophil inflammatory responses and cell death pathways are 
required in order to better understand neutrophil-driven inflammatory disease, and will be a 
focus of future investigations. The findings presented in this thesis add to an emerging 
literature that documents the important immuno-modulatory functions of neutrophils during 
infection and inflammation, and also emphasises the importance of cell identity in tailoring 
an appropriate immune response. 
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